About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
2462 genotypes with 4512 annotations displayed of selected term and subterms
Searched Term: adipose tissue phenotype
Allelic Composition
(Genetic Background)		 Annotated Term Reference
1700008P02Rikem1(IMPC)J/1700008P02Rikem1(IMPC)J
(C57BL/6NJ-1700008P02Rikem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp) 		increased total body fat amount J:211773
2300002M23Riktm1Lex/2300002M23Riktm1Lex
(B6;129S5-2300002M23Riktm1Lex/Mmucd) 		decreased total body fat amount J:171883
4921536K21Riktm1a(KOMP)Wtsi/4921536K21Riktm1a(KOMP)Wtsi
(C57BL/6N-4921536K21Riktm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
4930447C04Rikem1(IMPC)Bay/4930447C04Rikem1(IMPC)Bay
(C57BL/6N-4930447C04Rikem1(IMPC)Bay/BayMmucd) 		increased total body fat amount J:211773
4930591A17Riktm1a(KOMP)Wtsi/4930591A17Riktm1a(KOMP)Wtsi
(C57BL/6N-4930591A17Riktm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased gonadal fat pad weight J:168271
A430005L14Riktm1a(KOMP)Wtsi/A430005L14Riktm1a(KOMP)Wtsi
(C57BL/6N-A430005L14Riktm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ay/a
(involves: KK) 		increased total body fat amount J:26460
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		adipose tissue phenotype J:168271
Ay/A
(involves: C57BL/6) 		increased brown adipose tissue amount J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased percent body fat/body weight J:131039
increased retroperitoneal fat pad weight J:131039
Ay/A
Prkar2btm2Gsm/Prkar2b+
(involves: C57BL/6) 		increased percent body fat/body weight J:131039
Ay/A
Prkar2btm2Gsm/Prkar2btm2Gsm
(involves: C57BL/6) 		increased brown adipose tissue amount J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased percent body fat/body weight J:131039
increased retroperitoneal fat pad weight J:131039
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6) 		decreased white adipose tissue amount J:96865
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J) 		decreased total body fat amount J:211773
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6) 		abnormal brown adipose tissue morphology J:122438
abnormal fat cell morphology J:122438
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased fat cell size J:192806
decreased white adipose tissue amount J:192806
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased fat cell size J:192806
decreased white adipose tissue amount J:192806
Abfp4DBA/2/Abfp4DU6i
Abfp5DU6i/Abfp5DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:101006
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		abnormal adipose tissue morphology J:234876
browned white adipose tissue morphology J:234876
decreased body fat mass J:234876
decreased brown fat cell size J:234876
decreased white fat cell size J:234876
increased adipocyte glucose uptake J:234876
Abhd8tm1b(EUCOMM)Wtsi/Abhd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Abhd8tm1b(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6) 		decreased abdominal fat pad weight J:294591
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(C57BL/6N-Abhd16atm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified) 		decreased subcutaneous adipose tissue amount J:68427
decreased total body fat amount J:68427
Acad8m1Ytc/Acad8m1Ytc
(involves: C57BL/6) 		decreased brown fat cell lipid droplet size J:222356
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6) 		abnormal adipose tissue morphology J:102010
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6) 		abnormal brown adipose tissue morphology J:106714
abnormal brown adipose tissue physiology J:106714
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ace2em1(IMPC)Ccpcz/Ace2em1(IMPC)Ccpcz
(C57BL/6NCrl-Ace2em1(IMPC)Ccpcz/Ccpcz) 		increased total body fat amount J:211773
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal epididymal fat pad morphology J:128859
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal epididymal fat pad morphology J:128859
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi) 		decreased brown adipose tissue mass J:235775
decreased brown fat cell lipid droplet size J:235775
decreased epididymal fat pad weight J:235775
decreased inguinal fat pad weight J:235775
increased epididymal fat pad weight J:235775
Achetm1.1Hssh/Achetm1.1Hssh
(involves: 129S4/SvJae * C57BL/6) 		adipose tissue phenotype J:140622
decreased white adipose tissue amount J:140622
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		increased gonadal fat pad weight J:203753
increased inguinal fat pad weight J:203753
increased total body fat amount J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal brown adipose tissue morphology J:182660
abnormal brown adipose tissue physiology J:182660
abnormal brown adipose tissue thermogenesis J:182660
abnormal brown fat cell morphology J:182660
decreased brown fat cell lipid droplet size J:182660
increased adipocyte glucose uptake J:182660
increased brown adipose tissue amount J:182660
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6) 		decreased epididymal fat pad weight J:183258
decreased white adipose tissue amount J:183258
Acot13tm1Deco/Acot13tm1Deco
(Not Specified) 		decreased brown fat cell lipid droplet size J:204997
Acox1em1Wum/Acox1em1Wum
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		adipose tissue phenotype J:270463
Acsl1tm1Rcol/Acsl1tm1Rcol
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		adipose tissue phenotype J:155714
Acsl1tm1Rcol/Acsl1tm1Rcol
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased body fat mass J:162996
increased epididymal fat pad weight J:162996
increased gonadal fat pad weight J:162996
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss) 		decreased brown adipose tissue amount J:78070
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J) 		decreased epididymal fat pad weight J:160212
Acvr1ctm1b(EUCOMM)Hmgu/Acvr1ctm1b(EUCOMM)Hmgu
(B6N(Cg)-Acvr1ctm1b(EUCOMM)Hmgu/J) 		decreased total body fat amount J:211773
Ad/Ad
(involves: Chr 7 marker stock * Wild stock) 		increased abdominal adipose tissue amount J:6095
increased fat cell size J:6095
increased total body fat amount J:6095
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock) 		abnormal abdominal fat pad morphology J:6095
increased fat cell size J:6095
increased total body fat amount J:6095
increased white adipose tissue amount J:6095
Adam12tm1Asf/Adam12tm1Asf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased brown adipose tissue amount J:81009
Adam32tm1b(KOMP)Wtsi/Adam32tm1b(KOMP)Wtsi
(B6N(Cg)-Adam32tm1b(KOMP)Wtsi/2J) 		increased total body fat amount J:211773
Adamts1tm1Hku/Adamts1tm1Hku
(involves: 129S6/SvEvTac * C57BL/6) 		decreased total body fat amount J:62260
Adamts16em1(IMPC)H/Adamts16em1(IMPC)H
(C57BL/6N-Adamts16em1(IMPC)H/H) 		increased total body fat amount J:211773
Adamts17tm1.2Taks/Adamts17tm1.2Taks
(involves: C57BL * C57BL/6 * DBA) 		decreased subcutaneous adipose tissue amount J:295274
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg) 		abnormal adipose tissue amount J:280282
Adcy3Jll/Adcy3+
(C57BL/6J-Adcy3Jll) 		decreased brown fat cell size J:223554
decreased percent body fat/body weight J:223554
decreased total body fat amount J:223554
decreased white fat cell size J:223554
Adcy3Jll/Adcy3+
(involves: 129S1/SvImJ * C57BL/6J) 		decreased percent body fat/body weight J:223554
decreased total body fat amount J:223554
Adcy3Jll/Adcy3Jll
(involves: 129S1/SvImJ * C57BL/6J) 		decreased total body fat amount J:223554
Adcy3tm1a(EUCOMM)Wtsi/Adcy3+
(C57BL/6N-Adcy3tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6)) 		decreased white adipose tissue amount J:71968
Adgra1tm1.1Zgwg/Adgra1tm1.1Zgwg
(Not Specified) 		decreased brown adipose tissue amount J:329982
decreased brown fat cell lipid droplet size J:329982
decreased total body fat amount J:329982
decreased white adipose tissue amount J:329982
decreased white fat cell size J:329982
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg) 		abnormal adipose tissue development J:304292
abnormal white adipose tissue physiology J:304292
adipose tissue phenotype J:304292
decreased epididymal fat pad weight J:304292
decreased inguinal fat pad weight J:304292
decreased mesenteric fat pad weight J:304292
decreased retroperitoneal fat pad weight J:304292
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
Lepob/Lepob
(B6.Cg-Adigtm1.1(KOMP)Vlcg Lepob) 		decreased body fat mass J:304292
Adip1LG/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1) 		increased gonadal fat pad weight J:153477
increased inguinal fat pad weight J:153477
increased mesenteric fat pad weight J:153477
increased renal fat pad weight J:153477
increased total fat pad weight J:153477
Adip1LG/J/Adip1LG/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip2LG/J/Adip2LG/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip3LG/J/Adip3LG/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip3LG/J/Adip3SM/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip4LG/J/Adip4LG/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip5LG/J/Adip5LG/J
(involves: LG/J * SM/J) 		decreased white adipose tissue amount J:62610
Adip5LG/J/Adip5SM/J
(involves: LG/J * SM/J) 		decreased white adipose tissue amount J:62610
Adip6LG/J/Adip6LG/J
(involves: LG/J * SM/J) 		decreased total body fat amount J:62610
Adip7LG/J/?
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip8LG/J/Adip8LG/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip8LG/J/Adip8SM/J
(involves: LG/J * SM/J) 		increased white adipose tissue amount J:62610
Adip9129P3/J/Adip9C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ) 		increased white adipose tissue amount J:83139
Adip9C57BL/6ByJ/Adip9C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ) 		increased white adipose tissue amount J:83139
Adip10NZB/BlNJ/Adip10SM/J
(involves: NZB/BlNJ * SM/J) 		increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip10SM/J/Adip10SM/J
(involves: NZB/BlNJ * SM/J) 		increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip11NZB/BlNJ/Adip11SM/J
(involves: NZB/BlNJ * SM/J) 		increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip11SM/J/Adip11SM/J
(involves: NZB/BlNJ * SM/J) 		increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip12NZB/BlNJ/Adip12SM/J
(involves: NZB/BlNJ * SM/J) 		increased mesenteric fat pad weight J:103841
Adip12SM/J/Adip12SM/J
(involves: NZB/BlNJ * SM/J) 		increased mesenteric fat pad weight J:103841
Adip13NZB/BlNJ/Adip13NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
Adip13NZB/BlNJ/Adip13SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
Adip14NZB/BlNJ/Adip14SM/J
(involves: NZB/BlNJ * SM/J) 		increased retroperitoneal fat pad weight J:103841
Adip15NZB/BlNJ/Adip15SM/J
(involves: NZB/BlNJ * SM/J) 		increased mesenteric fat pad weight J:103841
Adip16NZB/BlNJ/Adip16SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip16SM/J/Adip16SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip17NZB/BlNJ/Adip17SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip17SM/J/Adip17SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip18NZB/BlNJ/Adip18NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip18NZB/BlNJ/Adip18SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip20129P3/J/Adip20129P3/J
(involves: 129P3/J * C57BL/6ByJ) 		abnormal fat pad morphology J:116127
increased gonadal fat pad weight J:116127
increased retroperitoneal fat pad weight J:116127
increased white adipose tissue amount J:83139
Adip20129P3/J/Adip20129P3/J
Adip9C57BL/6ByJ/Adip9C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ) 		increased white adipose tissue amount J:83139
Adip20129P3/J/Adip20C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ) 		abnormal fat pad morphology J:116127
increased gonadal fat pad weight J:116127
increased retroperitoneal fat pad weight J:116127
increased white adipose tissue amount J:83139
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J) 		increased percent body fat/body weight J:111346
increased total body fat amount J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased percent body fat/body weight J:111346
decreased total body fat amount J:111346
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal abdominal fat pad morphology J:199264
abnormal white adipose tissue morphology J:199264
decreased total fat pad weight J:199264
Adipoqtm1Ish/Adipoqtm1Ish
Dbhtm1Rpa/Dbh+
(involves: 129S7/SvEvBrd * C57BL/6J) 		adipose tissue phenotype J:199264
Adipoqtm1Ish/Adipoqtm1Ish
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased total fat pad weight J:199264
Adipoqtm1Pesch/Adipoqtm1Pesch
(B6.129S7-Adipoqtm1Pesch) 		abnormal inguinal fat pad morphology J:210480
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc) 		increased brown adipose tissue amount J:122027
increased percent body fat/body weight J:122027
increased white adipose tissue amount J:122027
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen) 		abnormal abdominal fat pad morphology J:122027
abnormal brown fat cell morphology J:122027
decreased brown adipose tissue mass J:122027
decreased fat cell size J:122027
decreased gonadal fat pad weight J:122027
decreased percent body fat/body weight J:122027
decreased renal fat pad weight J:122027
Adissptm1c(EUCOMM)Hmgu/Adissptm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		abnormal adipose tissue physiology J:332979
abnormal beige fat cell physiology J:332979
abnormal fat cell morphology J:332979
abnormal white adipose tissue morphology J:332979
decreased adipocyte glucose uptake J:332979
increased white adipose tissue mass J:332979
increased white fat cell size J:332979
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H) 		increased total body fat amount J:211773
Adpgktm2a(EUCOMM)Wtsi/Adpgktm2a(EUCOMM)Wtsi
(C57BL/6N-Adpgktm2a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Adprsem1(IMPC)Wtsi/Adprsem1(IMPC)Wtsi
(C57BL/6N-Adprsem1(IMPC)Wtsi/WtsiIeg) 		decreased total body fat amount J:211773
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J) 		increased percent body fat/body weight J:87718
Adrb1tm1Bkk/Adrb1tm1Bkk
Adrb2tm1Bkk/Adrb2tm1Bkk
Adrb3tm1Lowl/Adrb3tm1Lowl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N) 		abnormal brown adipose tissue morphology J:79309
increased brown fat cell size J:79309
increased interscapular fat pad weight J:79309
increased total body fat amount J:79309
Adrb2tm1Bkk/Adrb2tm1Bkk
(FVB.129-Adrb2tm1Bkk) 		abnormal epididymal fat pad morphology J:55552
Adrb3tm1Jpg/Adrb3tm1Jpg
(involves: 129S4/SvJae * C57BL/6J) 		increased percent body fat/body weight J:42702
increased total body fat amount J:42702
Adrb3tm1Lowl/Adrb3tm1Lowl
(FVB/N-Adrb3tm1Lowl) 		increased parametrial fat pad weight J:30060
increased total body fat amount J:30060
Adrm1Gt(OST128063)Lex/Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal abdominal fat pad morphology J:166694
increased total body fat amount J:166694
Aebp1tm1Hsro/Aebp1+
(involves: 129S4/SvJae * C57BL/6J) 		decreased total body fat amount J:125333
Aebp1tm1Hsro/Aebp1tm1Hsro
(involves: 129S4/SvJae * C57BL/6J) 		abnormal fat cell morphology J:125333
abnormal white adipose tissue morphology J:125333
decreased total body fat amount J:125333
decreased white adipose tissue amount J:125333
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Afg3l1tm1.1Arte/Afg3l1tm1.1Arte
Afg3l2tm1Arte/Afg3l2tm1Arte
Tg(Plp1-cre/ERT)3Pop/0
(involves: C57BL/6J * C57BL/6N) 		decreased body fat mass J:237410
Afpq9DBA/2/Afpq9DU6i
(involves: DBA/2J * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afpq9DU6i/Afpq9DU6i
(involves: DBA/2J * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afpq11DBA/2/Afpq11DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afpq11DU6i/Afpq11DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw1DU6/Afw1DU6
(involves: DU6 * DUKs) 		abnormal abdominal fat pad morphology J:49578
Afw2DU6/Afw2DU6
(involves: DU6 * DUKs) 		abnormal abdominal fat pad morphology J:49578
Afw3DU6/Afw3DU6
(involves: DU6 * DUKs) 		abnormal abdominal fat pad morphology J:49578
Afw5DU6/Afw5DU6
(involves: DU6 * DUKs) 		abnormal abdominal fat pad morphology J:49578
Afw9DU6i/?
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw12DBA/2/Afw12DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw12DU6i/Afw12DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw13PWK/Afw13PWK
(involves: C57BL/6 * PWK) 		abnormal abdominal fat pad morphology J:152067
Afw14DBA/2/Afw14DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw14DU6i/Afw14DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw15DU6i/?
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw16C57BL/6/Afw16C57BL/6
(involves: C57BL/6 * PWK) 		abnormal abdominal fat pad morphology J:152067
Afw17DBA/2/Afw17DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw18DBA/2/Afw18DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw18DU6i/Afw18DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw19DBA/2/Afw19DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Afw19DU6i/Afw19DU6i
(involves: DBA/2 * DU6i) 		abnormal abdominal fat pad morphology J:66233
Agbl1em1(IMPC)J/Agbl1em1(IMPC)J
(C57BL/6NJ-Agbl1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H) 		decreased total body fat amount J:211773
Agmotm2a(EUCOMM)Wtsi/Agmotm2a(EUCOMM)Wtsi
(involves: C57BL/6N) 		adipose tissue phenotype J:308367
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal epididymal fat pad morphology J:250301
decreased percent body fat/body weight J:250301
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal brown adipose tissue morphology J:186035
abnormal white fat cell morphology J:186035
adipose tissue necrosis J:186035
brown adipose tissue inflammation J:186035
decreased brown adipose tissue amount J:186035
decreased white adipose tissue amount J:186035
decreased white fat cell number J:186035
decreased white fat cell size J:186035
lipodystrophy J:186035
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		abnormal abdominal fat pad morphology J:146649
absent subcutaneous adipose tissue J:146649
decreased brown adipose tissue amount J:146649
decreased percent body fat/body weight J:146649
decreased total body fat amount J:146649
decreased white adipose tissue amount J:146649
Agpat4tm1b(KOMP)Wtsi/Agpat4tm1b(KOMP)Wtsi
(C57BL/6N-Agpat4tm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Agr2tm1.1Lex/Agr2tm1.1Lex
(involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6) 		decreased total fat pad weight J:195573
Agrptm1(cre)Lowl/Agrp+
Slc32a1tm1Lowl/Slc32a1tm1Lowl
(involves: 129S6/SvEvTac * C57BL/6) 		decreased total body fat amount J:140858
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:199803
Agrptm1Mws/Agrptm1Mws
(B6.129S1-Agrptm1Mws) 		decreased total body fat amount J:117539
Agttm1.1Itl/Agttm1.1Itl
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL) 		adipose tissue phenotype J:178836
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA * ICR) 		decreased epididymal fat pad weight J:73163
decreased fat cell size J:73163
decreased total body fat amount J:73163
Agtr1atm1.1Uky/Agtr1atm1.1Uky
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6 * C57BL/6N * SJL) 		abnormal adipose tissue development J:192945
adipose tissue phenotype J:192945
decreased white fat cell number J:192945
increased white fat cell size J:192945
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd) 		abnormal epididymal fat pad morphology J:105210
decreased white fat cell size J:105210
increased white fat cell number J:105210
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N) 		abnormal white adipose tissue morphology J:263253
increased epididymal fat pad weight J:263253
increased fat cell size J:263253
Ahnaktm1Ysb/Ahnaktm1Ysb
(involves: 129S4/SvJae) 		decreased total body fat amount J:167048
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N) 		increased gonadal fat pad weight J:262001
increased inguinal fat pad weight J:262001
increased white adipose tissue amount J:262001
increased white fat cell size J:262001
Akap9tm1a(KOMP)Wtsi/Akap9+
(B6JTyr;B6N-Akap9tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N) 		decreased percent body fat/body weight J:213427
decreased total body fat amount J:213427
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129) 		abnormal white adipose tissue physiology J:208505
increased gonadal fat pad weight J:208505
increased inguinal fat pad weight J:208505
increased white adipose tissue amount J:208505
increased white fat cell size J:208505
Akt1tm1Mbb/Akt1tm1Mbb
(B6.129P2-Akt1tm1Mbb) 		decreased percent body fat/body weight J:182721
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		decreased percent body fat/body weight J:149156
decreased white adipose tissue amount J:149156
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		decreased percent body fat/body weight J:182721
decreased total body fat amount J:182721
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6) 		decreased adipocyte glucose uptake J:71491
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg) 		decreased brown adipose tissue mass J:84606
decreased white adipose tissue mass J:84606
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
(C57BL/6N-Aktiptm1a(EUCOMM)Hmgu) 		decreased subcutaneous adipose tissue amount J:276210
decreased total body fat amount J:276210
Aldh18a1tm1a(KOMP)Wtsi/Aldh18a1+
(C57BL/6N-Aldh18a1tm1a(KOMP)Wtsi/Wtsi) 		abnormal hypodermis fat layer morphology J:232539
Alg8em1(IMPC)J/Alg8+
(C57BL/6NJ-Alg8em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Alg9em1(IMPC)J/Alg9+
(C57BL/6NJ-Alg9em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Alg13tm1a(KOMP)Wtsi/Alg13tm1a(KOMP)Wtsi
(C57BL/6N-Alg13tm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J) 		increased abdominal fat pad weight J:198968
increased body fat mass J:198968
increased fat cell size J:198968
increased percent body fat/body weight J:198968
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased white adipose tissue amount J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD) 		increased fat cell size J:118221
increased total body fat amount J:118221
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J) 		increased total fat pad weight J:104825
Alpk2em1(IMPC)J/Alpk2em1(IMPC)J
(C57BL/6NJ-Alpk2em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J)) 		decreased total body fat amount J:39015
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ) 		decreased total body fat amount J:90370
Amer1tm1.1Nbar/Y
Tg(Prrx1-cre)1Cjt/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		abnormal fat cell differentiation J:173242
abnormal fat cell morphology J:173242
Amer1tm1.2Nbar/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL) 		decreased brown adipose tissue amount J:173242
decreased total body fat amount J:173242
decreased white adipose tissue amount J:173242
Anapc7em1(IMPC)J/Anapc7em1(IMPC)J
(C57BL/6NJ-Anapc7em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo) 		decreased subcutaneous adipose tissue amount J:152387
decreased total body fat amount J:152387
Angptl3hypl/Angptl3hypl
(involves: KK/Snk) 		decreased gonadal fat pad weight J:75358
Angptl3tm1Akos/Angptl3tm1Akos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		adipose tissue phenotype J:103363
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj) 		decreased epididymal fat pad weight J:107479
Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:103363
Angptl4tm1Jig/Angptl4+
(involves: 129/Sv * C57BL/6) 		decreased total body fat amount J:93455
Angptl4tm1Jig/Angptl4tm1Jig
(involves: 129/Sv * C57BL/6) 		abnormal adipose tissue physiology J:93455
decreased total body fat amount J:93455
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal white adipose tissue morphology J:97552
increased total body fat amount J:97552
Angptl8tm1(KOMP)Vlcg/Angptl8tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased percent body fat/body weight J:217262
decreased total body fat amount J:217262
Ank2tm1Bnt/Ank2+
(involves: 129) 		abnormal fat cell differentiation J:222913
decreased adipocyte glucose uptake J:222913
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J) 		abnormal fat cell differentiation J:222913
increased adipocyte glucose uptake J:222913
increased epididymal fat pad weight J:222913
increased fat cell size J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J) 		abnormal fat cell differentiation J:222913
decreased adipocyte glucose uptake J:222913
increased adipocyte glucose uptake J:222913
increased epididymal fat pad weight J:222913
increased fat cell size J:222913
increased total body fat amount J:222913
Ankrd9tm1(KOMP)Wtsi/Ankrd9tm1(KOMP)Wtsi
(C57BL/6N-Ankrd9tm1(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ankrd10tm2b(EUCOMM)Hmgu/Ankrd10+
(C57BL/6N-Ankrd10tm2b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased brown adipose tissue amount J:130984
increased fat cell size J:130984
increased white adipose tissue amount J:130984
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified) 		abnormal adipose tissue morphology J:115806
abnormal adipose tissue physiology J:115806
abnormal fat pad morphology J:115806
Ap1g1tm1b(EUCOMM)Hmgu/Ap1g1+
(B6N(Cg)-Ap1g1tm1b(EUCOMM)Hmgu/J) 		increased total body fat amount J:211773
Ap1s2tm1Pschu/Y
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adipose tissue development J:216244
abnormal fat cell differentiation J:216244
abnormal interscapular fat pad morphology J:216244
decreased epididymal fat pad weight J:216244
decreased subcutaneous adipose tissue amount J:216244
decreased total body fat amount J:216244
lipodystrophy J:216244
Ap1s2tm1Pschu/Ap1s2tm1Pschu
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adipose tissue development J:216244
abnormal fat cell differentiation J:216244
abnormal interscapular fat pad morphology J:216244
decreased subcutaneous adipose tissue amount J:216244
decreased total body fat amount J:216244
lipodystrophy J:216244
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/J) 		decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Orl) 		decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/MbpMmucd) 		decreased total body fat amount J:211773
ApcMin/Apc+
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		adipose tissue phenotype J:130429
Apmapem1(IMPC)J/Apmapem1(IMPC)J
(C57BL/6NJ-Apmapem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs) 		abnormal white adipose tissue morphology J:247647
abnormal white adipose tissue physiology J:247647
decreased brown adipose tissue mass J:247647
decreased white adipose tissue mass J:247647
decreased white fat cell size J:247647
increased white fat cell number J:247647
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J) 		increased white adipose tissue amount J:105136
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev) 		decreased epididymal fat pad weight J:219838
decreased white fat cell lipid droplet size J:219838
decreased white fat cell size J:219838
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		decreased brown adipose tissue mass J:60585
decreased epididymal fat pad weight J:60585
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		abnormal gonadal fat pad morphology J:184647
increased fat cell size J:184647
Apoetm1Unc/Apoetm1Unc
Gofm1C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm2C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm2C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm3C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm4C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		abnormal gonadal fat pad morphology J:115779
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal epididymal fat pad morphology J:151284
abnormal fat cell morphology J:151284
Apol6em1Hsul/Apol6em1Hsul
(Not Specified) 		abnormal fat cell differentiation J:344362
decreased body fat mass J:344362
decreased epididymal fat pad weight J:344362
decreased renal fat pad weight J:344362
decreased white adipose tissue mass J:344362
decreased white fat cell size J:344362
Appl1Gt(RRS819)Byg/Appl1Gt(RRS819)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal brown adipose tissue physiology J:211794
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H) 		decreased total body fat amount J:211773
Aqp7tm1Ask/Aqp7tm1Ask
(involves: CD-1) 		abnormal white adipose tissue physiology J:98734
increased fat cell size J:98734
increased gonadal fat pad weight J:98734
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		adipose tissue phenotype J:125011
Artm1(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J) 		increased percent body fat/body weight J:108849
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal fat cell morphology J:98775, J:81789
increased gonadal fat pad weight J:98775
increased renal fat pad weight J:98775
increased white adipose tissue amount J:98775
Artm1Ska/Y
Tg(CMV-cre)1Ipc/?
(involves: C57BL/6 * CBA) 		increased white adipose tissue amount J:85484
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal adipose tissue amount J:196857
decreased gonadal fat pad weight J:196857
increased brown adipose tissue amount J:196857
increased interscapular fat pad weight J:196857
increased mesenteric fat pad weight J:196857
increased omental fat pad weight J:196857
Artm3(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J) 		increased percent body fat/body weight J:108849
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong) 		adipose tissue phenotype J:216529
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6) 		absent subcutaneous adipose tissue J:119516
Arhgap5tm1Jset/Arhgap5tm1Jset
(involves: 129S2/SvPas * C57BL/6J) 		abnormal adipose tissue physiology J:83120
decreased subcutaneous adipose tissue amount J:83120
Arhgap21em1(IMPC)J/Arhgap21+
(C57BL/6NJ-Arhgap21em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Arhgef11tm1.1Mak/Arhgef11tm1.1Mak
(B6.129P2(C)-Arhgef11tm1.1Mak) 		abnormal white adipose tissue physiology J:233950
abnormal white fat cell differentation J:233950
decreased percent body fat/body weight J:233950
decreased white adipose tissue mass J:233950
decreased white fat cell number J:233950
Arid4btm1b(EUCOMM)Wtsi/Arid4b+
(C57BL/6N-Arid4btm1b(EUCOMM)Wtsi/Bay) 		decreased total body fat amount J:211773
Arid5btm1Whit/Arid5b+
(involves: 129S1/Sv * C57BL/6J) 		decreased percent body fat/body weight J:130390
decreased white adipose tissue amount J:130390
Arid5btm1Whit/Arid5btm1Whit
(involves: 129S1/Sv * C57BL/6J) 		abnormal adipose tissue morphology J:130390
decreased brown adipose tissue amount J:130390
decreased brown fat lipid droplet number J:130390
decreased percent body fat/body weight J:130390
decreased white adipose tissue amount J:130390
Arid5btm1Whit/Arid5btm1Whit
(involves: 129S1/Sv) 		abnormal fat cell morphology J:130274
Ark2nem1Wehi/Ark2nem1Wehi
(C57BL/6J-8030462N17Rikem1Wehi) 		increased total body fat amount J:330717
increased white adipose tissue mass J:330717
Arl4atm1Asch/Arl4atm1Asch
(involves: C57BL/6J) 		adipose tissue phenotype J:75778
Arl6tm2Vcs/Arl6tm2Vcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased percent body fat/body weight J:180524
Arl10tm1.1(KOMP)Vlcg/Arl10tm1.1(KOMP)Vlcg
(C57BL/6N-Arl10tm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Armcx3tm1.1Eso/Y
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		decreased total body fat amount J:345411
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr) 		increased total body fat amount J:268298
Arpc2tm1a(EUCOMM)Wtsi/Arpc2+
(B6JTyr;B6N-Arpc2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal brown fat cell morphology J:179646
decreased gonadal fat pad weight J:179646
decreased percent body fat/body weight J:179646
decreased white fat cell size J:179646
Arsbm1J/Arsbm1J
(C57BL/6J-Arsbm1J/GrsrJ) 		decreased percent body fat/body weight J:149960
Arsjem1(IMPC)J/Arsjem1(IMPC)J
(C57BL/6NJ-Arsjem1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		decreased body fat mass J:263695
decreased brown adipose tissue amount J:263695
decreased epididymal fat pad weight J:263695
decreased inguinal fat pad weight J:263695
decreased mesenteric fat pad weight J:263695
decreased retroperitoneal fat pad weight J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		adipose tissue phenotype J:241193
decreased body fat mass J:241193
decreased percent body fat/body weight J:241193
decreased subcutaneous adipose tissue amount J:241193
decreased white adipose tissue amount J:241193
decreased white fat cell size J:241193
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1) 		decreased gonadal fat pad weight J:232306
Asap1Gt(RRS873)Byg/Asap1Gt(RRS873)Byg
(FVB.129P2(B6)-Asap1Gt(RRS873)Byg) 		abnormal adipose tissue development J:277387
abnormal fat cell differentiation J:277387
decreased gonadal fat pad weight J:277387
decreased retroperitoneal fat pad weight J:277387
decreased white fat cell number J:277387
decreased white fat cell size J:277387
Asb2tm2b(KOMP)Wtsi/Asb2+
(C57BL/6N-Asb2tm2b(KOMP)Wtsi/Kmpc) 		decreased total body fat amount J:211773
Ash1lGt(AL0395)Wtsi/Ash1lGt(AL0395)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased abdominal adipose tissue amount J:227516
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:320329
Aspatm1Mata/Aspatm1Mata
(involves: 129S5/SvEvBrd) 		decreased total body fat amount J:89099
Aspmtm1a(KOMP)Wtsi/Aspmtm1a(KOMP)Wtsi
(C57BL/6N-Aspmtm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		abnormal white adipose tissue physiology J:155421
decreased abdominal adipose tissue amount J:155421
decreased brown fat cell size J:155421
decreased white adipose tissue amount J:155421
decreased white fat cell size J:155421
Atf2tm1Sis/Atf2+
Creb5tm1Sis/Creb5+
(involves: C57BL/6 * CBA) 		adipose tissue phenotype J:156376
decreased subcutaneous adipose tissue amount J:156376
decreased white adipose tissue amount J:156376
decreased white fat cell size J:156376
Atf3tm1.2Kitab/Atf3tm1.2Kitab
Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA) 		abnormal white adipose tissue physiology J:231262
abnormal white fat cell morphology J:231262
decreased abdominal adipose tissue amount J:231262
decreased epididymal fat pad weight J:231262
decreased inguinal fat pad weight J:231262
decreased subcutaneous adipose tissue amount J:231262
decreased white adipose tissue amount J:231262
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		decreased total fat pad weight J:152695
Atg5tm1Myok/Atg5tm1Myok
Tg(Pomc1-cre)1Gsb/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		adipose tissue phenotype J:232686
Atg12tm1.1Jdth/Atg12tm1.1Jdth
Tg(Pomc1-cre)1Gsb/0
(involves: C57BL/6 * FVB/N) 		adipose tissue phenotype J:232686
increased body fat mass J:232686
increased total body fat amount J:232686
Atl1tm1.1Cbla/Atl1tm1.1Cbla
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6.Cg-Reep1Gt(OST398247)Tigm Atl1tm1.1Cbla) 		decreased white adipose tissue amount J:334532
Atl2tm2b(EUCOMM)Hmgu/Atl2+
(C57BL/6N-Atl2tm2b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc) 		abnormal adipose tissue distribution J:222034
abnormal fat cell differentiation J:222034
decreased subcutaneous adipose tissue amount J:222034
Atp5if1em1Jpy/Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy) 		increased epididymal fat pad weight J:313048
Atp5if1tm1a(EUCOMM)Wtsi/Atp5if1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atp5if1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Atp6ap2em1Nira/Y
(C57BL/6J-Atp6ap2em1Nira) 		decreased epididymal fat pad weight J:324587
Atp6v0a1tm1b(EUCOMM)Hmgu/Atp6v0a1+
(C57BL/6N-Atp6v0a1tm1b(EUCOMM)Hmgu/Tcp) 		decreased total body fat amount J:211773
Atp6v0bem1(IMPC)J/Atp6v0b+
(C57BL/6NJ-Atp6v0bem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Atp6v0d1em1Nju/Atp6v0d1em1Nju
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		decreased brown adipose tissue amount J:346448
decreased epididymal fat pad weight J:346448
decreased inguinal fat pad weight J:346448
decreased retroperitoneal fat pad weight J:346448
decreased total body fat amount J:346448
lipodystrophy J:346448
Atp7atm1.1Mjp/Y
Mnx1tm4(cre)Tmj/Mnx1+
(involves: 129S1/Sv * C57BL/6) 		abnormal gonadal fat pad morphology J:221066
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		decreased subcutaneous adipose tissue amount J:123200
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J) 		decreased total body fat amount J:71075
Atrnmg/Atrnmg
(C3H/HeJ.Cg-Atrnmg) 		decreased total body fat amount J:71075
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		increased gonadal fat pad weight J:135320
Atxn2tm1Plt/Atxn2tm1Plt
(involves: 129X1/SvJ * C57BL/6) 		abnormal abdominal fat pad morphology J:103805
Atxn7em1(IMPC)Bay/Atxn7em1(IMPC)Bay
(C57BL/6N-Atxn7em1(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
AU040320em1(IMPC)J/AU040320em1(IMPC)J
(C57BL/6NJ-AU040320em1(IMPC)J/J) 		increased total body fat amount J:211773
Azgp1tm1.1Sbah/Azgp1tm1.1Sbah
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adipose tissue physiology J:118213
B4galt1tm1Shur/B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased subcutaneous adipose tissue amount J:37846
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased gonadal fat pad weight J:144416
decreased subcutaneous adipose tissue amount J:144416
Batq1MH/?
(involves: C57BL/6J * MH) 		increased brown adipose tissue amount J:55483
Batq2MH/Batq2C57BL/6J
(involves: C57BL/6J * MH) 		increased brown adipose tissue amount J:55483
Batq2MH/Batq2MH
(involves: C57BL/6J * MH) 		increased brown adipose tissue amount J:55483
Baz2bem1(IMPC)Wtsi/Baz2bem1(IMPC)Wtsi
(C57BL/6N-Baz2bem1(IMPC)Wtsi/Wtsi) 		increased total body fat amount J:211773
Bbs1tm1Vcs/Bbs1tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal fat pad morphology J:128532
increased brown adipose tissue amount J:128532
increased total body fat amount J:128532
Bbs2tm1.1Huss/Bbs2tm1.1Huss
(involves: 129S6/SvEv * C57BL/6) 		increased fat cell size J:296033
increased total body fat amount J:296033
Bbs2tm1Vcs/Bbs2tm1Vcs
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		abnormal abdominal fat pad morphology J:94467
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd) 		increased abdominal adipose tissue amount J:134093
Bbs4tm1Vcs/Bbs4tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased total body fat amount J:90812
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Bbs9m1Btlr/Bbs9m1Btlr
(C57BL/6J-Bbs9m1Btlr) 		increased body fat mass J:265189
Bbs10tm1.2Vmar/Bbs10tm1.2Vmar
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:227230
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal fat cell morphology J:189019
increased adipocyte glucose uptake J:189019
increased epididymal fat pad weight J:189019
increased fat cell size J:189019
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N) 		decreased epididymal fat pad weight J:129967
decreased percent body fat/body weight J:129967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		abnormal brown adipose tissue physiology J:278806
increased total body fat amount J:278806
Bckdhbem1(IMPC)J/Bckdhb+
(C57BL/6NJ-Bckdhbem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex) 		decreased total body fat amount J:117564
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL) 		abnormal percent body fat/body weight J:181308
Bcl2l11em1(IMPC)H/Bcl2l11em1(IMPC)H
(C57BL/6NTac-Bcl2l11em1(IMPC)H/H) 		decreased total body fat amount J:211773
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(ACTA1-rtTA,tetO-cre)102Monk/0
(involves: C3H * C57BL/6) 		increased body fat mass J:271078
increased white adipose tissue amount J:271078
increased white fat cell size J:271078
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		abnormal gonadal fat pad morphology J:271078
decreased adipocyte glucose uptake J:271078
increased adipocyte glucose uptake J:271078
increased body fat mass J:271078
increased subcutaneous adipose tissue amount J:271078
increased white fat cell size J:271078
white adipose tissue inflammation J:271078
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal adipose tissue morphology J:170742
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
Ins2Akita/Ins2+
(B6.Cg-Ins2Akita Bdkrb2tm1Jfh) 		decreased subcutaneous adipose tissue amount J:108948
Bdt3DBA/2J/Bdt3DBA/2J
(involves: C57BL/6J * DBA/2J) 		increased total fat pad weight J:104825
Bdwtq129S1/SvImJ/Bdwtq129S1/SvImJ
(C57BL/6J-Chr 7129S1/SvImJ) 		abnormal fat pad morphology J:131438
decreased gonadal fat pad weight J:131438
decreased inguinal fat pad weight J:131438
decreased mesenteric fat pad weight J:131438
decreased retroperitoneal fat pad weight J:131438
Becn1tm1b(KOMP)Wtsi/Becn1+
(C57BL/6N-Becn1tm1b(KOMP)Wtsi/Ieg) 		increased total body fat amount J:211773
Bfq1LP/J/Bfq1LP/J
(involves: C57BL/10SnJ * LP/J) 		decreased percent body fat/body weight J:42700
decreased retroperitoneal fat pad weight J:42700
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		abnormal fat cell morphology J:126780
decreased adipocyte glucose uptake J:126780
increased total body fat amount J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		abnormal fat cell morphology J:126780
decreased adipocyte glucose uptake J:126780
increased total body fat amount J:126780
Bhmttm1b(EUCOMM)Hmgu/Bhmttm1b(EUCOMM)Hmgu
(C57BL/6N-Bhmttm1b(EUCOMM)Hmgu/Bay) 		decreased total body fat amount J:211773
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J) 		decreased total body fat amount J:177865
decreased white fat cell size J:177865
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129) 		increased total fat pad weight J:115188
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra) 		decreased abdominal adipose tissue amount J:110697
decreased subcutaneous adipose tissue amount J:110697
decreased total body fat amount J:110697
Bmncrtm1.1Xhl/Bmncrtm1.1Xhl
(Not Specified) 		increased bone marrow adipose tissue amount J:270992
Bmp1tm1.1Dgr/Bmp1tm1.1Dgr
Tll1tm2.1Dgr/Tll1tm2.1Dgr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL) 		decreased gonadal fat pad weight J:210366
decreased inguinal fat pad weight J:210366
Bntq1DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		increased white adipose tissue amount J:95898
Bola3tm1a(EUCOMM)Wtsi/Bola3tm1a(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * C57BL/6N * FVB/NJ) 		abnormal brown adipose tissue physiology J:287367
abnormal brown adipose tissue thermogenesis J:287367
decreased adipocyte glucose uptake J:287367
increased white adipose tissue mass J:287367
Borcs6tm1.1(KOMP)Vlcg/Borcs6+
(B6N(Cg)-Borcs6tm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased white adipose tissue amount J:170095
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1) 		decreased white adipose tissue amount J:170095
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd) 		decreased white adipose tissue amount J:170095
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB) 		decreased subcutaneous adipose tissue amount J:81559
decreased total body fat amount J:81559
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		decreased subcutaneous adipose tissue amount J:155810
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		abnormal adipose tissue morphology J:159964
increased epididymal fat pad weight J:159964
increased fat cell size J:159964
increased interscapular fat pad weight J:159964
increased total body fat amount J:159964
Brs3tm1Hoh/Brs3tm1Hoh
(involves: 129P2/OlaHsd * C57BL/6J) 		increased white adipose tissue amount J:44242
Brs3tm1Jfb/Brs3tm1Jfb
(B6.129X1-Brs3tm1Jfb) 		abnormal epididymal fat pad morphology J:134021
adipose tissue phenotype J:134021
increased brown adipose tissue amount J:134021
increased white adipose tissue amount J:134021
Brs3tm1Lex/Brs3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:185494
Bsbob2SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ) 		abnormal white adipose tissue amount J:90614
increased percent body fat/body weight J:90614
Bsbob4SPRET/EiJ/?
Bsbob5C57BL/6J/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ) 		increased percent body fat/body weight J:90614
Bsbob5SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ) 		decreased percent body fat/body weight J:90614
BsbobC57BL/6J/BsbobSPRET/EiJ
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ) 		decreased gonadal fat pad weight J:90700
decreased percent body fat/body weight J:90614
decreased retroperitoneal fat pad weight J:90700
decreased total body fat amount J:90700, J:90614
decreased white adipose tissue amount J:90700
BsbobSPRET/EiJ/BsbobSPRET/EiJ
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ) 		abnormal epididymal fat pad morphology J:127206
abnormal fat pad morphology J:127206
decreased gonadal fat pad weight J:90700
decreased percent body fat/body weight J:90614
decreased retroperitoneal fat pad weight J:90700
decreased total body fat amount J:90700, J:90614, J:127206
decreased white adipose tissue amount J:90700
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Ddx4-cre)1Dcas/0
(involves: 129 * 129S4/SvJaeSor * FVB/N) 		adipose tissue phenotype J:211072
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor) 		lipodystrophy J:211072
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal epididymal fat pad morphology J:211142
abnormal fat cell differentiation J:183701
abnormal fat pad morphology J:183701
abnormal white adipose tissue amount J:183701
abnormal white adipose tissue morphology J:211142
abnormal white adipose tissue physiology J:211142
abnormal white fat cell morphology J:183701
decreased brown adipose tissue amount J:183701
decreased gonadal fat pad weight J:183701
decreased interscapular fat pad weight J:183701
decreased renal fat pad weight J:183701
decreased subcutaneous adipose tissue amount J:183701
decreased total body fat amount J:183701
decreased white adipose tissue amount J:211142
decreased white fat cell number J:183701
decreased white fat cell size J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		abnormal epididymal fat pad morphology J:173404
abnormal hypodermis fat layer morphology J:173404
abnormal white fat cell differentation J:173404
decreased brown adipose tissue amount J:173404
decreased gonadal fat pad weight J:173404
decreased inguinal fat pad weight J:173404
decreased mesenteric fat pad weight J:173404
decreased retroperitoneal fat pad weight J:173404
decreased subcutaneous adipose tissue amount J:173404
decreased total body fat amount J:173404
lipodystrophy J:211072
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics) 		decreased total body fat amount J:211773
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		abnormal brown adipose tissue morphology J:260853
abnormal infrapatellar fat pad morphology J:260853
abnormal white adipose tissue morphology J:260853
browned white adipose tissue morphology J:260853
decreased body fat mass J:260853
decreased bone marrow adipose tissue amount J:260853
decreased brown adipose tissue mass J:260853
decreased subcutaneous adipose tissue amount J:260853
decreased white adipose tissue amount J:260853
lipodystrophy J:260853
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno) 		abnormal adipose tissue development J:200947
decreased gonadal fat pad weight J:200947
decreased inguinal fat pad weight J:200947
decreased interscapular fat pad weight J:200947
decreased mesenteric fat pad weight J:200947
increased brown adipose tissue amount J:200947
lipodystrophy J:200947
Bsxtm1Tre/Bsxtm1Tre
(B6.129-Bsxtm1Tre) 		increased percent body fat/body weight J:122746
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac) 		decreased subcutaneous adipose tissue amount J:91128
decreased total body fat amount J:91128
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fat cell size J:293084
lipodystrophy J:293084
Bub1btm1Jvd/Bub1btm3.1Jvd
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fat cell size J:293084
lipodystrophy J:293084
Bub1btm2.1Jvd/Bub1b+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal fat pad morphology J:194926
decreased fat cell size J:194926
decreased inguinal fat pad weight J:194926
decreased mesenteric fat pad weight J:194926
decreased subcutaneous adipose tissue amount J:194926
decreased total body fat amount J:194926
Bub3tm1Jvd/Bub3+
Rae1tm1Jvd/Rae1+
(Not Specified) 		decreased subcutaneous adipose tissue amount J:105717
decreased total body fat amount J:105717
Bvestm1.1(KOMP)Vlcg/Bvestm1.1(KOMP)Vlcg
(C57BL/6N-Bvestm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex) 		increased body fat mass J:344722
increased inguinal fat pad weight J:344722
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex) 		decreased body fat mass J:241403
decreased gonadal fat pad weight J:241403
decreased subcutaneous adipose tissue amount J:241403
C1qtnf2tm1Lex/C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex) 		decreased body fat mass J:282612
decreased epididymal fat pad weight J:282612
decreased inguinal fat pad weight J:282612
decreased white adipose tissue amount J:282612
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		adipose tissue phenotype J:237401
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg) 		adipose tissue phenotype J:212299
increased percent body fat/body weight J:212299
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm) 		abnormal beige fat cell physiology J:284780
abnormal brown adipose tissue thermogenesis J:284780
decreased adipocyte glucose uptake J:284780
increased brown fat cell lipid droplet size J:284780
increased brown fat lipid droplet number J:284780
increased white fat cell size J:284780
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6) 		decreased total body fat amount J:60633, J:58966
decreased white adipose tissue amount J:60633
increased brown adipose tissue amount J:58966
C3tm1Hrc/C3tm1Hrc
(involves: 129) 		decreased total body fat amount J:87945
C3ar1tm1Dgen/C3ar1tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal fat pad morphology J:148831
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6) 		abnormal adipose tissue physiology J:123294
abnormal fat cell morphology J:123294
C9orf72tm1.1(KOMP)Mbp/C9orf72tm1.1(KOMP)Mbp
(C57BL/6N-C9orf72tm1.1(KOMP)Mbp/Ucd) 		decreased total body fat amount J:211773
Cabp1tm1b(EUCOMM)Wtsi/Cabp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cabp1tm1b(EUCOMM)Wtsi/H) 		decreased total body fat amount J:211773
Cacna1smdg/Cacna1smdg
(involves: STOCK T/t4) 		increased brown adipose tissue amount J:14970
Cacna2d2em1(IMPC)Mbp/Cacna2d2+
(C57BL/6N-Cacna2d2em1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Cadtm1c(KOMP)Wtsi/Cadtm1c(KOMP)Wtsi
Tg(Adipoq-rtTA)2Zvw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6 * C57BL/6N) 		decreased white fat cell size J:260830
Cadtm1c(KOMP)Wtsi/Cadtm1c(KOMP)Wtsi
Tg(Adipoq-rtTA)2Zvw/0
Tg(tetO-cre)1Jaw/0
Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129 * C57BL/6 * C57BL/6N * FVB/N) 		adipose tissue phenotype J:260830
Calhm4em1(IMPC)Tcp/Calhm4em1(IMPC)Tcp
(C57BL/6NCrl-Calhm4em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Calm1em1Gkim/Calm1em1Gkim
(C57BL/6N-Calm1em1Gkim) 		increased body fat mass J:272366
Camk1dem1(IMPC)Mbp/Camk1dem1(IMPC)Mbp
(C57BL/6NCrl-Camk1dem1(IMPC)Mbp/Mmucd) 		increased total body fat amount J:211773
Camk2btm1.1Ics/Camk2b+
(B6J.129S2(Cg)-Camk2btm1.1Ics) 		increased percent body fat/body weight J:219040
Camk2btm1.1Ics/Camk2btm1.1Ics
(B6J.129S2(Cg)-Camk2btm1.1Ics) 		increased percent body fat/body weight J:219040
Camkk2tm1.1Arm/Camkk2tm1.1Arm
(involves: C57BL/6) 		decreased total body fat amount J:136219
increased brown adipose tissue amount J:136219
increased percent body fat/body weight J:136219
Camkmttm1b(EUCOMM)Wtsi/Camkmttm1b(EUCOMM)Wtsi
(C57BL/6N-Camkmttm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Cand2tm1a(EUCOMM)Wtsi/Cand2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cand2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Carfhg1CAST/EiJ/?
(involves: CAST/EiJ * C57BL/6J-Socs2hg) 		increased total body fat amount J:68441
Carfhg2CAST/EiJ/?
(involves: CAST/EiJ * C57BL/6J-Socs2hg) 		increased total body fat amount J:68441
Carfhg2CAST/EiJ/Carfhg2CAST/EiJ
(involves: CAST/EiJ * C57BL/6J-Socs2hg) 		increased total body fat amount J:111441
Carm1tm1Mtb/Carm1tm1Mtb
(involves: 129S6/SvEvTac) 		abnormal adipose tissue development J:159958
Carm1tm2.1Mtb/Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss) 		abnormal adipose tissue development J:159958
Carp2CAST/EiJ/Carp2CAST/EiJ
(involves: C57BL/6J-Socs2hg * CAST/EiJ) 		increased percent body fat/body weight J:111441
increased total fat pad weight J:111441
Cartpttm1Hmh/Cartpt+
(involves: 129P2/OlaHsd * C57BL/6) 		increased total body fat amount J:97913
Cartpttm1Hmh/Cartpttm1Hmh
(involves: 129P2/OlaHsd * C57BL/6) 		increased total body fat amount J:97913
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal fat cell morphology J:75192
abnormal gonadal fat pad morphology J:75192
abnormal mammary fat pad morphology J:75192
absent subcutaneous adipose tissue J:75192
decreased subcutaneous adipose tissue amount J:75192
decreased total body fat amount J:75192
decreased white adipose tissue amount J:75192
decreased white fat cell lipid droplet size J:75192
increased brown adipose tissue amount J:75192
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL) 		abnormal fat cell morphology J:89326
Cav1tm1Mls/Cav1tm1Mls
(B6.Cg-Cav1tm1Mls) 		abnormal brown fat cell morphology J:105133
abnormal fat cell morphology J:205741
increased brown fat cell lipid droplet size J:105133
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls) 		abnormal adipose tissue physiology J:182288
decreased total body fat amount J:182288
Cav2tm1Mls/Cav2tm1Mls
(involves: 129/Sv * C57BL/6J * SJL) 		adipose tissue phenotype J:75490
Cavin2tm1(KOMP)Vlcg/Cavin2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac) 		abnormal fat cell morphology J:205741
Cavin3tm1Pemi/Cavin3tm1Pemi
(B6.129S4-Cavin3tm1Pemi) 		lipodystrophy J:202374
Cbltm1Ddlb/Cbl+
(involves: 129S1/Sv * C57BL/6) 		decreased white adipose tissue amount J:94416
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6J) 		abnormal mammary fat pad morphology J:76895
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6) 		abnormal fat cell morphology J:94416
decreased total body fat amount J:94416
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6) 		abnormal epididymal fat pad morphology J:121012
decreased brown adipose tissue amount J:121012
decreased total body fat amount J:121012
Cbx4tm1.1(KOMP)Vlcg/Cbx4+
(C57BL/6N-Cbx4tm1.1(KOMP)Vlcg/Tcp) 		increased total body fat amount J:211773
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Cby1tm1Ktkm/Cby1tm1Ktkm
(Not Specified) 		abnormal fat cell differentiation J:122334
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm) 		decreased subcutaneous adipose tissue amount J:147413
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J) 		increased total body fat amount J:228688
Ccar2tm1Dac/Ccar2tm1Dac
Lepob/Lepob
(involves: 129 * C57BL/6J) 		increased total body fat amount J:228688
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J) 		abnormal fat pad morphology J:220560
decreased subcutaneous adipose tissue amount J:220560
decreased white fat cell size J:220560
Ccdc7aTg(Prnp-Sirt1)10Imai/?
(B6.Cg-Ccdc7aTg(Prnp-Sirt1)10Imai) 		abnormal brown adipose tissue physiology J:203814
Ccdc8em1(IMPC)Tcp/Ccdc8+
(C57BL/6NCrl-Ccdc8em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm) 		increased total body fat amount J:189183
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp) 		abnormal brown adipose tissue thermogenesis J:332421
abnormal fat cell differentiation J:332421
abnormal white adipose tissue morphology J:332421
abnormal white adipose tissue physiology J:332421
decreased brown fat cell size J:332421
decreased epididymal fat pad weight J:332421
decreased mesenteric fat pad weight J:332421
decreased subcutaneous adipose tissue amount J:332421
decreased white fat cell size J:332421
increased brown fat cell number J:332421
Ccdc103em4(IMPC)H/Ccdc103+
(C57BL/6N-Ccdc103em4(IMPC)H/H) 		increased total body fat amount J:211773
Ccdc122tm1a(KOMP)Wtsi/Ccdc122tm1a(KOMP)Wtsi
(C57BL/6N-Ccdc122tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J) 		abnormal epididymal fat pad morphology J:110277
abnormal gonadal fat pad morphology J:126512
decreased fat cell size J:110277
increased percent body fat/body weight J:126512
increased total fat pad weight J:126512
Ccl25tm1Lex/Ccl25tm1Lex
(B6;129S5-Ccl25tm1Lex/Ieg) 		increased total body fat amount J:82809, J:172753
Ccn3tm1.1Ecan/Ccn3tm1.1Ecan
(B6.Cg-Ccn3tm1.1Ecan) 		adipose tissue phenotype J:158478
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H) 		decreased total body fat amount J:211773
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6) 		abnormal brown adipose tissue physiology J:224589
abnormal fat cell differentiation J:224589
abnormal fat pad morphology J:224589
adipose tissue phenotype J:224589
decreased inguinal fat pad weight J:224589
decreased renal fat pad weight J:224589
decreased retroperitoneal fat pad weight J:224589
decreased total body fat amount J:224589
decreased white fat cell size J:224589
Cd14tm1Frm/Cd14tm1Frm
(B6.129S4-Cd14tm1Frm) 		decreased total body fat amount J:118467
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6) 		abnormal fat pad morphology J:126461
decreased percent body fat/body weight J:126461
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv) 		abnormal brown adipose tissue physiology J:220343
decreased adipocyte glucose uptake J:220343
decreased brown adipose tissue amount J:220343
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6) 		abnormal fat cell morphology J:217719
Cd300lgtm1a(KOMP)Wtsi/Cd300lgtm1a(KOMP)Wtsi
(C57BL/6N-Cd300lgtm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Cdc27tm1dIcs/Cdc27+
(C57BL/6N-Cdc27tm1dIcs/Ics) 		increased total body fat amount J:211773
Cdc73tm1Btt/Cdc73tm1Btt
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased abdominal adipose tissue amount J:135255
decreased subcutaneous adipose tissue amount J:135255
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Cdipttm1b(EUCOMM)Wtsi/Cdipt+
(C57BL/6N-Cdipttm1b(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Cdk7Gt(D032B11)1.1Wrst/Cdk7Gt(D032B11)1.1Wrst
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvPas * 129S2/SvPas * C57BL/6 * SJL) 		decreased subcutaneous adipose tissue amount J:183925
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj) 		decreased abdominal fat pad weight J:195460
decreased subcutaneous adipose tissue amount J:195460
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas) 		increased brown adipose tissue amount J:118516
increased inguinal fat pad weight J:118516
increased parametrial fat pad weight J:118516
increased white fat cell number J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		increased brown adipose tissue amount J:118516
increased inguinal fat pad weight J:118516
increased parametrial fat pad weight J:118516
increased total body fat amount J:118516
increased white fat cell number J:118516
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv) 		increased brown adipose tissue amount J:118516
increased inguinal fat pad weight J:118516
increased parametrial fat pad weight J:118516
increased white fat cell number J:118516
Cdkn1ctm1Sje/Cdkn1c+
(involves: 129S2/SvHsd * 129S7/SvEvBrd) 		abnormal brown adipose tissue morphology J:232408
abnormal interscapular fat pad morphology J:232408
decreased brown adipose tissue amount J:232408
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6) 		increased abdominal fat pad weight J:181979
increased total body fat amount J:181979
Cebpatm1.1(Cebpb)Ylee/Cebpatm1.1(Cebpb)Ylee
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal brown adipose tissue morphology J:77646
abnormal fat cell morphology J:77646
abnormal white adipose tissue morphology J:77646
decreased white adipose tissue amount J:77646
increased brown adipose tissue amount J:77646
Cebpatm1.1(Cebpb)Ylee/Cebpatm1.1Gonz
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal white adipose tissue morphology J:77646
decreased white adipose tissue amount J:77646
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal inguinal fat pad morphology J:28320
decreased brown adipose tissue amount J:28320
decreased white adipose tissue amount J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal fat cell morphology J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased brown adipose tissue amount J:35795
decreased white adipose tissue amount J:89611
Cebpatm1Nerl/Cebpatm1Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:72330
Cebpatm2Nerl/Cebpatm2Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal gonadal fat pad morphology J:72330
decreased white adipose tissue amount J:72330
Cebpatm3Nerl/Cebpatm3Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:72330
Cebpatm4Nerl/Cebpatm4Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal gonadal fat pad morphology J:72330
decreased white adipose tissue amount J:72330
Cebpatm5Nerl/Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:120098
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:120098
decreased adipocyte glucose uptake J:120098
Cebpbtm1Kish/Cebpbtm1Kish
(involves: 129P2/OlaHsd) 		abnormal brown adipose tissue morphology J:45062
Cebpbtm1Kish/Cebpbtm1Kish
Cebpdtm1Aki/Cebpdtm1Aki
(involves: 129P2/OlaHsd) 		abnormal brown adipose tissue thermogenesis J:45062
abnormal brown fat cell morphology J:45062
abnormal brown fat lipid droplet number J:45062
decreased epididymal fat pad weight J:45062
decreased white adipose tissue amount J:45062
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1) 		abnormal adipose tissue physiology J:52286
decreased gonadal fat pad weight J:62132
decreased percent body fat/body weight J:62132
decreased uterine fat pad weight J:52286
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6) 		abnormal brown adipose tissue physiology J:117502
decreased brown adipose tissue amount J:117502
decreased epididymal fat pad weight J:117502
Cebpdtm1Aki/Cebpdtm1Aki
(involves: 129P2/OlaHsd) 		abnormal brown adipose tissue morphology J:45062
abnormal epididymal fat pad morphology J:45062
Cebpztm1b(EUCOMM)Hmgu/Cebpz+
(C57BL/6N-Cebpztm1b(EUCOMM)Hmgu/Orl) 		increased total body fat amount J:211773
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased percent body fat/body weight J:124658
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cenpjtm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Cep19tm1.1Jmgi/Cep19tm1.1Jmgi
(involves: 129S2/SvPas * C57BL/6J) 		increased percent body fat/body weight J:206667
increased total body fat amount J:206667
Cep19tm1b(EUCOMM)Hmgu/Cep19tm1b(EUCOMM)Hmgu
(C57BL/6N-Cep19tm1b(EUCOMM)Hmgu/Bay) 		increased total body fat amount J:211773
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac) 		increased percent body fat/body weight J:206667
increased total body fat amount J:206667
Cep250tm1a(EUCOMM)Wtsi/Cep250tm1a(EUCOMM)Wtsi
(C57BL/6N-Cep250tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N) 		decreased brown fat cell lipid droplet size J:215519
decreased fat cell size J:215519
decreased total body fat amount J:215519
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac) 		increased white adipose tissue amount J:158743
increased white fat cell size J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6) 		abnormal brown adipose tissue morphology J:262803
decreased brown adipose tissue mass J:262803
increased white adipose tissue mass J:262803
increased white fat cell size J:262803
Ces5aem1(IMPC)J/Ces5aem1(IMPC)J
(C57BL/6NJ-Ces5aem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Cfap69tm1b(KOMP)Wtsi/Cfap69tm1b(KOMP)Wtsi
(C57BL/6N-Cfap69tm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Cfap161em1(IMPC)Ccpcz/Cfap161em1(IMPC)Ccpcz
(C57BL/6NCrl-Cfap161em1(IMPC)Ccpcz/Ccpcz) 		decreased total body fat amount J:211773
Chadtm1Gast/Chadtm1Gast
(B6.129-Chadtm1Gast) 		decreased total body fat amount J:203141
Chaserrem1Wei/Chaserr+
(involves: BALB/c * C57BL/6) 		decreased total fat pad weight J:281371
Chaserrem2Wei/Chaserr+
(involves: BALB/c * C57BL/6) 		decreased total fat pad weight J:281371
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased white adipose tissue amount J:146743
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6J) 		absent subcutaneous adipose tissue J:137079
decreased subcutaneous adipose tissue amount J:137079
Chd7em1Kangn/Chd7em1Kangn
Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * SJL/J) 		increased bone marrow adipose tissue amount J:336448
Chd7em1Kangn/Chd7em1Kangn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1) 		increased bone marrow adipose tissue amount J:336448
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi) 		decreased body fat mass J:330596
decreased percent body fat/body weight J:330596
Chd7Whi/Chd7+
(involves: C3HeB/FeJ) 		decreased total body fat amount J:104123
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J) 		decreased total body fat amount J:211773
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased gonadal fat pad weight J:67919
Chrm3tm1Jwe/Chrm3tm1Jwe
(129S6/SvEvTac-Chrm3tm1Jwe) 		decreased gonadal fat pad weight J:67919
Chrnb2tm1b(EUCOMM)Hmgu/Chrnb2tm1b(EUCOMM)Hmgu
(C57BL/6N-Chrnb2tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Chsy3em2(IMPC)Mbp/Chsy3em2(IMPC)Mbp
(C57BL/6NCrl-Chsy3em2(IMPC)Mbp/Mmucd) 		decreased total body fat amount J:211773
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ) 		decreased brown adipose tissue mass J:85229
decreased white adipose tissue mass J:85229
decreased white fat cell size J:215366
Cidebtm1Pli/Cidebtm1Pli
(Not Specified) 		abnormal fat pad morphology J:126556
abnormal white adipose tissue morphology J:126556
decreased total body fat amount J:126556
increased fat cell size J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel) 		abnormal white adipose tissue morphology J:226899
abnormal white adipose tissue physiology J:226899
abnormal white fat cell morphology J:226899
decreased percent body fat/body weight J:226899
decreased white adipose tissue amount J:226899
decreased white fat cell size J:226899
increased adipocyte glucose uptake J:226899
increased brown adipose tissue amount J:226899
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg) 		decreased total body fat amount J:211773
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka) 		abnormal brown adipose tissue morphology J:140863
abnormal white adipose tissue morphology J:140863
decreased subcutaneous adipose tissue amount J:140863
decreased white adipose tissue amount J:140863
Cidectm1Pli/Cidectm1Pli
(Not Specified) 		abnormal brown adipose tissue morphology J:140122
abnormal fat cell morphology J:140122
abnormal fat pad morphology J:140122
abnormal gonadal fat pad morphology J:140122
decreased gonadal fat pad weight J:140122
decreased inguinal fat pad weight J:140122
decreased mesenteric fat pad weight J:140122
decreased retroperitoneal fat pad weight J:140122
decreased subcutaneous adipose tissue amount J:140122
decreased total body fat amount J:140122
Cidectm1Pli/Cidectm1Pli
Lepob/Lepob
(involves: C57BL/10J) 		abnormal adipose tissue amount J:140122
abnormal gonadal fat pad morphology J:140122
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts) 		decreased subcutaneous adipose tissue amount J:148467
decreased total body fat amount J:148467
Ckbtm1.1(KOMP)Wtsi/Ckbtm1.1(KOMP)Wtsi
(C57BL/6N-Ckbtm1.1(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal abdominal fat pad morphology J:80901
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg) 		increased body fat mass J:279934
Clec2htm1.1Apma/Clec2htm1.1Apma
(B6(Cg)-Clec2htm1.1Apma) 		abnormal renal fat pad morphology J:322835
increased abdominal adipose tissue amount J:322835
increased abdominal fat pad weight J:322835
Clec2htm1.1Apma/Clec2htm1.1Apma
Rag1tm1Mom/Rag1tm1Mom
(B6.Cg-Rag1tm1Mom Clec2htm1.1Apma) 		abnormal adipose tissue amount J:322835
Clec3aem1(IMPC)J/Clec3aem1(IMPC)J
(C57BL/6NJ-Clec3aem1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Clec11aem1Sjm/Clec11aem1Sjm
(involves: C57BL/6 * C57BL/Ka) 		abnormal fat cell morphology J:239391
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6) 		decreased total body fat amount J:160186
Cln6tm1b(EUCOMM)Hmgu/Cln6tm1b(EUCOMM)Hmgu
(C57BL/6N-Cln6tm1b(EUCOMM)Hmgu/Tcp) 		decreased total body fat amount J:211773
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt) 		increased fat cell size J:98343
increased percent body fat/body weight J:98343
Clockm1Jt/Clockm1Jt
Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR) 		increased fat cell size J:135847
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
increased total body fat amount J:211773
Clpstm1Lowe/Clpstm1Lowe
(involves: 129S6/SvEvTac * Black Swiss) 		decreased percent body fat/body weight J:75167
Clrn2em1(IMPC)J/Clrn2em1(IMPC)J
(C57BL/6NJ-Clrn2em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Clstn3tm1b(EUCOMM)Hmgu/Clstn3tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		decreased bone marrow adipose tissue amount J:293885
decreased brown adipose tissue amount J:293885
decreased brown fat cell size J:293885
decreased white adipose tissue amount J:293885
decreased white fat cell size J:293885
Clstn3tm1c(EUCOMM)Hmgu/Clstn3tm1c(EUCOMM)Hmgu
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6 * C57BL/6N * CBA * SJL) 		decreased bone marrow adipose tissue amount J:293885
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6) 		decreased percent body fat/body weight J:148522
Cluhtm1.1Eir/Cluhtm1.1Eir
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL) 		increased brown fat lipid droplet number J:249661
Cmklr2tm1.1Dgen/Cmklr2tm1.1Dgen
(involves: C57BL/6J) 		decreased brown fat cell size J:273922
decreased white fat cell size J:273922
increased white fat cell size J:273922
Cmpk2tm1b(KOMP)Wtsi/Cmpk2tm1b(KOMP)Wtsi
(C57BL/6N-Cmpk2tm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Cmtr2tm1.1(KOMP)Vlcg/Cmtr2+
(B6N(Cg)-Cmtr2tm1.1(KOMP)Vlcg/2J) 		decreased total body fat amount J:211773
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya) 		decreased body fat mass J:180033
decreased brown fat cell size J:180033
decreased percent body fat/body weight J:180033
decreased subcutaneous adipose tissue amount J:180033
decreased white fat cell size J:180033
Cnot4tm1b(EUCOMM)Wtsi/Cnot4+
(C57BL/6N-Cnot4tm1b(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya) 		decreased brown adipose tissue amount J:274297
decreased brown fat cell size J:274297
decreased subcutaneous adipose tissue amount J:274297
decreased white adipose tissue amount J:274297
Cnot7em1(IMPC)Rbrc/Cnot7em1(IMPC)Rbrc
(C57BL/6NJcl-Cnot7em1(IMPC)Rbrc/Rbrc) 		decreased total body fat amount J:211773
Cnr1tm1Lex/Cnr1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:93697
Cntnap5aem1(IMPC)J/Cntnap5aem1(IMPC)J
(C57BL/6NJ-Cntnap5aem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Col1a1Aga2/Col1a1+
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal adipose tissue distribution J:129569
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ) 		decreased percent body fat/body weight J:216423
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		increased white adipose tissue amount J:187378
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased total body fat amount J:177113
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		adipose tissue phenotype J:211215
decreased gonadal fat pad weight J:211215
Col1a2tm1b(EUCOMM)Wtsi/Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/Bay) 		decreased total body fat amount J:211773
Col2a1M2J/Col2a1+
(B6;C3Fe-Col2a1M2J/GrsrJ) 		decreased percent body fat/body weight J:187363
increased percent body fat/body weight J:187363
Col3a1Tsk2/Col3a1+
(C3H101H-Col3a1Tsk2/H) 		adipose tissue inflammation J:31216
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm) 		decreased total body fat amount J:211773
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased adipocyte glucose uptake J:171817
decreased subcutaneous adipose tissue amount J:171817
Copb2em1(IMPC)Bay/Copb2+
(C57BL/6N-Copb2em1(IMPC)Bay/Bay) 		decreased total body fat amount J:211773
Coprstm1.1Efab/Coprstm1.1Efab
(Not Specified) 		abnormal fat cell differentiation J:221154
abnormal white adipose tissue physiology J:221154
decreased retroperitoneal fat pad weight J:221154
decreased white fat cell number J:221154
increased white fat cell size J:221154
Coq2tm1b(EUCOMM)Hmgu/Coq2+
(C57BL/6N-Coq2tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Cox7a2lGt(OST241316)Lex/Cox7a2lGt(OST241316)Lex
(B6.129S5-Cox7a2lGt(OST241316)Lex) 		whitened brown adipose tissue morphology J:215964
Cox7a2lGt(OST241316)Lex/Cox7a2lGt(OST241316)Lex
Tg(CAG-COX7A2L)#Sinos/0
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal brown adipose tissue morphology J:215964
Cpefat/Cpefat
(involves: HRS/J) 		increased total body fat amount J:10872
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J) 		abnormal percent body fat/body weight J:10872
Cpefat/Cpefat
Fina1C57BLKS/J/Fina1C57BLKS/J
(involves: C57BLKS/J * HRS/J) 		increased total body fat amount J:100832
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6) 		increased total body fat amount J:95741
Cpt1ctm1b(EUCOMM)Wtsi/Cpt1ctm1b(EUCOMM)Wtsi
(C57BL/6N-Cpt1ctm1b(EUCOMM)Wtsi/Ucd) 		increased total body fat amount J:211773
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp) 		decreased epididymal fat pad weight J:208570
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac) 		decreased body fat mass J:345514
decreased percent body fat/body weight J:345514
decreased white fat cell size J:345514
increased white fat cell number J:345514
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA) 		decreased fat cell size J:75361
decreased percent body fat/body weight J:75361
decreased white adipose tissue amount J:75361
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J) 		abnormal fat cell morphology J:208708
increased total body fat amount J:208708
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6) 		abnormal adipose tissue physiology J:83683
abnormal white fat cell morphology J:83683
decreased brown fat cell size J:83683
decreased total body fat amount J:83683
Crls1tm1Geno/Crls1tm1Geno
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		abnormal brown adipose tissue morphology J:266083
abnormal brown adipose tissue physiology J:266083
abnormal brown adipose tissue thermogenesis J:266083
abnormal brown fat cell morphology J:266083
decreased adipocyte glucose uptake J:266083
decreased epididymal fat pad weight J:266083
decreased fat cell mitochondrial DNA content J:266083
decreased interscapular fat pad weight J:266083
decreased subcutaneous adipose tissue amount J:266083
increased brown fat cell lipid droplet size J:266083
Crls1tm1Geno/Crls1tm1Geno
Tg(Ucp1-cre/ERT2)426Biat/0
(involves: C57BL/6N) 		abnormal brown adipose tissue morphology J:266083
adipose tissue phenotype J:266083
decreased interscapular fat pad weight J:266083
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased white adipose tissue amount J:142448
Crtc2tm1a(EUCOMM)Wtsi/Crtc2tm1a(EUCOMM)Wtsi
(B6.B6N-Crtc2tm1a(EUCOMM)Wtsi) 		increased adipocyte glucose uptake J:229999
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal brown fat cell morphology J:167211
abnormal white adipose tissue physiology J:167211
decreased brown fat cell lipid droplet size J:167211
decreased total body fat amount J:167211
decreased white fat cell size J:167211
increased brown fat cell number J:167211
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Asn/Cry2tm1Asn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal brown adipose tissue morphology J:128437
decreased abdominal adipose tissue amount J:128437
decreased subcutaneous adipose tissue amount J:128437
decreased total body fat amount J:128437
Crybg1tm1b(KOMP)Wtsi/Crybg1+
(C57BL/6N-Crybg1tm1b(KOMP)Wtsi/Tcp) 		decreased total body fat amount J:211773
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg) 		abnormal abdominal fat pad morphology J:102499
increased abdominal adipose tissue amount J:102499
increased gonadal fat pad weight J:102499
increased mesenteric fat pad weight J:102499
increased subcutaneous adipose tissue amount J:102499
increased total body fat amount J:102499
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal mesenteric fat pad morphology J:142440
increased fat cell size J:142440
Csmd3em1(IMPC)Mbp/Csmd3em1(IMPC)Mbp
(C57BL/6NCrl-Csmd3em1(IMPC)Mbp/Mmucd) 		decreased total body fat amount J:211773
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adipose tissue development J:184220
abnormal brown adipose tissue morphology J:184220
decreased white fat cell number J:184220
increased epididymal fat pad weight J:184220
increased gonadal fat pad weight J:184220
Cspg4tm1Ychan/Cspg4tm1Ychan
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129 * C57BL/6N) 		decreased epididymal fat pad weight J:184220
Ctdspl2tm2b(KOMP)Wtsi/Ctdspl2+
(C57BL/6N-Ctdspl2tm2b(KOMP)Wtsi/Bay) 		decreased total body fat amount J:211773
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd) 		decreased fat cell mitochondrial DNA content J:176727
increased fat cell size J:176727
increased total body fat amount J:176727
Cux1tm1Rhsc/Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J) 		decreased total body fat amount J:100055
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA) 		decreased white adipose tissue amount J:126841
increased fat cell size J:126841
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		adipose tissue phenotype J:217569
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased brown adipose tissue mass J:217569
increased brown fat cell size J:217569
increased gonadal fat pad weight J:217569
increased mesenteric fat pad weight J:217569
increased retroperitoneal fat pad weight J:217569
increased subcutaneous adipose tissue amount J:217569
increased total body fat amount J:217569
increased white adipose tissue mass J:217569
increased white fat cell size J:217569
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J) 		decreased total body fat amount J:211773
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN) 		decreased total body fat amount J:91486
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Cybbtm1.1Abk/Cybbtm1.1Abk
Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk) 		decreased fat cell size J:245699
increased epididymal fat pad weight J:245699
Cybc1tm1a(KOMP)Wtsi/Cybc1tm1a(KOMP)Wtsi
(C57BL/6N-Cybc1tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Cygbtm1b(EUCOMM)Wtsi/Cygbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cygbtm1b(EUCOMM)Wtsi/Tcp) 		decreased total body fat amount J:211773
Cyp4x1tm1.1Beld/Cyp4x1tm1.1Beld
(involves: C57BL/6) 		increased abdominal adipose tissue amount J:254435
increased epididymal fat pad weight J:254435
increased white fat cell size J:254435
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased total body fat amount J:147610
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju) 		increased total body fat amount J:211773
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6) 		increased gonadal fat pad weight J:48086
increased mammary fat pad weight J:48086
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac) 		increased fat cell size J:65805
increased gonadal fat pad weight J:65805
increased renal fat pad weight J:65805
increased total body fat amount J:65805
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv) 		abnormal white adipose tissue morphology J:216958
increased abdominal adipose tissue amount J:216958
increased total body fat amount J:51076
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J) 		increased abdominal fat pad weight J:79603, J:82070
increased gonadal fat pad weight J:82070
increased renal fat pad weight J:82070
Cyp27b1tm1b(EUCOMM)Hmgu/Cyp27b1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp27b1tm1b(EUCOMM)Hmgu/Tcp) 		decreased total body fat amount J:211773
Cystm1tm1b(EUCOMM)Hmgu/Cystm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cystm1tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi) 		abnormal white adipose tissue physiology J:272118
decreased gonadal fat pad weight J:272118
decreased inguinal fat pad weight J:272118
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp) 		decreased total body fat amount J:211773
Dazap1em1(IMPC)Ccpcz/Dazap1+
(C57BL/6NCrl-Dazap1em1(IMPC)Ccpcz/Ccpcz) 		decreased total body fat amount J:211773
Dbitm1Smdp/Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal white adipose tissue physiology J:204137
Dbitm2.1Smdp/Dbitm2.2Smdp
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		abnormal white adipose tissue physiology J:204137
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/MbpMmucd) 		decreased total body fat amount J:211773
Dbsq1C57BLKS/J/Dbsq1C3H/HeJ
Leprdb/Leprdb
(involves: C3H/HeJ * C57BLKS) 		abnormal fat pad morphology J:116038
Dbsq1C57BLKS/J/Dbsq1C57BLKS/J
Leprdb/Leprdb
(involves: C3H/HeJ * C57BLKS) 		abnormal fat pad morphology J:116038
Dbsty2NZO/HlLt/Dbsty2NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt) 		increased white adipose tissue amount J:65256
Dbsty2NZO/HlLt/Dbsty2NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		increased white adipose tissue amount J:65256
Dbx1tm2Jcor/Dbx1tm1Tmj
Tg(Nkx2-1-cre)2Sand/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased percent body fat/body weight J:221571
Dclk2em1(IMPC)J/Dclk2em1(IMPC)J
(C57BL/6NJ-Dclk2em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg) 		decreased total body fat amount J:211773
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		increased total body fat amount J:214136
white adipose tissue inflammation J:214136
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng) 		decreased percent body fat/body weight J:134371
Ddx51tm1a(KOMP)Wtsi/Ddx51+
(C57BL/6N-Ddx51tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Del(7Coro1a-Spn)1Dolm/+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6N * CD-1) 		abnormal abdominal fat pad morphology J:210018
Del(8Npy5r-Npy1r)1Snby/Del(8Npy5r-Npy1r)1Snby
(involves: 129 * C57BL/6) 		increased gonadal fat pad weight J:225097
increased inguinal fat pad weight J:225097
increased mesenteric fat pad weight J:225097
increased retroperitoneal fat pad weight J:225097
increased total body fat amount J:225097
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae) 		decreased percent body fat/body weight J:72926
Del(11Cops3-Rnf112)1Jrl/+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased abdominal fat pad weight J:83302
increased percent body fat/body weight J:83302
Del(16Lipi-Usp25)1Dja/+
(involves: 129P2/OlaHsd * C57BL/6) 		increased percent body fat/body weight J:184302
increased subcutaneous adipose tissue amount J:184302
increased total body fat amount J:184302
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA) 		decreased body fat mass J:276600
Depdc5tm1b(EUCOMM)Hmgu/Depdc5+
(C57BL/6N-Depdc5tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Dfb/Dfb+
(BALB/cByJ-Dfb/J) 		decreased percent body fat/body weight J:110189
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased percent body fat/body weight J:111346
Dgat1tm1Far/Dgat1tm1Far
(B6J.129S4-Dgat1tm1Far) 		decreased mammary fat pad weight J:128259
Dgat2tm1Lex/Dgat2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased subcutaneous adipose tissue amount J:103485
Dgkiem1(IMPC)Wtsi/Dgkiem1(IMPC)Wtsi
(C57BL/6N-Dgkiem1(IMPC)Wtsi/Wtsi) 		increased body fat mass J:295189
increased percent body fat/body weight J:295189
Dguokem1(IMPC)J/Dguokem1(IMPC)J
(C57BL/6NJ-Dguokem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		absent subcutaneous adipose tissue J:294620
decreased total body fat amount J:294620
Dhcr24tm1Lex/Dhcr24tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal mesenteric fat pad morphology J:87402
decreased subcutaneous adipose tissue amount J:87402
Dio2tm1Acb/Dio2tm1Acb
Tg(Cga-cre)3Sac/0
(involves: C57BL/6J * SJL) 		decreased total body fat amount J:197623
Dipk1atm1a(EUCOMM)Wtsi/Dipk1atm1a(EUCOMM)Wtsi
(C57BL/6N-Dipk1atm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased total body fat amount J:81054
Dlg4tm1e(EUCOMM)Wtsi/Dlg4tm1e(EUCOMM)Wtsi
(C57BL/6N-Dlg4tm1e(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Dlk1em1(IMPC)Wtsi/Dlk1em1(IMPC)Wtsi
(C57BL/6N-Dlk1em1(IMPC)Wtsi/WtsiIeg) 		increased total body fat amount J:211773
Dlk1tm1.1Jvs/Dlk1+
Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		decreased brown adipose tissue mass J:167124
Dlk1tm1.2Jvs/Dlk1+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased fat cell size J:194130
Dlk1tm1Hsul/Dlk1+
(involves: 129 * C57BL/6J) 		abnormal fat pad morphology J:77909
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J)) 		abnormal fat pad morphology J:77909
increased fat cell size J:77909
Dll1m1Mhda/Dll1+
(C3HeB/FeJ-Dll1m1Mhda) 		decreased total body fat amount J:150183
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos) 		decreased total body fat amount J:150183
Dmbx1tm1Sse/Dmbx1tm1Sse
(involves: ICR) 		abnormal fat cell morphology J:125193
Dmdem1(IMPC)Hmgu/Y
(C57BL/6N-Dmdem1(IMPC)Hmgu/Ieg) 		decreased total body fat amount J:211773
Dmdem1(IMPC)Hmgu/Dmdem1(IMPC)Hmgu
(C57BL/6N-Dmdem1(IMPC)Hmgu/Ieg) 		decreased total body fat amount J:211773
Dmdmdx-5Cv/Y
(B6Ros.Cg-Dmdmdx-5Cv) 		decreased body fat mass J:177391
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx) 		decreased body fat mass J:177391
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx) 		adipose tissue phenotype J:160773
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx) 		increased total body fat amount J:160773
Dmp1tm1.1(KOMP)Vlcg/Dmp1tm1.1(KOMP)Vlcg
(C57BL/6N-Dmp1tm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH) 		increased total body fat amount J:211773
Dnajb4tm1Suky/Dnajb4tm1Suky
(Not Specified) 		increased white adipose tissue amount J:321624
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh) 		decreased percent body fat/body weight J:98194
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg) 		decreased white adipose tissue amount J:204025
Dnase1l2tm1(KOMP)Wtsi/Dnase1l2tm1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
increased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/H) 		decreased total body fat amount J:211773
Dnd1em1(IMPC)Bay/Dnd1em1(IMPC)Bay
(C57BL/6N-Dnd1em1(IMPC)Bay/Bay) 		increased total body fat amount J:211773
Dnm3ostm1Tkk/Dnm3ostm1Tkk
(involves: 129 * C57BL/6 * ICR) 		abnormal epididymal fat pad morphology J:143209
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Dob1AKR/J/Dob1AKR/J
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:20129
Dob1AKR/J/Dob1SWR/J
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:20129
Dob2AKR/J/Dob2SWR/J
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:20700
Dob2SWR/J/Dob2SWR/J
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:20700
Dob3AKR/J/Dob3AKR/J
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:20700
Dob3AKR/J/Dob3SWR/J
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:20700
Dob7SWR/J/?
(involves: AKR/J * SWR/J) 		increased white adipose tissue amount J:43487
Dock7m/Dock7m
(B6.D(Cg)-Dock7m) 		abnormal brown adipose tissue mass J:45425
decreased white adipose tissue amount J:48831
Dock9em1(IMPC)J/Dock9em1(IMPC)J
(C57BL/6NJ-Dock9em1(IMPC)J/J) 		decreased total body fat amount J:211773
Dok1tm1Yyam/Dok1tm1Yyam
(B6.129S4-Dok1tm1Yyam) 		decreased brown adipose tissue mass J:133566
decreased epididymal fat pad weight J:133566
decreased fat cell size J:133566
decreased inguinal fat pad weight J:133566
decreased percent body fat/body weight J:133566
Dok1tm1Yyam/Dok1tm1Yyam
Ppargtm1Laz/Ppargtm1Laz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal fat cell morphology J:133566
adipose tissue phenotype J:133566
Dp(11Cops3-Rnf112)1Jrl/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased abdominal fat pad weight J:83302
decreased percent body fat/body weight J:83302
Dp(11Cops3-Rnf112)1Jrl/0
Tyrc-Brd/Tyrc-Brd
(B6Brd.Cg-Tyrc-Brd Dp(11Cops3-Rnf112)1Jrl) 		decreased abdominal fat pad weight J:138598
Dpp8em1(IMPC)J/Dpp8em1(IMPC)J
(C57BL/6NJ-Dpp8em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Dpttm1Hsh/Dpttm1Hsh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased total body fat amount J:78845
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J) 		decreased inguinal fat pad weight J:106832
Drd3tm1Stl/Drd3tm1Stl
(involves: 129S2/SvPas * C57BL/6) 		increased percent body fat/body weight J:89345
increased total body fat amount J:89345
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		decreased body fat mass J:138683
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk) 		decreased subcutaneous adipose tissue amount J:219200
decreased total body fat amount J:219200
Dsg3tm1Stan/Dsg3tm1Stan
(involves: 129X1/SvJ * C57BL/6J) 		decreased total body fat amount J:40804
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ) 		decreased abdominal adipose tissue amount J:83117
decreased subcutaneous adipose tissue amount J:83117
Duox2thyd/Duox2thyd
(B6(129)-Duox2thyd/J) 		decreased percent body fat/body weight J:121821
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
increased total body fat amount J:211773
Dus2tm1b(EUCOMM)Wtsi/Dus2+
(C57BL/6N-Dus2tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Dusp1tm1(KOMP)Wtsi/Dusp1tm1(KOMP)Wtsi
(C57BL/6N-Dusp1tm1(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased abdominal fat pad weight J:129718
decreased epididymal fat pad weight J:129718
decreased fat cell size J:129718
decreased total body fat amount J:129718
Dync1i2tm1a(EUCOMM)Wtsi/Dync1i2+
(C57BL/6N-Dync1i2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Dynlrb2tm1a(KOMP)Wtsi/Dynlrb2+
(C57BL/6N-Dynlrb2tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
E2f1tm1Meg/E2f1tm1Meg
E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		adipose tissue phenotype J:138289
decreased white adipose tissue amount J:138289
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		abnormal fat cell differentiation J:89720
decreased total body fat amount J:89720
increased adipocyte glucose uptake J:89720
E2f3tm1b(KOMP)Wtsi/E2f3+
(C57BL/6N-E2f3tm1b(KOMP)Wtsi/Kmpc) 		increased total body fat amount J:211773
E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		decreased white adipose tissue amount J:138289
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		decreased subcutaneous adipose tissue amount J:147179
Ebf2tm1.1Ggc/Ebf2tm1.1Ggc
(involves: 129S2/SvPas * C57BL/6J) 		abnormal fat cell morphology J:104946
Ech1tm1b(EUCOMM)Wtsi/Ech1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ech1tm1b(EUCOMM)Wtsi/Ieg) 		increased total body fat amount J:211773
Ecscrtm1a(KOMP)Wtsi/Ecscrtm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal white adipose tissue physiology J:236657
Edartm1.1Bamo/Edartm1.1Bamo
(involves: 129S4/SvJae * FVB) 		abnormal mammary fat pad morphology J:193816
Edn2tm1.1Nat/Edn2tm1.1Nat
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased total body fat amount J:201436
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac) 		abnormal brown adipose tissue morphology J:201436
Efemp1tm2Lmar/Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6) 		decreased subcutaneous adipose tissue amount J:132043
decreased total body fat amount J:132043
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd) 		decreased total body fat amount J:211773
Egfrwa2/Egfrwa2
Ptpn11tm1Paw/Ptpn11+
(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6) 		decreased subcutaneous adipose tissue amount J:75413
Ehd2tm1.1Cbm/Ehd2tm1.1Cbm
(B6N.129(Cg)-Ehd2tm1.1Cbm) 		abnormal adipose tissue physiology J:285350
abnormal beige fat cell morphology J:285350
abnormal white fat cell morphology J:285350
increased adipocyte glucose uptake J:285350
increased brown fat cell lipid droplet size J:285350
increased gonadal fat pad weight J:285350
increased inguinal fat pad weight J:285350
increased white fat cell lipid droplet size J:285350
increased white fat cell size J:285350
Ehd2tm1Cbm/Ehd2tm1Cbm
(involves: 129S1/Sv * 129X1/SvJ) 		increased white fat cell lipid droplet size J:285350
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		decreased brown fat cell size J:207678
decreased brown fat lipid droplet number J:207678
decreased interscapular fat pad weight J:207678
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ) 		abnormal brown adipose tissue physiology J:207678
increased brown fat cell lipid droplet size J:207678
increased epididymal fat pad weight J:207678
increased interscapular fat pad weight J:207678
increased white fat cell lipid droplet size J:207678
Eif2ak1em1(IMPC)Bay/Eif2ak1em1(IMPC)Bay
(C57BL/6N-Eif2ak1em1(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
Eif2b5tm1Itl/Eif2b5tm1Itl
(involves: 129S/SvEv * C57BL * Swiss Webster) 		decreased percent body fat/body weight J:179801
Eif3mtm1.1Nju/Eif3m+
(involves: 129 * FVB/N) 		adipose tissue phenotype J:204915
decreased total fat pad weight J:204915
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * BALB/c) 		abnormal white adipose tissue physiology J:72217
decreased gonadal fat pad weight J:72217
decreased inguinal fat pad weight J:72217
decreased retroperitoneal fat pad weight J:72217
decreased total body fat amount J:72217
decreased white adipose tissue amount J:72217
Eif4g1em1(IMPC)Hmgu/Eif4g1+
(C57BL/6NCrl-Eif4g1em1(IMPC)Hmgu/Ieg) 		increased total body fat amount J:211773
Eif4hGt(Ex279)Byg/Eif4hGt(Ex279)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inguinal fat pad weight J:181945
decreased total body fat amount J:181945
Eif6tm1Sbif/Eif6+
(involves: 129 * C57BL/6) 		abnormal fat cell morphology J:141257
decreased total body fat amount J:141257
Elmod1tm1b(EUCOMM)Hmgu/Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H) 		decreased total body fat amount J:211773
Elmod2tm1b(EUCOMM)Hmgu/Elmod2+
(C57BL/6N-Elmod2tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Elp1tm1Id/Elp1tm1.1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		decreased total body fat amount J:188923
Elp1tm1Id/Elp1tm1.1Id
Tg(IKBKAP*)#Sasl/0
(involves: 129S1/Sv * C57BL/6N) 		decreased epididymal fat pad weight J:229459
decreased total body fat amount J:229459
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		decreased total body fat amount J:188923
Emc3tm1b(EUCOMM)Wtsi/Emc3+
(C57BL/6N-Emc3tm1b(EUCOMM)Wtsi/Ieg) 		increased total body fat amount J:211773
Emc8tm1b(EUCOMM)Hmgu/Emc8+
(C57BL/6N-Emc8tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Emx1tm1.1(KOMP)Vlcg/Emx1tm1.1(KOMP)Vlcg
(C57BL/6N-Emx1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
EnamAbte2/Enam+
(C3HeB/FeJ-EnamAbte2) 		decreased total body fat amount J:220423
Enamabte/Enam+
(C3HeB/FeJ-Enamabte) 		decreased total body fat amount J:220423
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl) 		increased percent body fat/body weight J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl) 		increased body fat mass J:225402
increased percent body fat/body weight J:225402
Enhotm1Cmwo/Enhotm1Cmwo
(B6.129S1-Enhotm1Cmwo) 		adipose tissue phenotype J:216870
Enox1tm1.1(KOMP)Vlcg/Enox1+
(C57BL/6N-Enox1tm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Enpp1tm1Gdg/Enpp1tm1Gdg
(involves: 129S1/Sv) 		abnormal adipose tissue morphology J:133011
Enpp1ttw-Ham/Enpp1ttw-Ham
(Jcl:ICR-Enpp1ttw-Ham) 		decreased abdominal adipose tissue amount J:250073
decreased white fat cell size J:250073
Entpd6tm1a(KOMP)Wtsi/Entpd6tm1a(KOMP)Wtsi
(C57BL/6N-Entpd6tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Eomestm1b(EUCOMM)Wtsi/Eomes+
(C57BL/6N-Eomestm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Epas1em1(IMPC)Wtsi/Epas1em1(IMPC)Wtsi
(C57BL/6N-Epas1em1(IMPC)Wtsi/Wtsi) 		increased total body fat amount J:211773
Epfpq1L6/Epfpq1L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfpq1L6/Epfpq1M16i
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfpq2L6/Epfpq2L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfpq3L6/Epfpq3L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfpq4L6/Epfpq4L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:88793
Epfq1L6/Epfq1L6
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Epfq1L6/Epfq1M16i
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Epfq2L6/Epfq2L6
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Epfq2L6/Epfq2M16i
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Epfq3L6/Epfq3L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfq4L6/Epfq4L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfq5L6/Epfq5L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epfq5L6/Epfq5M16i
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Epg5tm1Ygz/Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		decreased white adipose tissue amount J:196603
decreased white fat cell lipid droplet size J:196603
decreased white fat cell size J:196603
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		increased body fat mass J:173769
Eprs1tm1.1Xen/Eprs1tm1.1Xen
(C57BL/6-Eprs1tm1.1Xen) 		abnormal adipose tissue physiology J:244749
decreased abdominal adipose tissue amount J:244749
decreased brown adipose tissue amount J:244749
decreased white fat cell size J:244749
Eprs1tm2.1Xen/Eprs1tm2.1Xen
Rps6kb1tm1Nte/Rps6kb1tm1Nte
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased epididymal fat pad weight J:244749
decreased inguinal fat pad weight J:244749
decreased interscapular fat pad weight J:244749
decreased mesenteric fat pad weight J:244749
decreased retroperitoneal fat pad weight J:244749
Eps15l1em1(IMPC)J/Eps15l1em1(IMPC)J
(C57BL/6NJ-Eps15l1em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Epxtm1b(EUCOMM)Wtsi/Epxtm1b(EUCOMM)Wtsi
(C57BL/6N-Epxtm1b(EUCOMM)Wtsi/Orl) 		increased total body fat amount J:211773
Erap1tm2b(EUCOMM)Wtsi/Erap1tm2b(EUCOMM)Wtsi
(C57BL/6N-Erap1tm2b(EUCOMM)Wtsi/Kmpc) 		decreased total body fat amount J:211773
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased subcutaneous adipose tissue amount J:41161
Ercc2tm1Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:48256
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal fat cell morphology J:48256
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
Xpatm1Hvs/Xpatm1Hvs
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adipose tissue distribution J:76608
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh) 		abnormal abdominal fat pad morphology J:122013
lipodystrophy J:122013
Erlec1em1(IMPC)Mbp/Erlec1em1(IMPC)Mbp
(C57BL/6N-Erlec1em1(IMPC)Mbp/Ucd) 		decreased total body fat amount J:211773
Esco1tm1(KOMP)Wtsi/Esco1tm1(KOMP)Wtsi
(C57BL/6N-Esco1tm1(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Esr1tm1Geog/Esr1tm1Geog
(involves: 129X1/SvJ * C57BL/6) 		increased gonadal fat pad weight J:135981
increased mammary fat pad weight J:135981
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased gonadal fat pad weight J:66077
increased retroperitoneal fat pad weight J:66077
increased total body fat amount J:66077
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Esr1tm1Ksk) 		adipose tissue phenotype J:65806
increased epididymal fat pad weight J:65806
increased inguinal fat pad weight J:65806
increased parametrial fat pad weight J:65806
increased renal fat pad weight J:65806
increased white adipose tissue amount J:65806
increased white fat cell number J:65806
increased white fat cell size J:65806
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		increased gonadal fat pad weight J:66077
increased retroperitoneal fat pad weight J:66077
increased total body fat amount J:66077
Esr1tm1Syeh/Esr1tm1Syeh
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129X1/SvJ * FVB/N) 		increased total body fat amount J:147191
Esr1tm4.2Ksk/Esr1tm4.2Ksk
(involves: C57BL/6 * C57BL/6NTac * CBA) 		increased total body fat amount J:191182
Esr1tm4.2Ksk/Esr1tm4.2Ksk
Mir22tm1Boet/Mir22tm1Boet
Tg(Ckmm-cre)5Khn/0
(involves: 129S2/SvPas * C57BL/6 * FVB) 		adipose tissue phenotype J:266382
Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas) 		increased total body fat amount J:123373
Esrratm1Vgi/Esrratm1Vgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal adipose tissue physiology J:86433
decreased epididymal fat pad weight J:86433
decreased fat cell mitochondrial DNA content J:119525
decreased inguinal fat pad weight J:86433
decreased percent body fat/body weight J:86433
decreased retroperitoneal fat pad weight J:86433
decreased white fat cell size J:86433
increased brown fat cell lipid droplet size J:119525
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss) 		absent subcutaneous adipose tissue J:122058
Exoc3tm2b(EUCOMM)Hmgu/Exoc3+
(C57BL/6N-Exoc3tm2b(EUCOMM)Hmgu/Wtsi) 		decreased total body fat amount J:211773
F2tm1b(EUCOMM)Hmgu/F2+
(C57BL/6N-F2tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
F7tm1b(EUCOMM)Hmgu/F7+
(C57BL/6N-F7tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto) 		decreased uterine fat pad weight J:64975
increased epididymal fat pad weight J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal brown adipose tissue morphology J:167535
abnormal brown adipose tissue physiology J:167535
decreased brown adipose tissue amount J:167535
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		abnormal brown adipose tissue morphology J:217245
abnormal brown adipose tissue thermogenesis J:217245
decreased brown adipose tissue mass J:217245
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob) 		increased adipocyte glucose uptake J:111878
increased white adipose tissue amount J:111878
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota) 		decreased subcutaneous adipose tissue amount J:81609
increased adipocyte glucose uptake J:81609
Faddtm1e.1(KOMP)Wtsi/Fadd+
(C57BL/6N-Faddtm1e.1(KOMP)Wtsi/Ucd) 		increased total body fat amount J:211773
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi) 		abnormal white adipose tissue physiology J:258290
adipose tissue phenotype J:258290
decreased white fat cell size J:258290
white adipose tissue inflammation J:258290
Fam20atm1b(KOMP)Wtsi/Fam20atm1b(KOMP)Wtsi
(C57BL/6N-Fam20atm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Fam81bem1(IMPC)J/Fam81bem1(IMPC)J
(C57BL/6NJ-Fam81bem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Fam120aem1(IMPC)J/Fam120aem1(IMPC)J
(C57BL/6NJ-Fam120aem1(IMPC)J/J) 		decreased total body fat amount J:211773
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Fancltm1b(EUCOMM)Hmgu/Fancltm1b(EUCOMM)Hmgu
(C57BL/6N-Fancltm1b(EUCOMM)Hmgu/Nju) 		increased total body fat amount J:211773
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased total body fat amount J:127793
decreased total fat pad weight J:127793
Fasntm1Sem/Fasntm1Sem
Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased total body fat amount J:127482
Fatmq1C57BL/6J/Fatmq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased total body fat amount J:117545
Fatmq1CAST/EiJ/Fatmq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased total body fat amount J:117545
Fatmq2C57BL/6J/Fatmq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased total body fat amount J:117545
Fatmq2CAST/EiJ/Fatmq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased total body fat amount J:117545
Fatpad3CAST/EiJ/?
(involves: CAST/EiJ * M16i) 		abnormal fat pad morphology J:108423
increased gonadal fat pad weight J:108423
Fatq1MH/?
(involves: C57BL/6J * MH) 		increased white adipose tissue amount J:55483
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Fbn1em1Chop/Fbn1+
(C57BL/6-Fbn1em1Chop) 		decreased body fat mass J:251851
Fbn1tm2.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		decreased subcutaneous adipose tissue amount J:206074
Fbn1tm3.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		decreased subcutaneous adipose tissue amount J:206074
Fbn1tm3.2Lysa/Fbn1+
(Not Specified) 		decreased subcutaneous adipose tissue amount J:181493
Fbn1tm3.2Lysa/Fbn1tm3.2Lysa
(Not Specified) 		decreased subcutaneous adipose tissue amount J:181493
Fcortm1Jnak/Fcortm1Jnak
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		increased white fat cell size J:184684
Fcrl2tm1Lex/Fcrl2tm1Lex
(B6;129S5-Fcrl2tm1Lex/Mmucd) 		increased total body fat amount J:171883
Fechm1Pas/Fechm1Pas
(involves: 129/Sv * BALB/c) 		decreased total body fat amount J:2021
Fen1tm2Klng/Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6) 		increased fat cell size J:138901
increased white adipose tissue amount J:138901
Ffar3tm1Dgen/Ffar3tm1Dgen
(B6.129P2-Ffar3tm1Dgen) 		abnormal adipose tissue physiology J:160365
Ffar3tm1Reh/Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased epididymal fat pad weight J:143567
Ffar4tm1(KOMP)Vlcg/Ffar4tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal beige fat cell physiology J:240649
abnormal brown adipose tissue physiology J:240649
abnormal brown fat cell differentiation J:240649
abnormal white adipose tissue morphology J:240649
abnormal white adipose tissue physiology J:240649
abnormal white fat cell differentation J:240649
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		increased total body fat amount J:182599
increased white adipose tissue amount J:182599
increased white fat cell size J:182599
Fgf10tm1b(EUCOMM)Wtsi/Fgf10+
(C57BL/6N-Fgf10tm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Fgf10tm1Ska/Fgf10tm1Ska
(involves: C57BL/6 * CBA) 		abnormal adipose tissue morphology J:108349
abnormal mammary fat pad morphology J:73434
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf) 		abnormal adipose tissue morphology J:157309
abnormal brown fat cell morphology J:157309
increased brown adipose tissue amount J:157309
increased gonadal fat pad weight J:157309
increased total body fat amount J:157309
increased white fat cell size J:157309
Fgf21tm1Lex/Fgf21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		abnormal brown adipose tissue physiology J:240649
abnormal brown adipose tissue thermogenesis J:240649
abnormal white adipose tissue physiology J:240649
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit) 		abnormal white fat cell size J:157334
decreased white adipose tissue amount J:157334
decreased white fat cell size J:157334
increased white adipose tissue amount J:157334
increased white fat cell size J:157334
Fgfr2tm1Dsn/Fgfr2tm1Dsn
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		adipose tissue inflammation J:119723
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal brown fat cell morphology J:199844
decreased white fat cell number J:199844
increased brown fat cell lipid droplet size J:199844
increased white adipose tissue amount J:199844
increased white fat cell size J:199844
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6) 		increased epididymal fat pad weight J:302658
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Lepob/Lepob
Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased subcutaneous adipose tissue amount J:212437
decreased white adipose tissue amount J:212437
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal brown fat cell morphology J:212437
abnormal white adipose tissue morphology J:212437
abnormal white adipose tissue physiology J:212437
abnormal white fat cell morphology J:212437
decreased brown fat lipid droplet number J:212437
increased brown fat cell lipid droplet size J:212437
Flnbtm1b(KOMP)Wtsi/Flnb+
(C57BL/6N-Flnbtm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Flt4Chy/Flt4+
(involves: C3H) 		abnormal adipose tissue distribution J:72387
Fmo3em1Jmbn/Fmo3em1Jmbn
(C57BL/6-Fmo3em1Jmbn) 		decreased total body fat amount J:254352
Fmo3em1Jmbn/Fmo3em1Jmbn
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal beige fat cell morphology J:254352
decreased total body fat amount J:254352
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe) 		abnormal fat pad morphology J:223365
abnormal inguinal fat pad morphology J:223365
decreased abdominal adipose tissue amount J:223365
decreased epididymal fat pad weight J:223365
decreased subcutaneous adipose tissue amount J:223365
decreased white fat cell size J:223365
Fndc3aem1(IMPC)Tcp/Fndc3aem1(IMPC)Tcp
(C57BL/6N-Fndc3aem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Fndc9tm1.1(KOMP)Vlcg/Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Fob1F line/Fob1F line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fob1F line/Fob1L line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fob2F line/Fob2F line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fob3F line/Fob3F line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fob3F line/Fob3L line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fob3aL line/Fob3aL line
(F.L-Fob3a) 		decreased total body fat amount J:90000
Fob3bL line/Fob3bL line
(F.L-Fob3b) 		decreased total body fat amount J:90000
Fob4F line/Fob4F line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fob4F line/Fob4L line
(involves: F line * L line) 		increased white adipose tissue amount J:59227
Fosem1(IMPC)Mbp/Fos+
(C57BL/6N-Fosem1(IMPC)Mbp/Ucd) 		increased total body fat amount J:211773
Fosl2tm2Wag/Fosl2tm2Wag
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		adipose tissue phenotype J:211215
increased gonadal fat pad weight J:211215
Foxa2tm1.1Stf/Foxa2tm1.1Stf
Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln) 		decreased total body fat amount J:155391
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk) 		abnormal beige fat cell morphology J:216477
decreased body fat mass J:216477
decreased brown fat cell size J:216477
decreased white fat cell size J:216477
increased adipocyte glucose uptake J:216477
Foxc2tm1Miu/Foxc2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased brown adipose tissue amount J:83436
Foxj3tm1b(EUCOMM)Wtsi/Foxj3+
(C57BL/6N-Foxj3tm1b(EUCOMM)Wtsi/Bay) 		decreased total body fat amount J:211773
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified) 		abnormal adipose tissue physiology J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac) 		increased percent body fat/body weight J:179687
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg) 		decreased white fat cell size J:236585
Foxp2tm2.2Woen/Foxp2+
(involves: C57BL/6 * C57BL/6J) 		decreased total fat pad weight J:150425
Fshrtm1(KOMP)Vlcg/Fshrtm1(KOMP)Vlcg
(C57BL/6N-Fshrtm1(KOMP)Vlcg/Nju) 		increased total body fat amount J:211773
Fshrtm1Saco/Fshrtm1Saco
(involves: 129) 		abnormal abdominal fat pad morphology J:65577
increased total fat pad weight J:65577
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		abnormal abdominal fat pad morphology J:119526
abnormal adipose tissue distribution J:119526
Ftms1SJL/J/Ftms1SJL/J
(involves: MRL/MpJ * SJL/J) 		increased total body fat amount J:106033
FtoI367F/Fto+
(involves: C3H/HeH * C57BL/6J) 		decreased percent body fat/body weight J:152163
decreased total body fat amount J:152163
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J) 		decreased percent body fat/body weight J:152163
decreased total body fat amount J:152163
Ftotm1.1Rdc/Ftotm1.1Rdc
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased total body fat amount J:194922
Ftotm1.2Pzg/Ftotm1.2Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		increased total body fat amount J:166984
Ftotm1.3Pzg/Ftotm1.3Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		increased total body fat amount J:166984
Ftotm1Urt/Ftotm1Urt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased gonadal fat pad weight J:147471
decreased total body fat amount J:147471
decreased white fat cell size J:147471
Ftotm1Urt/Ftotm1Urt
Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal adipose tissue morphology J:219118
increased fat cell size J:219118
increased gonadal fat pad weight J:219118
increased inguinal fat pad weight J:219118
increased interscapular fat pad weight J:219118
increased percent body fat/body weight J:219118
Fut4em1(IMPC)Ics/Fut4em1(IMPC)Ics
(C57BL/6N-Fut4em1(IMPC)Ics/Ics) 		increased total body fat amount J:211773
Fyttd1em1(IMPC)J/Fyttd1em1(IMPC)J
(C57BL/6NJ-Fyttd1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Fzd3tm1b(EUCOMM)Hmgu/Fzd3+
(C57BL/6N-Fzd3tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal fat cell differentiation J:232077
abnormal white adipose tissue physiology J:209000
decreased brown adipose tissue amount J:209000
decreased epididymal fat pad weight J:232077
decreased gonadal fat pad weight J:209000, J:225236
decreased inguinal fat pad weight J:209000
decreased omental fat pad weight J:209000
decreased renal fat pad weight J:209000
decreased total body fat amount J:232077
decreased white fat cell size J:232077
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd) 		abnormal brown adipose tissue thermogenesis J:219653
abnormal white adipose tissue physiology J:219653
decreased abdominal adipose tissue amount J:219653
decreased body fat mass J:219653
decreased total fat pad weight J:219653
decreased white adipose tissue mass J:219653
decreased white fat cell size J:219653
G2e3em1(IMPC)Tcp/G2e3em1(IMPC)Tcp
(C57BL/6NCrl-G2e3em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Gabbr1tm1Dgen/Gabbr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		absent subcutaneous adipose tissue J:101679
Gabra2em1(IMPC)H/Gabra2em1(IMPC)H
(C57BL/6N-Gabra2em1(IMPC)H/H) 		decreased total body fat amount J:211773
Gabrg3em1(IMPC)J/Gabrg3em1(IMPC)J
(C57BL/6NJ-Gabrg3em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv) 		abnormal brown adipose tissue physiology J:213702
Galnt18tm1b(KOMP)Wtsi/Galnt18tm1b(KOMP)Wtsi
(C57BL/6N-Galnt18tm1b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Gamttm1Isb/Gamttm1Isb
(involves: 129S1/Sv * 129X1/SvJ) 		decreased total body fat amount J:90367
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Gas7em1(IMPC)J/Gas7em1(IMPC)J
(C57BL/6NJ-Gas7em1(IMPC)J/J) 		increased total body fat amount J:211773
Gata3tm3Gsv/Gata3tm3Gsv
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		absent subcutaneous adipose tissue J:117058
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb) 		decreased subcutaneous adipose tissue amount J:191142
decreased total body fat amount J:191142
decreased white adipose tissue amount J:191142
increased adipocyte glucose uptake J:191142
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		decreased body fat mass J:300368
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		decreased abdominal adipose tissue amount J:176507
decreased subcutaneous adipose tissue amount J:176507
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL) 		decreased brown adipose tissue amount J:81772
decreased gonadal fat pad weight J:81772
decreased interscapular fat pad weight J:81772
decreased total body fat amount J:81772
Gdatm1a(KOMP)Wtsi/Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Gdap2em1(IMPC)Wtsi/Gdap2em1(IMPC)Wtsi
(C57BL/6N-Gdap2em1(IMPC)Wtsi/WtsiIeg) 		decreased total body fat amount J:211773
Gdf3tm1Zuk/Gdf3tm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal fat cell morphology J:143083
decreased white adipose tissue amount J:143083
Gdf15tm1Breit/Gdf15tm1Breit
(B6.Cg-Gdf15tm1Breit) 		increased inguinal fat pad weight J:197174
increased mesenteric fat pad weight J:197174
increased retroperitoneal fat pad weight J:197174
increased total body fat amount J:197174
increased white adipose tissue amount J:197174
Gemin4em1(IMPC)Ics/Gemin4+
(C57BL/6N-Gemin4em1(IMPC)Ics/Ics) 		increased total body fat amount J:211773
Gfi1btm1b(EUCOMM)Hmgu/Gfi1b+
(C57BL/6N-Gfi1btm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Gfpq1CAST/EiJ/Gfpq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		increased gonadal fat pad weight J:117545
Gfra2tm1Msa/Gfra2tm1Msa
(either: B6.129-Gfra2tm1Msa or 129S2.129-Gfra2tm1Msa) 		decreased gonadal fat pad weight J:93911
Ggcxtm1.1Kry/Ggcxtm1.1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB/N) 		decreased epididymal fat pad weight J:264734
GhSma1/Gh+
(C3HeB/FeJ-GhSma1) 		increased white adipose tissue amount J:89518
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1) 		increased brown adipose tissue amount J:89518
increased white adipose tissue amount J:89518
Ghtm1.1(KOMP)Vlcg/Ghtm1.1(KOMP)Vlcg
(C57BL/6N-Ghtm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Ghrtm1.1Jero/Ghrtm1.1Jero
(B6.129X1-Ghrtm1.1Jero) 		decreased epididymal fat pad weight J:155335
decreased inguinal fat pad weight J:155335
increased percent body fat/body weight J:155335
Ghrtm1c(KOMP)Wtsi/Ghrtm1c(KOMP)Wtsi
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6N) 		increased brown adipose tissue amount J:206358
increased gonadal fat pad weight J:206358
increased mesenteric fat pad weight J:206358
increased retroperitoneal fat pad weight J:206358
increased subcutaneous adipose tissue amount J:206358
increased total body fat amount J:206358
increased white fat cell size J:206358
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd) 		decreased epididymal fat pad weight J:95149
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		increased interscapular fat pad weight J:105686
increased percent body fat/body weight J:105686, J:132437
increased retroperitoneal fat pad weight J:105686, J:132437
increased white adipose tissue amount J:132437
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased abdominal fat pad weight J:107763
Ghrtm2Mwat/Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL) 		increased total body fat amount J:95149
Ghrhtm1b(EUCOMM)Wtsi/Ghrhtm1b(EUCOMM)Wtsi
(C57BL/6N-Ghrhtm1b(EUCOMM)Wtsi/Tcp) 		increased total body fat amount J:211773
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit) 		increased total body fat amount J:3735
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit/J) 		increased total body fat amount J:95779
Ghrhrlit/Ghrhrlit
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * C57BL/6J) 		increased total body fat amount J:95779
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Ghrltm1Mws/Ghrltm1Mws
(involves: C57BL/6) 		abnormal adipose tissue amount J:90698
Ghsrtm1Lowl/Ghsrtm1Lowl
(involves: C57BL/6J) 		decreased total body fat amount J:104704
Gimap6tm1a(KOMP)Wtsi/Gimap6tm1a(KOMP)Wtsi
(C57BL/6N-Gimap6tm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Gk5m1Btlr/Gk5m1Btlr
(C57BL/6J-Gk5m1Btlr) 		decreased white fat cell number J:243852
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(C57BL/6N-Gkn2tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129S1/Sv * 129X1/SvJ) 		decreased total body fat amount J:206563
Glp2rtm1.1Xfg/Glp2rtm1.1Xfg
Tg(Pomc1-cre)16Lowl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased percent body fat/body weight J:189593
Glra1nmf11/Glra1nmf11
(C57BL/6J-Glra1nmf11/J) 		decreased white adipose tissue amount J:78134
Gm94tm1b(KOMP)Wtsi/Gm94+
(C57BL/6N-Gm94tm1b(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Gm16364tm1Zhaoy/Gm16364tm1Zhaoy
(involves: C57BL/6) 		decreased fat cell size J:322340
Gm16364tm2Zhaoy/Gm16364tm2Zhaoy
(involves: C57BL/6) 		decreased white adipose tissue mass J:322340
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq) 		increased percent body fat/body weight J:341056
increased total body fat amount J:341056
Gmdstm1a(KOMP)Wtsi/Gmdstm1a(KOMP)Wtsi
(C57BL/6N-Gmdstm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
GnasOedsml/Gnas+
(involves: 101/H * C3H/HeH) 		increased brown adipose tissue amount J:65007
Gnastm1Kel/Gnas+
(involves: 129S2/SvPas * C57BL/6J) 		decreased brown adipose tissue amount J:91703
decreased interscapular fat pad weight J:91703
decreased white adipose tissue amount J:91703
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1) 		abnormal brown adipose tissue morphology J:60971
decreased brown adipose tissue amount J:60971
decreased epididymal fat pad weight J:60971
decreased interscapular fat pad weight J:60971
decreased white adipose tissue amount J:60971
increased brown adipose tissue amount J:60971
increased brown fat cell lipid droplet size J:60971
increased interscapular fat pad weight J:60971
increased white adipose tissue amount J:60971
Gnastm2Jop/Gnas+
(involves: 129S/SvEv) 		decreased percent body fat/body weight J:182868
decreased total body fat amount J:182868
Gnastm3Jop/Gnas+
(involves: 129S/SvEv) 		decreased total body fat amount J:182868
Gnastm3Kel/Gnas+
(involves: 129P2/OlaHsd * C57BL/6J * DS/2) 		abnormal fat pad morphology J:143477
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss * CD-1) 		abnormal adipose tissue morphology J:99237
increased brown adipose tissue amount J:99237
increased interscapular fat pad weight J:99237
increased total body fat amount J:99237
increased white adipose tissue amount J:99237
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		decreased total body fat amount J:102504
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0
(involves: FVB) 		abnormal adipose tissue development J:159612
abnormal white adipose tissue physiology J:159612
decreased body fat mass J:159612
decreased epididymal fat pad weight J:159612
decreased inguinal fat pad weight J:159612
decreased mesenteric fat pad weight J:159612
decreased renal fat pad weight J:159612
decreased subcutaneous adipose tissue amount J:159612
decreased white adipose tissue amount J:159612
decreased white fat cell size J:159612
Gnaztm1.1(KOMP)Vlcg/Gnaz+
(C57BL/6N-Gnaztm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Gnf1C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52)) 		decreased total body fat amount J:99312
Gnf2C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52)) 		decreased total body fat amount J:99312
Gnf3C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52)) 		decreased total body fat amount J:99312
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N) 		decreased inguinal fat pad weight J:92791
decreased retroperitoneal fat pad weight J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N) 		decreased inguinal fat pad weight J:92791
decreased retroperitoneal fat pad weight J:92791
Gng12em1(IMPC)J/Gng12em1(IMPC)J
(C57BL/6NJ-Gng12em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Gng13tm1.1(KOMP)Vlcg/Gng13+
(C57BL/6N-Gng13tm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Gngt2em1(IMPC)Bay/Gngt2em1(IMPC)Bay
(C57BL/6N-Gngt2em1(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
Gnl1em1(IMPC)Tcp/Gnl1em1(IMPC)Tcp
(C57BL/6N-Gnl1em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ) 		decreased gonadal fat pad weight J:134068
decreased percent body fat/body weight J:134068
decreased retroperitoneal fat pad weight J:134068
Gpamtm1Lex/Gpamtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased gonadal fat pad weight J:84541
decreased percent body fat/body weight J:84541
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6) 		decreased brown adipose tissue amount J:213618
decreased total body fat amount J:213618
decreased total fat pad weight J:213618
Gpbar1tm1Ktan/Gpbar1+
(involves: 129X1/SvJ * C57BL/6N) 		abnormal adipose tissue amount J:114971
Gpbar1tm1Ktan/Gpbar1tm1Ktan
(involves: 129X1/SvJ * C57BL/6N) 		abnormal adipose tissue amount J:114971
Gpd2tm1Lbr/Gpd2tm1Lbr
(B6.129X1-Gpd2tm1Lbr) 		decreased epididymal fat pad weight J:78828
decreased parametrial fat pad weight J:78828
decreased white adipose tissue amount J:78828
Gpd2tm1Tka/Gpd2tm1Tka
(B6.Cg-Gpd2tm1Tka) 		decreased brown adipose tissue mass J:87244
decreased brown fat cell lipid droplet size J:87244
Gpld1tm1.1(KOMP)Vlcg/Gpld1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpld1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Gpm6atm1Lex/Gpm6atm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:103485
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen) 		increased gonadal fat pad weight J:111942
increased percent body fat/body weight J:111942
increased retroperitoneal fat pad weight J:111942
Gpr15em1(IMPC)J/Gpr15em1(IMPC)J
(C57BL/6NJ-Gpr15em1(IMPC)J/J) 		increased total body fat amount J:211773
Gpr21tm1Dgen/Gpr21tm1Dgen
(B6.129P2-Gpr21tm1Dgen) 		decreased percent body fat/body weight J:181127
Gpr22tm1b(KOMP)Wtsi/Gpr22tm1b(KOMP)Wtsi
(C57BL/6N-Gpr22tm1b(KOMP)Wtsi/H) 		decreased total body fat amount J:211773
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6) 		increased total body fat amount J:189617
Gpr37tm1Dgen/Gpr37tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased percent body fat/body weight J:101679
Gpr39tm1Lex/Gpr39tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased percent body fat/body weight J:124913
Gpr50tm1Dgen/Gpr50tm1Dgen
(involves: C57BL/6) 		decreased percent body fat/body weight J:131227
Gpr55em1(IMPC)Mbp/Gpr55em1(IMPC)Mbp
(C57BL/6NCrl-Gpr55em1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased abdominal fat pad weight J:302257
increased body fat mass J:302257
increased epididymal fat pad weight J:302257
increased mesenteric fat pad weight J:302257
increased retroperitoneal fat pad weight J:302257
Gpr65tm1b(KOMP)Wtsi/Gpr65tm1b(KOMP)Wtsi
(C57BL/6N-Gpr65tm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(B6.Cg-Gpr68tm1.1Yaxu) 		adipose tissue phenotype J:149315
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		abnormal brown adipose tissue morphology J:149315
increased brown adipose tissue amount J:149315
Gpr68tm1Yaxu/Gpr68tm1Yaxu
(involves: C57BL/6) 		abnormal brown adipose tissue morphology J:149315
decreased brown adipose tissue amount J:149315
Gpr82tm1Shbg/Y
(C3Fe.Cg-Gpr82tm1Shbg) 		abnormal adipose tissue amount J:301613
decreased fat cell size J:301613
decreased total body fat amount J:301613
Gpr82tm1Shbg/Gpr82tm1Shbg
(C3Fe.Cg-Gpr82tm1Shbg) 		abnormal adipose tissue amount J:301613
decreased fat cell size J:301613
decreased total body fat amount J:301613
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6) 		increased white adipose tissue amount J:144372
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL) 		decreased white adipose tissue amount J:138126
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Adipoq-cre)#Pesch/0
(involves: 129S/SvEv * FVB) 		abnormal adipose tissue physiology J:213603
abnormal brown adipose tissue physiology J:213603
abnormal epididymal fat pad morphology J:213603
abnormal interscapular fat pad morphology J:213603
increased body fat mass J:213603
increased brown fat cell size J:213603
increased white fat cell size J:213603
whitened brown adipose tissue morphology J:213603
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv) 		abnormal epididymal fat pad morphology J:213603
increased body fat mass J:213603
increased brown fat cell size J:213603
increased white fat cell size J:213603
whitened brown adipose tissue morphology J:213603
Greb1lem1(IMPC)J/Greb1l+
(C57BL/6NJ-Greb1lem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Grik1tm1b(KOMP)Mbp/Grik1tm1b(KOMP)Mbp
(C57BL/6N-Grik1tm1b(KOMP)Mbp/H) 		decreased total body fat amount J:211773
Grik4em1(IMPC)Mbp/Grik4em1(IMPC)Mbp
(C57BL/6N-Grik4em1(IMPC)Mbp/MbpMmucd) 		increased total body fat amount J:211773
Grm1crv4/Grm1crv4
(BALB/cPas-Grm1crv4) 		increased brown adipose tissue amount J:112290
Grm3tm1b(KOMP)Wtsi/Grm3tm1b(KOMP)Wtsi
(C57BL/6N-Grm3tm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased total body fat amount J:82809
Grm8tm1Duv/Grm8tm1Duv
(B6.129S1-Grm8tm1Duv) 		increased percent body fat/body weight J:101087
Gsk3atm1.1Jrw/Gsk3atm1.1Jrw
(involves: 129S6/SvEvTac * C57BL/6) 		decreased percent body fat/body weight J:130033
Gsk3atm1a(EUCOMM)Wtsi/Gsk3atm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Gsk3atm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Gstm6tm1b(EUCOMM)Hmgu/Gstm6tm1b(EUCOMM)Hmgu
(C57BL/6N-Gstm6tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Gsto1em1(IMPC)J/Gsto1em1(IMPC)J
(C57BL/6NJ-Gsto1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Gt(ROSA)26Sortm1(Akt1/EGFP)Glas/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased total body fat amount J:94134
Gt(ROSA)26Sortm1(CAG-LMNA*)Cyh/Gt(ROSA)26Sor+
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6JNarl * FVB) 		abnormal white adipose tissue morphology J:284048
decreased body fat mass J:284048
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Tardbptm1.1Pcw/Tardbp+
(involves: 129 * C57BL/6 * SJL) 		decreased total body fat amount J:164406
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Tardbptm1.1Pcw/Tardbptm1.1Pcw
(involves: 129 * C57BL/6 * SJL) 		decreased total body fat amount J:164406
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
Tg(Pomc-EGFP)1Low/0
Tg(Gnrh1-cre)1Dlc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA) 		increased abdominal adipose tissue amount J:199640
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg
Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N) 		decreased gonadal fat pad weight J:201507
decreased white fat cell number J:201507
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		increased retroperitoneal fat pad weight J:169459
increased subcutaneous adipose tissue amount J:169459
increased total body fat amount J:169459
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sortm9(CAG-tdTomato)Hze
Oxttm1.1(cre)Dolsn/Oxt+
(involves: 129S6/SvEvTac * C57BL/6) 		increased total body fat amount J:192007
Gt(ROSA)26Sortm1(Irx3*)Hui/Gt(ROSA)26Sor+
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		abnormal white adipose tissue physiology J:208887
decreased fat cell size J:208887
decreased percent body fat/body weight J:208887
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Lepob/Lepob
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		adipose tissue phenotype J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		abnormal brown adipose tissue morphology J:237232
lipodystrophy J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		abnormal white fat cell differentation J:237232
absent epididymal fat pad J:237232
lipodystrophy J:237232
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB) 		decreased total body fat amount J:194290
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Agrp-cre)1Gsb/0
(involves: 129 * C57BL/6J * FVB/N) 		adipose tissue phenotype J:209418
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB/N) 		decreased epididymal fat pad weight J:209418
decreased total body fat amount J:209418
increased adipose tissue noradrenaline turnover J:209418
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/?
Tg(Fabp4-cre/ERT2)1Ipc/0
Tyk2tm1Shmd/Tyk2tm1Shmd
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		adipose tissue phenotype J:195099
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
Tg(Agrp-cre)1Gsb/?
(involves: C57BL/6 * FVB/N) 		decreased gonadal fat pad weight J:133218
Gt(ROSA)26Sortm1(Tgfbr1*)Crm/Gt(ROSA)26Sor+
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		decreased subcutaneous adipose tissue amount J:134135
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		increased abdominal fat pad weight J:166829
increased total body fat amount J:166829
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		increased abdominal fat pad weight J:166829
increased total body fat amount J:166829
Gt(ROSA)26Sortm2(Foxo1)Jnk/Gt(ROSA)26Sor+
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat,-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		increased total body fat amount J:162892
Gt(ROSA)26Sortm2(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Agrp-cre)1Gsb/0
(involves: 129 * C57BL/6J * FVB/N) 		adipose tissue phenotype J:209418
Gt(ROSA)26Sortm2(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB/N) 		adipose tissue phenotype J:209418
Gt(ROSA)26Sortm3(Irf4)Evdr/Gt(ROSA)26Sor+
Tg(Ucp1-cre)1Evdr/0
(involves: 129 * C57BL/6J * FVB) 		abnormal adipose tissue development J:214637
abnormal white fat cell size J:214637
browned white adipose tissue morphology J:214637
decreased body fat mass J:214637
decreased epididymal fat pad weight J:214637
decreased inguinal fat pad weight J:214637
Gt(ROSA)26Sortm3(RNAi:Fabp4)Mrl/Gt(ROSA)26Sor+
(B6NTac.Cg-Gt(ROSA)26Sortm3(RNAi:Fabp4)Mrl) 		increased total body fat amount J:177476
Gtf2a1tm1a(KOMP)Wtsi/Gtf2a1+
(C57BL/6N-Gtf2a1tm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased total body fat amount J:182346
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar) 		increased subcutaneous adipose tissue amount J:178241
increased total body fat amount J:178241
Gulp1em1(IMPC)J/Gulp1em1(IMPC)J
(C57BL/6NJ-Gulp1em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Gusbmps/Gusbmps
(involves: C57BL/6By) 		decreased white adipose tissue amount J:13923
Gxylt2em1(IMPC)Bay/Gxylt2em1(IMPC)Bay
(C57BL/6N-Gxylt2em1(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
Gy/Y
(involves: C3H/Sn * C57BL/6Ei) 		decreased total body fat amount J:88352
H6pdtm1c(EUCOMM)Wtsi/H6pdtm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		decreased epididymal fat pad weight J:292236
decreased fat cell size J:292236
decreased mesenteric fat pad weight J:292236
decreased subcutaneous adipose tissue amount J:292236
Hacd2tm1a(EUCOMM)Hmgu/Hacd2tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		abnormal brown adipose tissue thermogenesis J:333944
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg) 		decreased total body fat amount J:179084
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan) 		abnormal brown adipose tissue morphology J:117738
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa) 		decreased abdominal adipose tissue amount J:296531
decreased fat cell size J:296531
decreased subcutaneous adipose tissue amount J:296531
decreased total body fat amount J:296531
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Hdac3tm1Swh/Hdac3tm1.1Swh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased total body fat amount J:134288
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased brown adipose tissue amount J:85774
increased epididymal fat pad weight J:85774
increased interscapular fat pad weight J:85774
increased white adipose tissue amount J:85774
increased white fat cell size J:85774
Hdgfl3em1(IMPC)Tcp/Hdgfl3em1(IMPC)Tcp
(C57BL/6NCrl-Hdgfl3em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Hecaem1(IMPC)J/Hecaem1(IMPC)J
(C57BL/6NJ-Hecaem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Hectd3tm1(NCOM)Cmhd/Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju) 		increased total body fat amount J:211773
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J) 		decreased subcutaneous adipose tissue amount J:107145
Helqem1(IMPC)Mbp/Helqem1(IMPC)Mbp
(C57BL/6N-Helqem1(IMPC)Mbp/MbpMmucd) 		increased total body fat amount J:211773
Herc1em3(IMPC)Wtsi/Herc1em3(IMPC)Wtsi
(C57BL/6N-Herc1em3(IMPC)Wtsi/Wtsi) 		increased total body fat amount J:211773
Herc2mpc178H/Herc2mpc178H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased total body fat amount J:87617
Hgsnatem4(IMPC)Tcp/Hgsnatem4(IMPC)Tcp
(C57BL/6NCrl-Hgsnatem4(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Hhatlem1(IMPC)Mbp/Hhatl+
(C57BL/6N-Hhatlem1(IMPC)Mbp/Ucd) 		increased total body fat amount J:211773
Hhatlem1(IMPC)Mbp/Hhatlem1(IMPC)Mbp
(C57BL/6N-Hhatlem1(IMPC)Mbp/Ucd) 		increased total body fat amount J:211773
Hif1atm1Stom/Hif1atm1Stom
Tg(Vil1-cre)20Syr/0
(B6.Cg-Hif1atm1Stom Tg(Vil1-cre)20Syr) 		decreased body fat mass J:325395
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo) 		decreased epididymal fat pad weight J:160941
decreased white fat cell size J:160941
Hilpdatm1Xen/Hilpdatm1Xen
(C57BL/6-Hilpdatm1Xen) 		adipose tissue phenotype J:301866
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		abnormal retroperitoneal fat pad morphology J:237329
Hkdc1em1(IMPC)Bay/Hkdc1em1(IMPC)Bay
(C57BL/6N-Hkdc1em1(IMPC)Bay/BayMmucd) 		increased total body fat amount J:211773
Hlb44/?
(C57BL/6J-Hlb44) 		increased percent body fat/body weight J:82961
hlb52/?
(C57BL/6J-hlb52/J) 		increased percent body fat/body weight J:82961
hlb52/hlb52
(C57BL/6J-hlb52/J) 		increased percent body fat/body weight J:82961
Hlb80/?
(C57BL/6J-Hlb80) 		increased percent body fat/body weight J:82961
Hlb81/?
(C57BL/6J-Hlb81) 		increased percent body fat/body weight J:82961
Hlb93/?
(C57BL/6J-Hlb93) 		increased percent body fat/body weight J:82961
hlb124/?
(C57BL/6J-hlb124/J) 		increased percent body fat/body weight J:82961
Hlb125/?
(C57BL/6J-Hlb125) 		increased percent body fat/body weight J:82961
Hlb131/?
(C57BL/6J-Hlb131/J) 		increased percent body fat/body weight J:82961
Hlb132/?
(C57BL/6J-Hlb132) 		increased percent body fat/body weight J:82961
Hlb147/?
(C57BL/6J-Hlb147) 		increased percent body fat/body weight J:82961
Hlb163/?
(C57BL/6J-Hlb163) 		increased percent body fat/body weight J:82961
Hlb181/?
(C57BL/6J-Hlb181) 		increased percent body fat/body weight J:82961
Hlb197/?
(C57BL/6J-Hlb197) 		increased percent body fat/body weight J:82961
Hlb199/?
(C57BL/6J-Hlb199) 		increased percent body fat/body weight J:82961
Hlb228/?
(involves: 129 * C57BL/6) 		increased percent body fat/body weight J:82961
Hlb230/?
(C57BL/6J-Hlb230/J) 		increased percent body fat/body weight J:82961
hlb349A/hlb349A
(involves: 129S1/SvImJ * C57BL/6J) 		increased percent body fat/body weight J:82961
hlb541/?
(C57BL/6J-hlb541/J) 		increased percent body fat/body weight J:77944
hlb575/hlb575
(C57BL/6J-hlb575/J) 		increased percent body fat/body weight J:82961
hlb579/?
(C57BL/6J-hlb579/J) 		increased percent body fat/body weight J:77944
hlb583/?
(C57BL/6J-hlb583/J) 		increased percent body fat/body weight J:77944
Hmga2pg-Tg40BCha/Hmga2+
(involves: C57BL/6J * CBA/J) 		decreased percent body fat/body weight J:21153
Hmga2pg-Tg40BCha/Hmga2pg-Tg40BCha
(involves: C57BL/6J * CBA/J) 		decreased percent body fat/body weight J:21153
Hmga2tm1Cha/Hmga2tm1Cha
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal fat pad morphology J:61493
decreased inguinal fat pad weight J:61493
decreased mesenteric fat pad weight J:61493
Hmgcs2em1(IMPC)Tcp/Hmgcs2em1(IMPC)Tcp
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		increased body fat mass J:326918
Hmgn1em1(IMPC)Ics/Hmgn1em1(IMPC)Ics
(C57BL/6N-Hmgn1em1(IMPC)Ics/Ics) 		increased total body fat amount J:211773
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N) 		decreased fat cell size J:214639
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas) 		absent subcutaneous adipose tissue J:31627
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas) 		absent subcutaneous adipose tissue J:31627
Hook3tm1b(NCOM)Mfgc/Hook3tm1b(NCOM)Mfgc
(C57BL/6N-Hook3tm1b(NCOM)Mfgc/Tcp) 		decreased total body fat amount J:211773
Hrrh/Hrrh
(involves: FVB/N) 		decreased white adipose tissue amount J:192868
Hrctm1Blk/Hrctm1Blk
(B6.129S6-Hrctm1Blk) 		abnormal fat pad morphology J:117648
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn) 		decreased total body fat amount J:107191
increased brown adipose tissue amount J:107191
increased fat cell size J:107191
increased white adipose tissue amount J:107191
Hrh3tm1Kot/Hrh3tm1Kot
(involves: 129X1/SvJ * C57BL/6N) 		increased total body fat amount J:80824
Hs3st3a1tm1(KOMP)Vlcg/Hs3st3a1tm1(KOMP)Vlcg
(C57BL/6N-Hs3st3a1tm1(KOMP)Vlcg/MbpMmucd) 		decreased total body fat amount J:211773
Hsd11b1tm1.2Tuck/Hsd11b1tm1.2Tuck
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal epididymal fat pad morphology J:203302
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N) 		increased subcutaneous adipose tissue amount J:214146
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1) 		abnormal abdominal fat pad morphology J:89080
abnormal epididymal fat pad morphology J:89080
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(B6.129P2(Cg)-Hsd11b1tm1Yko) 		abnormal abdominal fat pad morphology J:89080
abnormal epididymal fat pad morphology J:89080
Hsd17b1tm1.1(KOMP)Vlcg/Hsd17b1tm1.1(KOMP)Vlcg
(C57BL/6N-Hsd17b1tm1.1(KOMP)Vlcg/J) 		decreased total body fat amount J:211773
Hsd17b3tm1.2Mpo/Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl) 		increased body fat mass J:301756
Hspbap1tm1b(EUCOMM)Hmgu/Hspbap1tm1b(EUCOMM)Hmgu
(C57BL/6N-Hspbap1tm1b(EUCOMM)Hmgu/Bay) 		decreased total body fat amount J:211773
Htr1btm1.1(KOMP)Vlcg/Htr1b+
(C57BL/6N-Htr1btm1.1(KOMP)Vlcg/J) 		decreased total body fat amount J:211773
Htr2btm1b(EUCOMM)Wtsi/Htr2b+
(C57BL/6N-Htr2btm1b(EUCOMM)Wtsi/Nju) 		increased total body fat amount J:211773
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke) 		increased percent body fat/body weight J:147514
increased white adipose tissue amount J:147514
Htr2ctm1Jke/Y
Tg(Pomc1-cre)16Lowl/0
(B6.Cg-Htr2ctm1Jke Tg(Pomc1-cre)16Lowl) 		adipose tissue phenotype J:147514
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2)) 		increased epididymal fat pad weight J:24339
increased renal fat pad weight J:24339
increased white adipose tissue amount J:24339
Htr2ctm1Jul/Y
(B6.129S-Htr2ctm1Jul) 		increased epididymal fat pad weight J:50262
increased renal fat pad weight J:50262
increased white adipose tissue amount J:50262
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk) 		decreased body fat mass J:142503
decreased brown adipose tissue mass J:142503
decreased white adipose tissue amount J:142503
Htr2ctm2Lex/Htr2ctm2Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		adipose tissue phenotype J:185494
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp) 		decreased white adipose tissue amount J:87451
Htr6tm1Arte/Htr6tm1Arte
(involves: C57BL/6) 		decreased total body fat amount J:145073
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		decreased total body fat amount J:50420
Hvf/Hvf+
(involves: C3H/HeH * C57BL/6J) 		decreased body fat mass J:277886
Iah1tm1b(EUCOMM)Hmgu/Iah1tm1b(EUCOMM)Hmgu
(involves: C57BL * C57BL/6N * DBA) 		increased mesenteric fat pad weight J:289414
Id2tm1Ago/Id2tm1Ago
(B6.129-Id2tm1Ago) 		adipose tissue phenotype J:138276
decreased inguinal fat pad weight J:138276
decreased interscapular fat pad weight J:138276
decreased white adipose tissue amount J:138276
Id4tm1Fsky/Id4tm1Fsky
(involves: 129P2/OlaHsd) 		abnormal fat cell morphology J:162236
Idetm1a(EUCOMM)Wtsi/Idetm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Idetm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Iduatm1.1Kmke/Iduatm1.1Kmke
(B6.129-Iduatm1.1Kmke) 		decreased percent body fat/body weight J:155619
Igf1tm1.1Dlr/Igf1tm1.1Dlr
Tg(Ttr-IGF1)1Sykr/0
(FVB.Cg-Igf1tm1.1Dlr Tg(Ttr-IGF1)1Sykr) 		decreased gonadal fat pad weight J:157350
decreased percent body fat/body weight J:157350
decreased total body fat amount J:157350
Igf1tm1Arge/Igf1+
Liftm1Stw/Liftm1Stw
(involves: 129S/SvEv * 129S1/Sv * C57BL/6 * MF1) 		abnormal white fat cell morphology J:87585
decreased gonadal fat pad weight J:87585
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Tg(Fabp4-cre)1Abel/?
(involves: C57BL/6 * FVB/N) 		abnormal fat cell morphology J:141321
abnormal gonadal fat pad morphology J:141321
increased fat cell size J:141321
increased total body fat amount J:141321
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ
(B6.C3-(D6Mit93-D6Mit150)) 		decreased total body fat amount J:112375
increased percent body fat/body weight J:99471
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini) 		abnormal brown adipose tissue thermogenesis J:271356
decreased subcutaneous adipose tissue amount J:271356
decreased total body fat amount J:271356
decreased white adipose tissue amount J:271356
decreased white fat cell number J:271356
whitened brown adipose tissue morphology J:271356
Igfbp3tm1Jep/Igfbp3tm1Jep
Igfbp4tm1Jep/Igfbp4tm1Jep
Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J) 		abnormal abdominal fat pad morphology J:112029
decreased total fat pad weight J:112029
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased white adipose tissue amount J:168345
Ikem2(IMPC)Kmpc/Ik+
(C57BL/6NTac-Ikem2(IMPC)Kmpc/Kmpc) 		increased total body fat amount J:211773
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		absent subcutaneous adipose tissue J:63054
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		increased abdominal fat pad weight J:108634
increased gonadal fat pad weight J:108634
increased inguinal fat pad weight J:108634
increased mesenteric fat pad weight J:108634
increased percent body fat/body weight J:108634
increased retroperitoneal fat pad weight J:108634
increased total body fat amount J:108634
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		adipose tissue phenotype J:166367
decreased adipocyte glucose uptake J:166367
Il12rb1tm1b(KOMP)Wtsi/Il12rb1tm1b(KOMP)Wtsi
(C57BL/6N-Il12rb1tm1b(KOMP)Wtsi/Bay) 		decreased total body fat amount J:211773
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd) 		increased percent body fat/body weight J:122588
increased total fat pad weight J:122588
increased white adipose tissue amount J:122588
Il31ratm1b(EUCOMM)Hmgu/Il31ratm1b(EUCOMM)Hmgu
(C57BL/6N-Il31ratm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Impacttm1.1Casb/Impacttm1.1Casb
(involves: C57BL/6J) 		decreased white adipose tissue amount J:279071
inad/inad
(C57BL/6-inad) 		decreased total body fat amount J:97670
Ino80dtm1b(EUCOMM)Wtsi/Ino80d+
(C57BL/6N-Ino80dtm1b(EUCOMM)Wtsi/Bay) 		decreased total body fat amount J:211773
Inpp5aem1(IMPC)Tcp/Inpp5a+
(C57BL/6NCrl-Inpp5aem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Ins2Akita/?
(involves: C57BL/6NSlc) 		decreased adipocyte glucose uptake J:130021
decreased body fat mass J:130021
increased adipocyte glucose uptake J:130021
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita) 		decreased subcutaneous adipose tissue amount J:108948
Insig1tm1.1Aztc/Insig1tm1.1Aztc
(Not Specified) 		abnormal white fat cell differentation J:208931
abnormal white fat cell morphology J:208931
increased gonadal fat pad weight J:208931
increased subcutaneous adipose tissue amount J:208931
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased white adipose tissue amount J:91350
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased white adipose tissue amount J:91350
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased total body fat amount J:80773
Insrtm1Jja/Insrtm1Jja
Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2) 		abnormal inguinal fat pad morphology J:80773
Insrtm1Khn/Insrtm1Khn
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N) 		abnormal gonadal fat pad morphology J:192274
increased abdominal adipose tissue amount J:192274
increased fat cell size J:192274
increased percent body fat/body weight J:192274
white adipose tissue inflammation J:192274
Insrtm1Khn/Insrtm1Khn
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6J * FVB) 		abnormal fat pad morphology J:51266
Insrtm1Khn/Insrtm1Khn
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6J * SJL) 		increased white adipose tissue amount J:64790
Insrtm1Khn/Insrtm1Khn
Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB) 		abnormal brown adipose tissue morphology J:169404
abnormal epididymal fat pad morphology J:169404
increased brown fat cell lipid droplet size J:169404
Insrtm1Shs/Insr+
(involves: C57BL/6CrSlc) 		decreased total body fat amount J:98723
Iqcb1em1(IMPC)Bay/Iqcb1+
(C57BL/6N-Iqcb1em1(IMPC)Bay/Bay) 		decreased total body fat amount J:211773
Iqsec3tm3b(KOMP)Wtsi/Iqsec3tm3b(KOMP)Wtsi
(C57BL/6N-Iqsec3tm3b(KOMP)Wtsi/Bay) 		increased total body fat amount J:211773
Irak2tm1b(EUCOMM)Wtsi/Irak2tm1b(EUCOMM)Wtsi
(C57BL/6N-Irak2tm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Irf4tm1Rdf/Irf4tm1Rdf
Tg(Ucp1-cre)1Evdr/0
(involves: 129S1/Sv * C57BL/6J * FVB) 		abnormal adipose tissue development J:214637
increased body fat mass J:214637
increased epididymal fat pad weight J:214637
increased inguinal fat pad weight J:214637
increased white fat cell size J:214637
Irs1Sml/Irs1+
(C3.Cg-Irs1Sml H2b/GrsrJ) 		decreased total body fat amount J:163661
Irs1Sml/Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ) 		decreased percent body fat/body weight J:163661
Irs1tm1Jos/Irs1tm1Jos
Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		abnormal gonadal fat pad morphology J:80976
decreased white adipose tissue amount J:80976
Irs1tm1Tka/Irs1tm1Tka
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA) 		decreased white adipose tissue amount J:68004
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased total body fat amount J:64791
Irs2tm1With/Irs2tm1With
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6J) 		increased total body fat amount J:97406
Irs2tm2Mfw/Irs2tm2Mfw
Irs4tm1.1Mfw/Y
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal adipose tissue amount J:221293
increased brown fat cell lipid droplet size J:221293
Irs2tm2Mfw/Irs2tm2Mfw
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased total body fat amount J:93415
Irs2tm2Tka/Irs2tm2Tka
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6) 		increased epididymal fat pad weight J:93416
Irx3tm1Hui/Irx3tm1Hui
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal white adipose tissue physiology J:208887
decreased fat cell size J:208887
decreased percent body fat/body weight J:208887
Ism1em1.1Kajs/Ism1em1.1Kajs
(involves: C57BL/6J * FVB/N) 		adipose tissue phenotype J:309734
Itchtm1b(EUCOMM)Hmgu/Itchtm1b(EUCOMM)Hmgu
(C57BL/6N-Itchtm1b(EUCOMM)Hmgu/H) 		decreased total body fat amount J:211773
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa) 		decreased brown adipose tissue mass J:144968
decreased epididymal fat pad weight J:144968
decreased fat cell size J:144968
decreased subcutaneous adipose tissue amount J:144968
increased adipocyte glucose uptake J:144968
Ivltm1b(KOMP)Wtsi/Ivltm1b(KOMP)Wtsi
(C57BL/6N-Ivltm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Izumo1rtm2a(KOMP)Wtsi/Izumo1rtm2a(KOMP)Wtsi
(C57BL/6N-Izumo1rtm2a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Jdp2tm1Kkyo/Jdp2tm1Kkyo
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal fat cell morphology J:139241
Jmjd4em1(IMPC)Wtsi/Jmjd4em1(IMPC)Wtsi
(C57BL/6N-Jmjd4em1(IMPC)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Jmjd8em1Kaso/Jmjd8em1Kaso
(C57BL/6-Jmjd8em1Kaso) 		abnormal white adipose tissue physiology J:319518
increased adipocyte glucose uptake J:319518
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J) 		decreased total fat pad weight J:210545
Juptm1Ruiz/Jup+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal fat cell differentiation J:192719
Juptm1Ruiz/Jup+
Tg(Myh6-Jup*)1Ajm/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal fat cell morphology J:192719
Kash5em1(IMPC)J/Kash5em1(IMPC)J
(C57BL/6NJ-Kash5em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Kat6bGt(pKC199)1Pgr/Kat6bGt(pKC199)1Pgr
(involves: 129S2/SvPas) 		decreased percent body fat/body weight J:178264
Kazntm1a(EUCOMM)Wtsi/Kazntm1a(EUCOMM)Wtsi
(C57BL/6N-Kazntm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Kbtbd2em1Btlr/Kbtbd2em1Btlr
Pik3r1em1Btlr/Pik3r1em1Btlr
(Not Specified) 		increased body fat mass J:236520
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr) 		abnormal white adipose tissue physiology J:236520
decreased epididymal fat pad weight J:236520
decreased inguinal fat pad weight J:236520
Kbtbd8em1(IMPC)Tcp/Kbtbd8em1(IMPC)Tcp
(C57BL/6N-Kbtbd8em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Kcnab2em1(IMPC)Mbp/Kcnab2em1(IMPC)Mbp
(C57BL/6NCrl-Kcnab2em1(IMPC)Mbp/MbpMmucd) 		increased total body fat amount J:211773
Kcne1tm1b(EUCOMM)Hmgu/Kcne1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcne1tm1b(EUCOMM)Hmgu/Ics) 		decreased total body fat amount J:211773
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse) 		decreased abdominal fat pad weight J:157001
decreased subcutaneous adipose tissue amount J:157001
Kcnn1tm1b(KOMP)Wtsi/Kcnn1tm1b(KOMP)Wtsi
(C57BL/6N-Kcnn1tm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Kctd7em2(IMPC)Bay/Kctd7em2(IMPC)Bay
(C57BL/6N-Kctd7em2(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
Kdm3atm1.1Jsak/Kdm3atm1.1Jsak
(involves: C57BL/6 * CBA) 		abnormal white adipose tissue morphology J:158258
increased epididymal fat pad weight J:158258
increased fat cell size J:158258
increased retroperitoneal fat pad weight J:158258
increased white adipose tissue amount J:158258
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha) 		abnormal brown adipose tissue morphology J:147295
abnormal brown adipose tissue physiology J:147295
increased brown adipose tissue amount J:147295
increased percent body fat/body weight J:147295
increased white fat cell lipid droplet size J:147295
Khdrbs1tm1Rchd/Khdrbs1tm1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal adipose tissue physiology J:115775
Khsrpem1(IMPC)Mbp/Khsrpem1(IMPC)Mbp
(C57BL/6NCrl-Khsrpem1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Kiss1tm1.1(cre)Uboe/Kiss1+
Nhlh2tm2Thbr/Nhlh2tm2Thbr
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * C57BL/6J) 		adipose tissue phenotype J:199640
Kiss1rtm1.1(KOMP)Vlcg/Kiss1rtm1.1(KOMP)Vlcg
(C57BL/6N-Kiss1rtm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J) 		decreased subcutaneous adipose tissue amount J:229255
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J)) 		decreased subcutaneous adipose tissue amount J:44109
Klkl/Klkl
(involves: C3H/J * C57BL/6J) 		decreased brown fat cell lipid droplet size J:66078
decreased white adipose tissue amount J:66078
increased brown adipose tissue amount J:66078
Kltm1Yin/Kltm1Yin
(Not Specified) 		decreased white adipose tissue amount J:86859
Klbtm1.1Akha/Klbtm1.1Akha
(C57BL/6-Klbtm1.1Akha) 		abnormal body fat mass J:195570
Klbtm1.1Sakl/Klbtm1.1Sakl
Tg(Fabp4-cre)1Rev/0
(involves: 129 * C57BL/6 * SJL) 		abnormal adipose tissue physiology J:189018
Klbtm1.2Sakl/Klb+
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased percent body fat/body weight J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		abnormal percent body fat/body weight J:189018
Klf3Gt(CH0516)Wtsi/Klf3Gt(CH0516)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased abdominal fat pad weight J:206507
Klf3Gt(XS0187)Wtsi/Klf3Gt(XS0187)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased abdominal fat pad weight J:206507
Klf3m1Cmhd/Klf3+
(involves: C3H/HeJ * C57BL/6J) 		decreased abdominal fat pad weight J:206507
decreased percent body fat/body weight J:206507
Klf3tm1Merc/Klf3tm1Merc
(FVB.129-Klf3tm1Merc) 		abnormal epididymal fat pad morphology J:137267
abnormal gonadal fat pad morphology J:137267
abnormal retroperitoneal fat pad morphology J:137267
decreased total body fat amount J:137267
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain) 		decreased total body fat amount J:129763
Klhdc2tm1b(EUCOMM)Hmgu/Klhdc2+
(C57BL/6N-Klhdc2tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH) 		decreased epididymal fat pad weight J:203736
increased total body fat amount J:203736
Kmt2bm1H/Kmt2b+
(involves: BALB/c * C3H/HeH) 		decreased epididymal fat pad weight J:203736
Kmt2btm1Afst/Kmt2b+
(involves: 129P2/OlaHsd) 		increased epididymal fat pad weight J:203736
Kmt2ctm1.1Jwle/Kmt2c+
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd * 129X1/SvJ) 		decreased body fat mass J:301497
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd) 		decreased body fat mass J:301497
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6J) 		abnormal brown fat cell differentiation J:207891
decreased brown adipose tissue amount J:207891
Kmt2etm1Apa/Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa) 		decreased total body fat amount J:145445
Kmt5btm1a(KOMP)Wtsi/Kmt5b+
(B6JTyr;B6N-Kmt5btm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Kptntm1a(EUCOMM)Wtsi/Kptntm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Kptntm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:175295
Krt71Ca-Rin/?
(C57BL/6Slc-Krt71Ca-Rin) 		decreased subcutaneous adipose tissue amount J:86407
Krt75em1(IMPC)Mbp/Krt75em1(IMPC)Mbp
(C57BL/6N-Krt75em1(IMPC)Mbp/MbpMmucd) 		increased total body fat amount J:211773
Krtap17-1tm1.1(KOMP)Vlcg/Krtap17-1tm1.1(KOMP)Vlcg
(C57BL/6N-Krtap17-1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Ksr1tm1Shaw/Ksr1tm1Shaw
(involves: DBA/1LacJ) 		decreased white fat cell number J:100406
increased fat cell size J:100406
Ksr2tm1Lex/Ksr2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:185494, J:185493
Ksr2tm2.1Lex/Ksr2tm2.1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:185493
Kti12tm1.1(KOMP)Vlcg/Kti12+
(C57BL/6N-Kti12tm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Lactb2Tg(Igh-Meis1)2770Amb/Lactb2Tg(Igh-Meis1)2770Amb
(FVB/NJ-Lactb2Tg(Igh-Meis1)2770Amb) 		abnormal fat pad morphology J:79618
Lamp2tm1Amcu/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		decreased brown fat cell lipid droplet size J:215605
decreased gonadal fat pad weight J:215605
decreased percent body fat/body weight J:215605
decreased white fat cell lipid droplet size J:215605
LbrGt(XE569)Byg/LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr) 		decreased subcutaneous adipose tissue amount J:138854
Lce1ftm1b(KOMP)Wtsi/Lce1ftm1b(KOMP)Wtsi
(C57BL/6N-Lce1ftm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Lclat1tm1Yugs/Lclat1tm1Yugs
(B6.Cg-Lclat1tm1Yugs) 		decreased brown adipose tissue mass J:163077
decreased brown fat cell lipid droplet size J:163077
decreased white adipose tissue mass J:163077
decreased white fat cell lipid droplet size J:163077
Lcn2tm1Aade/Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade) 		increased brown adipose tissue amount J:169355
increased fat cell size J:169355
increased white adipose tissue amount J:169355
Ldhatm1a(EUCOMM)Wtsi/Ldha+
(B6JTyr;B6N-Ldhatm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:165965
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her) 		abnormal fat pad morphology J:130278
increased percent body fat/body weight J:130278
Ldlrtm1Her/Ldlrtm1Her
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased total body fat amount J:84844
Ldlrtm1Her/Ldlrtm1Her
Scd1ab-2J/Scd1ab-2J
(B6.Cg-Ldlrtm1Her Scd1ab-2J) 		abnormal epididymal fat pad morphology J:130278
abnormal fat pad morphology J:130278
abnormal uterine fat pad morphology J:130278
decreased percent body fat/body weight J:130278
Ldlrtm1Her/Ldlrtm1Her
Scd1ab-J/Scd1ab-J
(B6.Cg-Ldlrtm1Her Scd1ab-J) 		abnormal epididymal fat pad morphology J:130278
abnormal fat pad morphology J:130278
abnormal uterine fat pad morphology J:130278
decreased percent body fat/body weight J:130278
Lef1tm1Rug/Lef1tm1Rug
(involves: 129S2/SvPas * C57BL/6) 		absent subcutaneous adipose tissue J:18378
Lefty1tm1b(KOMP)Wtsi/Lefty1+
(C57BL/6N-Lefty1tm1b(KOMP)Wtsi/Bay) 		increased total body fat amount J:211773
Lepm1Btlr/Lepm1Btlr
(C57BL/6J-Lepm1Btlr) 		increased body fat mass J:189953
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst) 		abnormal gonadal fat pad morphology J:167736
increased brown adipose tissue amount J:167736
increased brown fat cell lipid droplet size J:167736
increased inguinal fat pad weight J:167736
increased total body fat amount J:167736
increased white adipose tissue amount J:167736
increased white fat cell number J:167736
increased white fat cell size J:167736
Lepob/Lep+
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased white adipose tissue amount J:76479
Lepob/Lep+
Tg(Apoe-Lepr)1Kry/0
(involves: C57BL/6J) 		increased total body fat amount J:88655
Lepob/Lepob
(involves: C57BL/6J) 		increased fat cell size J:5765, J:219118
increased gonadal fat pad weight J:219118
increased inguinal fat pad weight J:219118
increased interscapular fat pad weight J:219118
increased percent body fat/body weight J:219118
Lepob/Lepob
(B6.Cg-Lepob/J) 		abnormal epididymal fat pad morphology J:22377
decreased white fat cell number J:22377
increased fat cell size J:189019
increased interscapular fat pad weight J:22377
increased percent body fat/body weight J:122746
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6) 		abnormal adipose tissue amount J:107169
Lepob/Lepob
(involves: 129 * C57BL/6) 		increased percent body fat/body weight J:121534
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs) 		abnormal fat cell morphology J:7702, J:5253
abnormal white adipose tissue morphology J:260830
increased fat cell size J:7702
Lepob/Lepob
Lgals12tm1Ftl/Lgals12+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased inguinal fat pad weight J:180097
Lepob/Lepob
Lgals12tm1Ftl/Lgals12tm1Ftl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased gonadal fat pad weight J:180097
decreased inguinal fat pad weight J:180097
Lepob/Lepob
Nfe2l2tm1.1Jgpi/Nfe2l2tm1.1Jgpi
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		abnormal white fat cell morphology J:208590
decreased white adipose tissue amount J:208590
Lepob/Lepob
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob) 		abnormal adipose tissue development J:208590
abnormal white fat cell morphology J:208590
decreased white adipose tissue amount J:208590
Lepob/Lepob
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		abnormal adipose tissue amount J:107169
decreased epididymal fat pad weight J:107169
decreased mesenteric fat pad weight J:107169
Lepob/Lepob
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		abnormal adipose tissue amount J:76479
Lepob/Lepob
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased total fat pad weight J:87803
Lepob/Lepob
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6) 		abnormal adipose tissue amount J:85176
Lepob/Lepob
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		abnormal gonadal fat pad morphology J:116568
abnormal white adipose tissue amount J:116568
decreased body fat mass J:116568
decreased fat cell size J:116568
Lepob/Lepob
Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6) 		abnormal fat cell morphology J:121534
increased percent body fat/body weight J:121534
Lepob/Lepob
Rcan2tm1Ypt/Rcan2tm1Ypt
(involves: 129 * C57BL/6) 		decreased epididymal fat pad weight J:169558
decreased retroperitoneal fat pad weight J:169558
Lepob/Lepob
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		increased percent body fat/body weight J:187736
Lepob/Lepob
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal adipose tissue morphology J:55722
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J) 		increased percent body fat/body weight J:118305
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl) 		white adipose tissue inflammation J:171755
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl) 		increased body fat mass J:313303
increased gonadal fat pad weight J:313303
increased subcutaneous adipose tissue amount J:313303
increased white fat cell size J:313303
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas) 		increased brown adipose tissue amount J:174584
increased total body fat amount J:174584
Leprdb/Lepr+
(involves: C57BLKS/J) 		increased total body fat amount J:71934
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl) 		increased body fat mass J:313303
increased gonadal fat pad weight J:313303
increased subcutaneous adipose tissue amount J:313303
increased white fat cell size J:313303
Leprdb/Leprdb
(involves: C57BLKS/J) 		abnormal adipose tissue morphology J:232827
abnormal white adipose tissue morphology J:260830
increased total body fat amount J:89242
Leprdb/Leprdb
(involves: C57BL/6 * C57BLKS/J) 		increased percent body fat/body weight J:164339, J:142218
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/Jcl) 		abnormal epididymal fat pad morphology J:110277
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb) 		increased body fat mass J:313303
increased gonadal fat pad weight J:313303
increased subcutaneous adipose tissue amount J:313303
increased white fat cell size J:313303
Leprdb/Leprdb
Repin1tm1.2Arte/Repin1tm1.2Arte
(involves: BALB/c * C57BL/6 * C57BLKS/J) 		abnormal adipose tissue physiology J:238672
decreased body fat mass J:238672
Leprdb/Leprdb
Tg(Fabp4-Fcor)1Jnak/0
(involves: C57BL/6 * C57BLKS/J * DBA/2) 		decreased abdominal adipose tissue amount J:184684
decreased white fat cell size J:184684
Leprdb/Leprdb
Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA) 		abnormal adipose tissue morphology J:232827
Leprm5Btlr/Leprm5Btlr
(C57BL/6-Leprm5Btlr) 		increased brown adipose tissue amount J:166105
increased mesenteric fat pad weight J:166105
increased omental fat pad weight J:166105
increased total body fat amount J:166105
Leprm8Btlr/Leprm8Btlr
(C57BL/6J-Leprm8Btlr) 		increased body fat mass J:267679
increased percent body fat/body weight J:267679
Leprtm1.1Chua/Leprtm1.1Chua
Ntstm1(cre)Mgmj/Nts+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB) 		abnormal percent body fat/body weight J:176657
increased gonadal fat pad weight J:176657
increased total body fat amount J:176657
Leprtm1.1Chua/Leprtm1.1Chua
Prlhtm1(cre)Smln/Prlh+
(involves: 129 * C57BL/6J) 		increased epididymal fat pad weight J:215557
increased subcutaneous adipose tissue amount J:215557
Leprtm1.1Chua/Leprtm1.1Chua
Slc17a6tm2(cre)Lowl/Slc17a6+
(involves: 129S6/SvEvTac) 		adipose tissue phenotype J:174691
Leprtm1.1Chua/Leprtm1.1Chua
Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac) 		increased total body fat amount J:174691
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB) 		increased total body fat amount J:173444
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Nr5a1-cre)2Lowl/0
(involves: 129 * C57BL/6J * FVB) 		abnormal fat pad morphology J:105327
abnormal gonadal fat pad morphology J:105327
abnormal renal fat pad morphology J:105327
increased total body fat amount J:105327
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Nr5a1-cre)2Lowl/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB) 		abnormal fat pad morphology J:105327
abnormal gonadal fat pad morphology J:105327
abnormal mesenteric fat pad morphology J:105327
abnormal renal fat pad morphology J:105327
increased total body fat amount J:105327
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB) 		abnormal epididymal fat pad morphology J:106354
abnormal fat pad morphology J:106354, J:105327
abnormal gonadal fat pad morphology J:105327
abnormal mesenteric fat pad morphology J:106354, J:105327
abnormal renal fat pad morphology J:106354, J:105327
increased total body fat amount J:106354, J:105327
Leprtm1.1Chua/Leprtm1.2Chua
Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased total body fat amount J:183754
Leprtm1.2Chua/Leprtm1.2Chua
Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased total body fat amount J:183754
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Leprtm1Jke/Leprtm1Jke
Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased total body fat amount J:184572
increased total body fat amount J:184572
Leprtm1Rck/Leprtm1.1Rck
Tg(Syn1-cre)671Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased total body fat amount J:72241
Leprtm1Yli/Leprtm1Yli
(B6.129-Leprtm1Yli) 		increased percent body fat/body weight J:142218
Leprtm2Mgmj/Leprtm2Mgmj
(B6.Cg-Leprtm2Mgmj) 		abnormal fat pad morphology J:122056
decreased gonadal fat pad weight J:122056
Leprtm2Yli/Leprtm2Yli
(B6.129-Leprtm2Yli) 		increased percent body fat/body weight J:142218
Leprtm3.1Yli/Lepr+
(B6.129-Leprtm3.1Yli) 		increased percent body fat/body weight J:161732
Leprtm3.1Yli/Leprtm3.1Yli
(B6.129-Leprtm3.1Yli) 		increased percent body fat/body weight J:161732
Leprtm4Mgmj/Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj) 		increased percent body fat/body weight J:164339
Leprtm5Mgmj/Leprtm5Mgmj
(B6.129-Leprtm5Mgmj) 		increased total body fat amount J:179119
Leprtm5Mgmj/Leprtm5Mgmj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased total body fat amount J:221245
Leprottm2a(KOMP)Wtsi/Leprottm2a(KOMP)Wtsi
(C57BL/6N-Leprottm2a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Letmd1em1(IMPC)Kmpc/Letmd1em1(IMPC)Kmpc
(C57BL/6NTac-Letmd1em1(IMPC)Kmpc/Kmpc) 		increased total body fat amount J:211773
Letmd1em1Mbp/Letmd1em1Mbp
(C57BL/6J-Letmd1em1Mbp) 		abnormal beige fat cell physiology J:321533
abnormal brown adipose tissue physiology J:321533
abnormal brown adipose tissue thermogenesis J:321533
increased body fat mass J:321533
whitened brown adipose tissue morphology J:321533
Lgals3tm1Poi/Lgals3tm1Poi
(B6.Cg-Lgals3tm1Poi/J) 		increased total body fat amount J:264129
Lgals12tm1Ftl/Lgals12tm1Ftl
(B6.129-Lgals12tm1Ftl) 		abnormal white adipose tissue physiology J:180097
adipose tissue phenotype J:180097
decreased brown adipose tissue mass J:180097
decreased epididymal fat pad weight J:180097
decreased inguinal fat pad weight J:180097
decreased percent body fat/body weight J:180097
decreased white fat cell size J:180097
Lgi1tm1.1Ics/Lgi1tm1.1Ics
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		decreased total body fat amount J:182795
Lgr4Gt(pGT0TMpfs)1Wcs/Lgr4Gt(pGT0TMpfs)1Wcs
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		abnormal epididymal fat pad morphology J:105945
Lgth6MRL/MpJ/Lgth6MRL/MpJ
(involves: MRL/MpJ * SJL/J) 		increased total body fat amount J:106033
Lgth6MRL/MpJ/Lgth6SJL/J
(involves: MRL/MpJ * SJL/J) 		increased total body fat amount J:106033
Lhcgrtm1Zmlei/Lhcgrtm1Zmlei
(either: 129X1/SvJ-Lhcgrtm1Zmlei or (involves: 129X1/SvJ * C57BL/6)) 		abnormal abdominal fat pad morphology J:66817
Limk2whe/Limk2whe
(B6.Cg-Lepob Limk2whe/GrsrJ) 		adipose tissue phenotype J:127016
Lin28atm1.1Gqda/Lin28atm1.1Gqda
(involves: 129S4/SvJae * C57BL/6) 		decreased total body fat amount J:199720
Lingo2em1(IMPC)Kmpc/Lingo2em1(IMPC)Kmpc
(C57BL/6NTac-Lingo2em1(IMPC)Kmpc/Kmpc) 		decreased total body fat amount J:211773
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		adipose tissue phenotype J:270182
decreased gonadal fat pad weight J:270182
Lipatm1Ggb/Lipatm1Ggb
(involves: 129P2/OlaHsd * CF-1) 		abnormal brown adipose tissue morphology J:68812
abnormal inguinal fat pad morphology J:68812
abnormal interscapular fat pad morphology J:68812
abnormal retroperitoneal fat pad morphology J:68812
abnormal white fat cell size J:68812
absent subcutaneous adipose tissue J:68812
decreased brown adipose tissue amount J:68812
decreased epididymal fat pad weight J:68812
decreased subcutaneous adipose tissue amount J:68812
decreased white adipose tissue amount J:68812
increased brown fat cell lipid droplet size J:68812
Lipetm1Gam/Lipetm1Gam
(involves: 129S4/SvJae * BALB/c) 		abnormal abdominal fat pad morphology J:82299
abnormal fat cell morphology J:82299
increased brown adipose tissue amount J:82299
Lipetm1Ishi/Lipetm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal brown adipose tissue morphology J:59889
abnormal white adipose tissue morphology J:59889
abnormal white adipose tissue physiology J:59889
increased fat cell size J:59889
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J) 		abnormal adipose tissue physiology J:85540
abnormal white fat cell morphology J:133126
decreased subcutaneous adipose tissue amount J:133126
decreased white adipose tissue amount J:133126
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal brown adipose tissue physiology J:74644
abnormal white adipose tissue physiology J:74644
Lipetm2Rze/Lipetm2Rze
Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA) 		increased percent body fat/body weight J:144744
LmnaDhe/Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ) 		decreased total body fat amount J:160175
LmnaDhe/LmnaDhe
(B6(D2)-LmnaDhe/TyGrsrJ) 		decreased subcutaneous adipose tissue amount J:160175
Lmnaem1Fenz/Lmna+
(C57BL/6-Lmnaem1Fenz) 		abnormal inguinal fat pad morphology J:338760
adipose tissue phenotype J:338760
decreased white adipose tissue mass J:338760
increased abdominal fat pad weight J:338760
increased brown adipose tissue mass J:338760
increased renal fat pad weight J:338760
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal fat cell differentiation J:221850
decreased subcutaneous adipose tissue amount J:221850
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6) 		decreased subcutaneous adipose tissue amount J:177632
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6NTac) 		decreased subcutaneous adipose tissue amount J:261974
Lmnatm1Lgf/Lmna+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased abdominal adipose tissue amount J:113119
decreased percent body fat/body weight J:141165
decreased subcutaneous adipose tissue amount J:113119
Lmnatm1Lgf/Lmnatm1Lgf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:113119
Lmnatm1Stw/Lmna+
(involves: 129S1/Sv * C57BL/6J) 		adipose tissue phenotype J:75101
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv) 		decreased white adipose tissue amount J:58702
Lmnatm2.1Gbon/Lmnatm2.1Gbon
(involves: 129 * C57BL/6) 		decreased white adipose tissue amount J:180603
Lmnatm2Stw/Lmnatm2Stw
(involves: 129S1/Sv) 		absent subcutaneous adipose tissue J:83382
Lmnatm3Lgf/Lmna+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased percent body fat/body weight J:141165
Lmnatm3Lgf/Lmnatm3Lgf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased abdominal adipose tissue amount J:141165
decreased subcutaneous adipose tissue amount J:141165
Lmnatm3Lgf/Lmnatm3Lgf
(involves: 129P2/OlaHsd) 		decreased total body fat amount J:167229
Lmnatm8Lgf/Lmnatm8Lgf
(involves: 129P2/OlaHsd) 		adipose tissue phenotype J:167229
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd) 		decreased total body fat amount J:211773
increased total body fat amount J:211773
Lncenc1em1Smoc/Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc) 		decreased brown adipose tissue mass J:306153
decreased brown fat cell size J:306153
decreased epididymal fat pad weight J:306153
decreased total body fat amount J:306153
decreased white fat cell size J:306153
Lncenc1em2Smoc/Lncenc1em2Smoc
(C57BL/6J-Lncenc1em2Smoc) 		decreased brown adipose tissue mass J:306153
decreased brown fat cell size J:306153
decreased epididymal fat pad weight J:306153
decreased inguinal fat pad weight J:306153
decreased total body fat amount J:306153
Lncpinttm1Vlcg/Lncpint+
(involves: 129S6/SvEvTac * C57BL/6NTac) 		decreased body fat mass J:233815
Lncpinttm1Vlcg/Lncpinttm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac) 		decreased body fat mass J:233815
decreased subcutaneous adipose tissue amount J:233815
Lnpeptm1Ske/Lnpeptm1Ske
(B6.129S-Lnpeptm1Ske) 		decreased brown adipose tissue amount J:220356
decreased total body fat amount J:220356
decreased white fat cell lipid droplet size J:220356
decreased white fat cell size J:220356
Lpar1mpc125H/Lpar1mpc125H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
Lpar1tm1Jch/Lpar1tm1Jch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased total body fat amount J:65882
Lpin1fld-2J/Lpin1fld-2J
(C3H/HeJ-Lpin1fld-2J/J) 		abnormal fat cell morphology J:66739
decreased body fat mass J:66739
decreased brown adipose tissue mass J:66739
decreased brown fat cell lipid droplet size J:66739
decreased white adipose tissue mass J:66739
decreased white fat cell lipid droplet size J:66739
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld) 		abnormal brown adipose tissue morphology J:63448
abnormal brown adipose tissue physiology J:63448
abnormal epididymal fat pad morphology J:63448
abnormal fat cell morphology J:66739, J:63448
abnormal white adipose tissue physiology J:63448
decreased brown adipose tissue mass J:66739, J:63448
decreased brown fat cell lipid droplet size J:66739
decreased epididymal fat pad weight J:63448
decreased inguinal fat pad weight J:63448
decreased interscapular fat pad weight J:63448
decreased white adipose tissue mass J:66739, J:63448
decreased white fat cell lipid droplet size J:66739
Lpin1fld/Lpin1fld
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		abnormal fat pad morphology J:220917
Lpin1fld/Lpin1fld
Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		abnormal fat pad morphology J:220917
Lpin2tm1Reue/Lpin2+
(involves: C57BL/6J) 		abnormal gonadal fat pad morphology J:189894
Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adipose tissue development J:220917
abnormal fat cell differentiation J:220917
Lpltm1Bres/Lpl+
(involves: 129S4/SvJae) 		increased total fat pad weight J:134171
Lpltm1Bres/Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J) 		abnormal adipose tissue morphology J:30062
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		increased abdominal adipose tissue amount J:307289
increased subcutaneous adipose tissue amount J:307289
Lrig1tm1a(EUCOMM)Wtsi/Lrig1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Lrig1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:165965
Lrig1tm1a(EUCOMM)Wtsi/Lrig1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased total body fat amount J:213427
Lrp1tm2Her/Lrp1tm2Her
Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal adipose tissue amount J:127398
abnormal adipose tissue physiology J:127398
abnormal brown fat cell morphology J:127398
abnormal fat pad morphology J:127398
decreased brown adipose tissue amount J:127398
decreased brown fat cell size J:127398
decreased brown fat lipid droplet number J:127398
decreased epididymal fat pad weight J:127398
decreased interscapular fat pad weight J:127398
decreased total body fat amount J:127398
decreased white fat cell size J:127398
Lrp1tm2Her/Lrp1tm2Her
Tg(Syn1-cre)671Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		decreased total body fat amount J:93329
Lrp6Gt(LST067)Byg/Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg) 		abnormal brown adipose tissue morphology J:182772
increased brown fat cell number J:182772
Lrrc8aem1Uia/Lrrc8aem1Uia
Tg(Adipoq-cre)1Evdr/0
(involves: 129 * C57BL/6 * FVB/NJ) 		abnormal fat cell morphology J:246515
adipose tissue phenotype J:246515
decreased epididymal fat pad weight J:246515
decreased inguinal fat pad weight J:246515
decreased total body fat amount J:246515
Lrrc8ctm1Maim/Lrrc8ctm1Maim
(B6J.129S2-Lrrc8ctm1Maim) 		decreased white adipose tissue amount J:247160
Lrrk1tm1b(KOMP)Wtsi/Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Lrrn3tm1Lex/Lrrn3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:171883
Lst1tm1.1(KOMP)Vlcg/Lst1tm1.1(KOMP)Vlcg
(C57BL/6N-Lst1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Ltbp1tm1a(EUCOMM)Wtsi/Ltbp1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ltbp1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Ly6atm1Pmf/Ly6atm1Pmf
(C.129P2-Ly6atm1Pmf) 		abnormal fat cell morphology J:83409
Ly86tm1a(KOMP)Wtsi/Ly86+
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd) 		decreased total body fat amount J:211773
Ly86tm1a(KOMP)Wtsi/Ly86tm1a(KOMP)Wtsi
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd) 		decreased total body fat amount J:211773
Lypd3tm1(KOMP)Vlcg/Lypd3tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		decreased abdominal adipose tissue amount J:235771
decreased body fat mass J:235771
decreased percent body fat/body weight J:235771
decreased subcutaneous adipose tissue amount J:235771
Lyplal1em1Espel/Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel) 		decreased white adipose tissue amount J:340413
decreased white fat cell size J:340413
Lysmd1em1(IMPC)J/Lysmd1em1(IMPC)J
(C57BL/6NJ-Lysmd1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Lztfl1tm1.3Zpl/Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		increased fat cell size J:287261
increased total body fat amount J:287261
Lztfl1tm1e(KOMP)Wtsi/Lztfl1tm1e(KOMP)Wtsi
(involves: 129S/SvEv * C57BL/6N) 		increased subcutaneous adipose tissue amount J:226512
increased white adipose tissue amount J:226512
Mad2l1bptm1.2Itl/Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		abnormal adipose tissue development J:234643
decreased adipocyte glucose uptake J:234643
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6) 		decreased epididymal fat pad weight J:222253
decreased omental fat pad weight J:222253
decreased percent body fat/body weight J:222253
decreased subcutaneous adipose tissue amount J:222253
decreased white fat cell size J:222253
increased white fat cell number J:222253
Magel2tm1Stw/Magel2tm1Stw
(C57BL/6-Magel2tm1Stw/J) 		increased body fat mass J:233299
Mamld1tm1.1(NCOM)Mfgc/Mamld1tm1.1(NCOM)Mfgc
(C57BL/6N-Mamld1tm1.1(NCOM)Mfgc/Tcp) 		increased total body fat amount J:211773
Manftm1a(KOMP)Wtsi/Manftm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * ICR) 		abnormal fat pad morphology J:211812
Map2k2tm1a(EUCOMM)Wtsi/Map2k2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Map2k2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Map3k14aly/Map3k14aly
(involves: C57BL/6J) 		abnormal mammary fat pad morphology J:117313
decreased mammary fat pad weight J:117313
Mapk8tm1.1Jcbr/Mapk8tm1.1Jcbr
(involves: 129S4/SvJae * C57BL/6) 		decreased gonadal fat pad weight J:195844
decreased percent body fat/body weight J:195844
Mapk8tm1Wag/Mapk8tm1Wag
(B6.129P2-Mapk8tm1Wag) 		abnormal fat cell morphology J:80452
decreased subcutaneous adipose tissue amount J:80452
decreased total body fat amount J:80452
increased epididymal fat pad weight J:80452
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased brown adipose tissue amount J:120128, J:163905
decreased percent body fat/body weight J:120128
decreased white adipose tissue amount J:120128, J:163905
increased adipocyte glucose uptake J:120128
Mark3tm1Hpw/Mark3tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		abnormal adipocyte glucose uptake J:163905
decreased brown adipose tissue amount J:163905
decreased total body fat amount J:163905
decreased white adipose tissue amount J:163905
Mark4Gt(XG191)Byg/Mark4Gt(XG191)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased brown fat cell lipid droplet size J:192469
decreased total body fat amount J:192469
Mark4Gt(XG191)Byg/Mark4Gt(XG191)Byg
(B6.129P2-Mark4Gt(XG191)Byg) 		decreased total body fat amount J:192469
Mars2tm1.1(KOMP)Vlcg/Mars2+
(C57BL/6N-Mars2tm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Mbd5Gt(Ayu21-B205)Imeg/Mbd5+
(B6.Cg-Mbd5Gt(Ayu21-B205)Imeg) 		decreased abdominal adipose tissue amount J:212073
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		decreased gonadal fat pad weight J:192212
decreased subcutaneous adipose tissue amount J:192212
Mboat4tm1Jagu/Mboat4tm1Jagu
(involves: C57BL/6) 		decreased total body fat amount J:151420
Mc2rtm1Dchi/Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi) 		decreased total body fat amount J:127445
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased brown fat lipid droplet number J:82809
decreased percent body fat/body weight J:82809
Mc3rem1(IMPC)Mbp/Mc3rem1(IMPC)Mbp
(C57BL/6N-Mc3rem1(IMPC)Mbp/MbpMmucd) 		increased total body fat amount J:211773
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl) 		increased total body fat amount J:178147
Mc3rtm1Butl/Mc3rtm1Butl
Tg(Nes-cre)1Kln/0
(B6.Cg-Mc3rtm1Butl Tg(Nes-Cre)1Kln) 		abnormal body fat mass J:178147
Mc3rtm1Butl/Mc3rtm1Butl
Tg(Nr5a1-cre)2Lowl/0
(involves: C57BL/6J * FVB/NJ) 		abnormal adipose tissue amount J:178147
Mc3rtm1Cone/Mc3rtm1Cone
(involves: 129S4/SvJae * C57BL/6J) 		increased total body fat amount J:78132
Mc3rtm1Lex/Mc3rtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:185494
Mc3rtm1Lvp/Mc3rtm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal brown fat cell morphology J:64365
decreased brown fat cell number J:64365
increased total body fat amount J:64365
increased white fat cell size J:64365
Mc4rGlu3/Mc4rGlu3
(C57BL/6J-Mc4rGlu3) 		increased percent body fat/body weight J:116205
Mc4rtm1.1Fbz/Mc4r+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NTac) 		increased abdominal fat pad weight J:225022
Mc4rtm1.1Fbz/Mc4rtm1.1Fbz
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NTac) 		increased abdominal fat pad weight J:225022
Mc4rtm1Lex/Mc4rtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased percent body fat/body weight J:185494
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		increased total body fat amount J:177386
white adipose tissue inflammation J:177386
Mc4rtm2.1Lowl/Mc4rtm2.1Lowl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N) 		increased total body fat amount J:216397
Mc4rtm2Lowl/Mc4rtm2Lowl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		increased total body fat amount J:216397
Mc4rtm2Lowl/Mc4rtm2Lowl
Slc17a6tm2(cre)Lowl/Slc17a6+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased total body fat amount J:216397
Mc4rtm2Lowl/Mc4rtm2Lowl
Tg(Sim1-cre)1Lowl/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased total body fat amount J:216397
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA) 		decreased subcutaneous adipose tissue amount J:192213
decreased white adipose tissue amount J:192213
Mchr1tm1Dgam/Mchr1tm1Dgam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased total body fat amount J:95740
Mchr1tm1Lex/Mchr1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
Mchr1tm1Sqn/Mchr1tm1Sqn
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased percent body fat/body weight J:81787
Mchr1tm1Yush/Mchr1tm1Yush
(involves: 129 * C57BL/6) 		decreased total body fat amount J:106819
Mcm2tm1(cre/ERT2)Scpr/Mcm2tm1(cre/ERT2)Scpr
(involves: 129S6/SvEvTac) 		decreased total body fat amount J:141493
Mcoln1tm1Sasl/Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6) 		absent subcutaneous adipose tissue J:135368
Mcrip2em1Eno/Mcrip2em1Eno
(C57BL/6N-Mcrip2em1Eno) 		abnormal brown adipose tissue physiology J:316902
whitened brown adipose tissue morphology J:316902
Mcutm1b(EUCOMM)Hmgu/Mcu+
(C57BL/6N-Mcutm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Mecomtm1Miku/Mecomtm1Miku
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JCrlj) 		abnormal interscapular fat pad morphology J:213153
increased brown fat cell lipid droplet size J:213153
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased total fat pad weight J:135824
Med13tm1Eno/Med13tm1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N) 		increased abdominal adipose tissue amount J:186193
increased brown adipose tissue amount J:186193
increased total body fat amount J:186193
increased white fat cell size J:186193
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		abnormal brown adipose tissue physiology J:298822
abnormal interscapular fat pad morphology J:298822
abnormal white adipose tissue morphology J:298822
abnormal white adipose tissue physiology J:298822
abnormal white fat cell size J:298822
decreased body fat mass J:298822
decreased gonadal fat pad weight J:298822
decreased inguinal fat pad weight J:298822
decreased mesenteric fat pad weight J:298822
decreased retroperitoneal fat pad weight J:298822
decreased subcutaneous adipose tissue amount J:298822
decreased white adipose tissue mass J:298822
decreased white fat cell number J:298822
whitened brown adipose tissue morphology J:298822
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-icre/ERT2)1Soff/0
(involves: C57BL/6J * C57BL/6N) 		abnormal white fat cell size J:298822
decreased gonadal fat pad weight J:298822
decreased inguinal fat pad weight J:298822
decreased white adipose tissue mass J:298822
decreased white fat cell number J:298822
increased white adipose tissue apoptosis J:298822
lipodystrophy J:298822
white adipose tissue inflammation J:298822
whitened brown adipose tissue morphology J:298822
Med25tm1b(KOMP)Wtsi/Med25+
(C57BL/6N-Med25tm1b(KOMP)Wtsi/Ics) 		increased total body fat amount J:211773
Memo1tm1.1Neh/Memo1tm1.1Neh
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased subcutaneous adipose tissue amount J:206626
decreased white adipose tissue amount J:206626
Meox1tm1Bmk/Meox1tm1Bmk
Meox2tm1Vpa/Meox2tm1Vpa
(involves: 129P2/OlaHsd * C57BL/6) 		decreased brown adipose tissue amount J:84754
Mep1atm1a(KOMP)Wtsi/Mep1atm1a(KOMP)Wtsi
(C57BL/6N-Mep1atm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Mettl24tm1a(KOMP)Wtsi/Mettl24tm1a(KOMP)Wtsi
(C57BL/6N-Mettl24tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Mettl26tm1.1(KOMP)Vlcg/Mettl26tm1.1(KOMP)Vlcg
(C57BL/6N-Mettl26tm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Mfap2tm1a(KOMP)Wtsi/Mfap2tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		abnormal bone marrow adipose tissue morphology J:236092
increased bone marrow adipose tissue amount J:236092
increased gonadal fat pad weight J:236092
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls) 		decreased total body fat amount J:194781
decreased white fat cell size J:194781
Mgme1em1(IMPC)J/Mgme1em1(IMPC)J
(C57BL/6NJ-Mgme1em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Micu1tm1bNarl/Micu1+
(C57BL/6N-Micu1tm1bNarl/Narl) 		increased total body fat amount J:211773
Micu3em1(IMPC)Mbp/Micu3em1(IMPC)Mbp
(C57BL/6N-Micu3em1(IMPC)Mbp/Ucd) 		decreased total body fat amount J:211773
Mid1em1(IMPC)Mbp/Mid1+
(C57BL/6NCrl-Mid1em1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Miga2tm1a(KOMP)Wtsi/Miga2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Miga2tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Minar2tm1b(KOMP)Wtsi/Minar2tm1b(KOMP)Wtsi
(C57BL/6N-Minar2tm1b(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Mindy2em1(IMPC)H/Mindy2em1(IMPC)H
(C57BL/6NTac-Mindy2em1(IMPC)H/H) 		increased total body fat amount J:211773
Mir22tm1Boet/Mir22tm1Boet
(B6.129S2-Mir22tm1Boet) 		decreased white adipose tissue amount J:266382
decreased white fat cell size J:266382
Mir92bem22Gpt/Mir92bem22Gpt
(involves: C57BL/6JGpt) 		decreased body fat mass J:346344
Mir129-2em1(IMPC)Kmpc/Mir129-2em1(IMPC)Kmpc
(C57BL/6NTac-Mir129-2em1(IMPC)Kmpc/Kmpc) 		increased total body fat amount J:211773
Mir188em1Xhl/Mir188em1Xhl
(C57BL/6-Mir188em1Xhl) 		abnormal fat cell differentiation J:222099
abnormal fat cell morphology J:222099
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6) 		decreased subcutaneous adipose tissue amount J:190154
decreased total body fat amount J:190154
decreased white adipose tissue amount J:190154
decreased white fat cell size J:190154
Mir485em1Ycao/Mir485em1Ycao
(C57BL/6-Mir485em1Ycao) 		decreased brown fat cell number J:335039
increased brown fat cell size J:335039
Mirc33tm1.1Wtsi/Mirc33tm1.1Wtsi
(C57BL/6N-Mirc33tm1.1Wtsi) 		decreased brown adipose tissue amount J:267719
decreased fat cell size J:267719
decreased white adipose tissue amount J:267719
Mirc54tm1.1Syu/Mirc54tm1.1Syu
(Not Specified) 		decreased white fat cell size J:310890
Mldhrem1Zhgn/Mldhrem1Zhgn
(involves: C57BL/6) 		decreased body fat mass J:303725
Mllt3tm1b(EUCOMM)Hmgu/Mllt3+
(C57BL/6N-Mllt3tm1b(EUCOMM)Hmgu/Cnrm) 		increased total body fat amount J:211773
Mlxtm1.1(KOMP)Vlcg/Mlxtm1.1(KOMP)Vlcg
(C57BL/6N-Mlxtm1.1(KOMP)Vlcg/J) 		decreased total body fat amount J:211773
Mlxipltm1Kuy/Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased brown adipose tissue amount J:89865
decreased epididymal fat pad weight J:89865
decreased white adipose tissue amount J:89865
Mmaaem1(IMPC)J/Mmaaem1(IMPC)J
(C57BL/6NJ-Mmaaem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Mmp14sabe/Mmp14sabe
(B6(129P2)-Mmp14sabe/GrsrJ) 		increased percent body fat/body weight J:127164
Mmp14tm1Stjw/Mmp14tm1Stjw
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6 * CD-1) 		adipose tissue phenotype J:198679
Mmp14tm1Stjw/Mmp14tm1Stjw
Twist2tm1.1(cre)Dor/Twist2+
(involves: 129X1/SvJ * C57BL/6) 		abnormal hypodermis fat layer morphology J:198679
increased bone marrow adipose tissue amount J:198679
Mmp19tm1Amp/Mmp19tm1Amp
(Not Specified) 		abnormal fat pad morphology J:90802
increased fat cell size J:90802
increased gonadal fat pad weight J:90802
Mmp20em1(IMPC)Ccpcz/Mmp20em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp20em1(IMPC)Ccpcz/Ccpcz) 		increased total body fat amount J:211773
Mobq1129P3/J/Mobq1129P3/J
(involves: 129P3/J * C57BL/10SnJ) 		decreased total body fat amount J:24238
Mobq1BALB/cJ/Mobq1BALB/cJ
(involves: BALB/cJ * C57BL/10SnJ) 		decreased total body fat amount J:24238
Mobq1C57BL/6J/Mobq1SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei) 		increased percent body fat/body weight J:88297
increased total body fat amount J:88297, J:24238
Mobq2C57BL/6J/Mobq2SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei) 		increased femoral fat pad weight J:24238
Mobq3SPRET/EiJ/Mobq3SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei) 		abnormal fat pad morphology J:24238
Mobq4C57BL/6J/Mobq4SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei) 		abnormal fat pad morphology J:24238
Mobq5CAST/EiJ/Mobq5C57BL/6J
(involves: CAST/Ei * C57BL/6J) 		decreased white adipose tissue amount J:48038
Mobq6CAST/EiJ/Mobq6C57BL/6J
(involves: CAST/Ei * C57BL/6J) 		decreased white adipose tissue amount J:48038
Mobq7CAST/EiJ/Mobq7C57BL/6J
(involves: CAST/Ei * C57BL/6J) 		decreased white adipose tissue amount J:48038
Mobq8CAST/EiJ/Mobq8C57BL/6J
(involves: CAST/Ei * C57BL/6J) 		increased white adipose tissue amount J:48038
Mobq8CAST/EiJ/Mobq8CAST/EiJ
(involves: CAST/Ei * C57BL/6J) 		increased white adipose tissue amount J:48038
Mocosem2(IMPC)Ics/Mocos+
(C57BL/6N-Mocosem2(IMPC)Ics/Ics) 		increased total body fat amount J:211773
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N) 		abnormal adipose tissue development J:336718
Mogat2tm1Far/Mogat2tm1Far
(B6.129S4-Mogat2tm1Far) 		decreased brown fat cell number J:149373
decreased percent body fat/body weight J:149373
Mohg4CAST/EiJ/Mohg4CAST/EiJ
(involves: CAST/EiJ * C57BL/6J-Socs2hg) 		decreased total fat pad weight J:111441
Mohg6CAST/EiJ/Mohg6CAST/EiJ
(involves: CAST/EiJ * C57BL/6J-Socs2hg) 		decreased total body fat amount J:111441
Mohg7CAST/EiJ/Mohg7CAST/EiJ
(involves: CAST/EiJ * C57BL/6J) 		decreased total body fat amount J:111441
decreased total fat pad weight J:111441
Mohg9CAST/EiJ/Mohg9CAST/EiJ
(involves: CAST/EiJ * C57BL/6J-Socs2hg) 		decreased total body fat amount J:111441
mpc81H/mpc81H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
mpc119H/mpc119H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
mpc184H/mpc184H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
mpc185H/mpc185H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
mpc286H/mpc286H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
mpc290H/mpc290H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
Mpgtm1Rhe/Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal fat pad morphology J:70603
Mpv17/Mpv17
(CFW-Mpv17/J) 		decreased subcutaneous adipose tissue amount J:143355
Mpv17l2tm1.1(KOMP)Mbp/Mpv17l2tm1.1(KOMP)Mbp
(C57BL/6N-Mpv17l2tm1.1(KOMP)Mbp/Ucd) 		increased total body fat amount J:211773
Mpzl2tm1b(EUCOMM)Hmgu/Mpzl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Mpzl2tm1b(EUCOMM)Hmgu/Bay) 		increased total body fat amount J:211773
Mpzl3rc/Mpzl3rc
(C57BL/6J-Mpzl3rc/J) 		decreased total body fat amount J:210832
Mpzl3tm1(KOMP)Mbp/Mpzl3tm1(KOMP)Mbp
(C57BL/6-Tyrc-Brd Mpzl3tm1(KOMP)Mbp) 		abnormal epididymal fat pad morphology J:210832
abnormal gonadal fat pad morphology J:210832
decreased subcutaneous adipose tissue amount J:210832
decreased white fat cell size J:210832
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz) 		decreased body fat mass J:199257
decreased total body fat amount J:199257
Mrap2tm1.1Maj/Mrap2tm1.1Maj
(either: B6.129-Mrap2tm1.1Maj or (involves: 129 * 129S6/SvEvTac)) 		increased brown adipose tissue amount J:199365
increased percent body fat/body weight J:199365
increased total body fat amount J:199365
increased white fat cell size J:199365
Mrap2tm1a(EUCOMM)Wtsi/Mrap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Mrap2tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Mrasem1(IMPC)H/Mrasem1(IMPC)H
(C57BL/6NTac-Mrasem1(IMPC)H/H) 		decreased total body fat amount J:211773
Mrps22tm1.1(KOMP)Vlcg/Mrps22+
(C57BL/6N-Mrps22tm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Mrps36em1(IMPC)Bay/Mrps36+
(C57BL/6N-Mrps36em1(IMPC)Bay/BayMmucd) 		increased total body fat amount J:211773
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd) 		increased total body fat amount J:211773
Mss51tm1(KOMP)Vlcg/Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased inguinal fat pad weight J:280597
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean) 		decreased epididymal fat pad weight J:146513
decreased percent body fat/body weight J:146513
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased epididymal fat pad weight J:75178
decreased inguinal fat pad weight J:75178
decreased parametrial fat pad weight J:75178
decreased retroperitoneal fat pad weight J:75178
decreased total body fat amount J:75178
mt-Nd6m1Jbst
mt-Tam1Jbst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl) 		decreased body fat mass J:238994
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		panniculitis J:137101
Mtbcq2NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased percent body fat/body weight J:122125
increased total body fat amount J:122125
Mtbcq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased abdominal fat pad weight J:122125
increased percent body fat/body weight J:122125
Mtbcq6NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		decreased percent body fat/body weight J:122125
decreased total body fat amount J:122125
Mtbcq7NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased percent body fat/body weight J:122125
increased total body fat amount J:122125
Mtgq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased percent body fat/body weight J:122125
increased total body fat amount J:122125
Mtmr1tm2b(KOMP)Wtsi/Mtmr1tm2b(KOMP)Wtsi
(C57BL/6N-Mtmr1tm2b(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Mtmr14tm1Ckq/Mtmr14tm1Ckq
(involves: 129S6/SvEvTac * C57BL/6J) 		increased body fat mass J:267733
Mtortm1.1Clyn/Mtor+
(involves: BALB/c * C57BL/6J) 		increased total body fat amount J:162945
Mturntm1.1(KOMP)Vlcg/Mturntm1.1(KOMP)Vlcg
(C57BL/6N-Mturntm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * FVB/N) 		decreased white adipose tissue amount J:73369
Myd88tm1Jcbr/Myd88tm1Jcbr
Tg(Nes-cre)1Kln/0
(B6.Cg-Myd88tm1Jcbr Tg(Nes-cre)1Kln) 		abnormal parametrial fat pad morphology J:153664
decreased epididymal fat pad weight J:153664
decreased fat cell size J:153664
decreased total body fat amount J:153664
Myf5tm3(cre)Sor/Myf5+
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N) 		increased total body fat amount J:119237
Myf5tm3(cre)Sor/Myf5+
Stat5btm1Mam/Stat5btm1Mam
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		increased total body fat amount J:119237
Myf5tm3(cre)Sor/Myf5+
Stat5btm1Mam/Stat5btm1Mam
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N) 		increased total body fat amount J:119237
Myf6tm1Eno/Myf6tm1Eno
Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		abnormal adipose tissue distribution J:48809
Myh1tm1b(KOMP)Wtsi/Myh1tm1b(KOMP)Wtsi
(C57BL/6N-Myh1tm1b(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Myl2tm1b(EUCOMM)Hmgu/Myl2+
(C57BL/6N-Myl2tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Myl3em1(IMPC)Wtsi/Myl3+
(C57BL/6N-Myl3em1(IMPC)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Mylk4em1(IMPC)J/Mylk4em1(IMPC)J
(C57BL/6NJ-Mylk4em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Myo6em1(IMPC)Tcp/Myo6em1(IMPC)Tcp
(C57BL/6N-Myo6em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Myo15atm1a(EUCOMM)Wtsi/Myo15atm1a(EUCOMM)Wtsi
(C57BL/6N-Myo15atm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Myogtm1Whk/Myogtm1Whk
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased brown adipose tissue amount J:14208
Myoz1tm1b(EUCOMM)Hmgu/Myoz1tm1b(EUCOMM)Hmgu
(C57BL/6N-Myoz1tm1b(EUCOMM)Hmgu/Ieg) 		abnormal body fat mass J:211773
Naa10em1(IMPC)Mbp/Naa10em1(IMPC)Mbp
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd) 		decreased total body fat amount J:211773
Naa40tm1Qwzh/Naa40tm1Qwzh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh) 		decreased percent body fat/body weight J:183119
decreased total body fat amount J:183119
Nadkem2(IMPC)Bay/Nadk+
(C57BL/6N-Nadkem2(IMPC)Bay/Bay) 		decreased total body fat amount J:211773
Nansem1(IMPC)Tcp/Nans+
(C57BL/6N-Nansem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Natd1tm1b(EUCOMM)Wtsi/Natd1tm1b(EUCOMM)Wtsi
(C57BL/6N-Natd1tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Nbastm1b(EUCOMM)Hmgu/Nbas+
(C57BL/6N-Nbastm1b(EUCOMM)Hmgu/Ieg) 		decreased total body fat amount J:211773
Nbeaem1(IMPC)Bay/Nbea+
(C57BL/6N-Nbeaem1(IMPC)Bay/BayMmucd) 		increased total body fat amount J:211773
NbeaGt(RRK418)Byg/NbeaGt(RRK418)Byg
(involves: 129P2/OlaHsd * C57BL/6N) 		abnormal interscapular fat pad morphology J:159572
NbeaTg(GH1)240BNec/NbeaTg(GH1)240BNec
(involves: C57BL/6 * SJL) 		abnormal interscapular fat pad morphology J:128767
Ncbp3tm1b(EUCOMM)Wtsi/Ncbp3+
(C57BL/6N-Ncbp3tm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Ncoa1tm1.1(KOMP)Vlcg/Ncoa1tm1.1(KOMP)Vlcg
(C57BL/6N-Ncoa1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J) 		increased fat cell size J:161276
increased total body fat amount J:161276
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal adipose tissue morphology J:117159
abnormal brown fat cell morphology J:144060
abnormal epididymal fat pad morphology J:117159
decreased brown adipose tissue amount J:144060
decreased brown fat cell lipid droplet size J:144060
decreased brown fat cell size J:144060
decreased epididymal fat pad weight J:117159
decreased total body fat amount J:117159, J:144060
decreased white adipose tissue amount J:117159, J:144060
decreased white fat cell size J:117159
Ncoa6em1(IMPC)J/Ncoa6+
(C57BL/6NJ-Ncoa6em1(IMPC)J/J) 		decreased total body fat amount J:211773
Ncor1tm1.1Anh/Ncor1tm1.1Anh
(involves: 129S4/SvJae * C57BL/6J) 		decreased total body fat amount J:213990
Ncor1tm1Laz/Ncor1tm1Laz
(C57BL/6-Ncor1tm1Laz) 		abnormal adipose tissue morphology J:142342
decreased gonadal fat pad weight J:142342
decreased percent body fat/body weight J:142342
decreased white fat cell size J:142342
Ncor2Gt(RRM275)Byg/Ncor2+
(B6.129P2-Ncor2Gt(RRM275)Byg) 		abnormal white adipose tissue physiology J:164558
decreased white fat cell size J:164558
increased white adipose tissue amount J:164558
increased white fat cell number J:164558
Ncor2tm1Rev/Ncor2tm1Rev
(involves: 129/Sv * C57BL/6) 		adipose tissue phenotype J:142665
increased epididymal fat pad weight J:142665
increased percent body fat/body weight J:142665
Ndufa10tm1e.1(EUCOMM)Hmgu/Ndufa10+
(C57BL/6N-Ndufa10tm1e.1(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Nebtm1(cre)Chen/Nebtm1(cre)Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		decreased total body fat amount J:111470
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6) 		abnormal adipose tissue distribution J:106077
increased total body fat amount J:106077
Net1tm1.2Jafr/Net1tm1.2Jafr
(involves: C57BL/6 * SJL) 		abnormal mammary fat pad morphology J:218290
Neurl4em1(IMPC)Mbp/Neurl4em1(IMPC)Mbp
(C57BL/6NCrl-Neurl4em1(IMPC)Mbp/Mmucd) 		decreased total body fat amount J:211773
Neurog3tm1Fgu/Neurog3tm3.1Ggr
Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal abdominal fat pad morphology J:161480
decreased total body fat amount J:161480
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr
Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal abdominal fat pad morphology J:161480
decreased total body fat amount J:161480
Nexmifem1(IMPC)Tcp/Y
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Nhlh2tm1b(KOMP)Mbp/Nhlh2tm1b(KOMP)Mbp
(C57BL/6N-Nhlh2tm1b(KOMP)Mbp/Tcp) 		increased total body fat amount J:211773
Nhlh2tm1Irk/Nhlh2+
(involves: 129S4/SvJae * C57BL/6) 		increased percent body fat/body weight J:96351
Nhlh2tm1Irk/Nhlh2tm1Irk
(involves: 129S4/SvJae * C57BL/6) 		increased percent body fat/body weight J:96351
Nhlh2tm2Thbr/Nhlh2tm2Thbr
Tg(Agrp-cre)1Gsb/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		adipose tissue phenotype J:199640
Nhlh2tm2Thbr/Nhlh2tm2Thbr
Tg(CMV-cre)1Cgn/0
(involves: 129S7/SvEvBrd * BALB/cJ * C57BL/6) 		increased abdominal adipose tissue amount J:199640
Nhlh2tm2Thbr/Nhlh2tm2Thbr
Tg(Gnrh1-cre)1Dlc/0
Tg(Pomc-EGFP)1Low/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * CBA) 		increased white adipose tissue amount J:199640
Nhlh2tm2Thbr/Nhlh2tm2Thbr
Tg(Pomc-EGFP)1Low/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * FVB/N) 		adipose tissue phenotype J:199640
Nhp2tm1a(KOMP)Wtsi/Nhp2+
(C57BL/6N-Nhp2tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Nidd5BALB/cA/Nidd5BALB/cA
(TSOD.C-Nidd5BALB/cA) 		decreased total body fat amount J:108693
NipblGt(RRS564)Byg/Nipbl+
(involves: 129P2/OlaHsd * CD-1) 		decreased brown adipose tissue amount J:154117
decreased white adipose tissue amount J:154117
Nlrp3tm1Bhk/Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J) 		increased body fat mass J:256504
white adipose tissue inflammation J:256504
Nmutm1Mko/Nmutm1Mko
(involves: 129 * C57BL/6) 		increased fat cell size J:93213
Nmur2tm1.1Eege/Nmur2tm1.1Eege
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased total body fat amount J:152493
Nmur2tm1Dgen/Nmur2tm1Dgen
(B6N.Cg-Nmur2tm1Dgen) 		decreased total body fat amount J:152371
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased white adipose tissue amount J:155090
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6) 		decreased white adipose tissue amount J:94571
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		increased white adipose tissue amount J:155090
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		abnormal adipose tissue amount J:133437
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6) 		increased brown adipose tissue amount J:198075
increased inguinal fat pad weight J:198075
increased retroperitoneal fat pad weight J:198075
increased white fat cell size J:198075
Nos3tm3.1Plh/Nos3tm3.1Plh
(involves: 129S4/SvJae * C57BL/6) 		decreased white fat cell size J:198075
NotumGt(OST172035)Lex/NotumGt(OST172035)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased body fat mass J:274615
Nox3het/Nox3het
(B6Ei.GL-Nox3het/J) 		decreased total body fat amount J:88596
Npc1m1N/Npc1m1N
(involves: BALB/c) 		decreased abdominal fat pad weight J:91430
Npeppsem1(IMPC)Hmgu/Npeppsem1(IMPC)Hmgu
(C57BL/6N-Npeppsem1(IMPC)Hmgu/Ieg) 		decreased total body fat amount J:211773
Npffr2tm1.1Hhzg/Npffr2tm1.1Hhzg
(involves: C57BL/6) 		abnormal brown adipose tissue thermogenesis J:267918
decreased inguinal fat pad weight J:267918
decreased mesenteric fat pad weight J:267918
decreased retroperitoneal fat pad weight J:267918
decreased white adipose tissue amount J:267918
increased epididymal fat pad weight J:267918
increased inguinal fat pad weight J:267918
increased mesenteric fat pad weight J:267918
increased retroperitoneal fat pad weight J:267918
increased white adipose tissue amount J:267918
Npr3kylb/Npr3kylb
(involves: BALB/c * C57BL/6J) 		decreased total body fat amount J:243806
Npr3lgj-2J/Npr3lgj-2J
(DBA/2J) 		abnormal abdominal fat pad morphology J:57460
abnormal adipose tissue distribution J:57460
abnormal adipose tissue morphology J:57460
Npr3lgj/Npr3lgj
(involves: BALB/cJ) 		abnormal abdominal fat pad morphology J:57460
abnormal adipose tissue distribution J:57460
abnormal adipose tissue morphology J:57460
Npr3stri/Npr3stri
(involves: 129/Sv * FVB/N) 		abnormal abdominal fat pad morphology J:57460
abnormal adipose tissue distribution J:57460
Npr3tm1Unc/Npr3tm1Unc
(B6.129-Npr3tm1Unc) 		abnormal interscapular fat pad morphology J:184488
decreased brown fat cell lipid droplet size J:184488
decreased epididymal fat pad weight J:184488
decreased inguinal fat pad weight J:184488
decreased interscapular fat pad weight J:184488
decreased retroperitoneal fat pad weight J:184488
decreased white fat cell size J:184488
Nptntm1b(EUCOMM)Hmgu/Nptntm1b(EUCOMM)Hmgu
(C57BL/6N-Nptntm1b(EUCOMM)Hmgu/H) 		decreased total body fat amount J:211773
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL) 		decreased epididymal fat pad weight J:180396
decreased subcutaneous adipose tissue amount J:180396
decreased total fat pad weight J:180396
Npy1rtm1Mnak/Npy1rtm1Mnak
(involves: 129P2/OlaHsd * C57BL/6) 		increased gonadal fat pad weight J:51684
increased retroperitoneal fat pad weight J:51684
Npy1rtm1Snby/Npy1rtm1Snby
Npy5rtm1Snby/Npy5rtm1Snby
(involves: 129 * C57BL/6) 		increased total body fat amount J:225097
increased white adipose tissue amount J:225097
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6) 		increased total body fat amount J:47972
Npy1rtm1Tped/Npy1rtm1Tped
(B6.129P2-Npy1rtm1Tped) 		increased adipocyte glucose uptake J:102554
increased epididymal fat pad weight J:102554
increased percent body fat/body weight J:102554
increased retroperitoneal fat pad weight J:87424
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		decreased white adipose tissue amount J:77345
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6) 		decreased white adipose tissue amount J:84570
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6) 		decreased brown adipose tissue amount J:84570
decreased white adipose tissue amount J:84570
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		adipose tissue phenotype J:77345
Npy2rtm1Pern/Npy2rtm1Pern
(involves: 129/Sv * BALB/c) 		increased total fat pad weight J:57961
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		abnormal fat pad morphology J:76479
decreased white adipose tissue amount J:76479
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6) 		decreased white adipose tissue amount J:84570
Npy4rtm1Lex/Npy4rtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		adipose tissue phenotype J:185494
Npy5rem1(IMPC)H/Npy5rem1(IMPC)H
(C57BL/6NTac-Npy5rem1(IMPC)H/H) 		increased total body fat amount J:211773
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased total body fat amount J:87803
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd) 		increased retroperitoneal fat pad weight J:87424
Npy6rtm1Hhzg/Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6) 		abnormal abdominal fat pad morphology J:210546
decreased brown adipose tissue amount J:210546
decreased epididymal fat pad weight J:210546
decreased inguinal fat pad weight J:210546
decreased mesenteric fat pad weight J:210546
decreased retroperitoneal fat pad weight J:210546
decreased total body fat amount J:210546
increased brown adipose tissue amount J:210546
increased epididymal fat pad weight J:210546
increased inguinal fat pad weight J:210546
increased retroperitoneal fat pad weight J:210546
increased total body fat amount J:210546
increased white adipose tissue amount J:210546
Npytm1(rtTA,tetO-cre/EGFP)Snby/Npy+
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		decreased white adipose tissue mass J:162000
increased body fat mass J:162000
increased white adipose tissue mass J:162000
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased total fat pad weight J:104699
Nqo1tm1Akj/Nqo1tm1Akj
(involves: C57BL/6) 		decreased abdominal adipose tissue amount J:120478
Nr1d1tm1(KOMP)Vlcg/Nr1d1tm1(KOMP)Vlcg
(C57BL/6N-Nr1d1tm1(KOMP)Vlcg/Bay) 		decreased total body fat amount J:211773
Nr1d1tm1Ven/Nr1d1tm1Ven
(B6.Cg-Nr1d1tm1Ven) 		increased adipocyte glucose uptake J:203422
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj) 		decreased epididymal fat pad weight J:200842
decreased interscapular fat pad weight J:200842
decreased retroperitoneal fat pad weight J:200842
decreased total body fat amount J:200842
decreased white fat cell size J:200842
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj) 		abnormal white adipose tissue physiology J:169333
decreased abdominal fat pad weight J:169333
decreased body fat mass J:169333
decreased brown adipose tissue mass J:169333
decreased epididymal fat pad weight J:169333
decreased white fat cell size J:169333
Nr2e1frc/Nr2e1frc
(either: B6.129-Nr2e1frc or 129P3/JEms.Cg-Nr2e1frc or B6129F1-Nr2e1frc) 		decreased total body fat amount J:71869
Nr3c1Gt(ESKN92)Hgs/Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs) 		adipose tissue phenotype J:141205
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		abnormal adipose tissue distribution J:57315
Nrxn1tm1b(KOMP)Wtsi/Nrxn1tm1b(KOMP)Wtsi
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H) 		decreased total body fat amount J:211773
Nsd3tm1b(EUCOMM)Hmgu/Nsd3+
(C57BL/6N-Nsd3tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6 * SJL) 		decreased total body fat amount J:227197
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased percent body fat/body weight J:213427
decreased total body fat amount J:213427
Ntrk2tm1Mini/Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased abdominal fat pad weight J:210229
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		abnormal adipose tissue distribution J:210229
adipose tissue phenotype J:210229
increased abdominal fat pad weight J:210229
increased gonadal fat pad weight J:210229
increased total body fat amount J:210229
Ntstm1(cre)Mgmj/Nts+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB) 		decreased total body fat amount J:176657
Ntsr1tm1Fer/Ntsr1tm1Fer
(C57BL/6-Ntsr1tm1Fer) 		increased white adipose tissue amount J:79712
Nucb2tm1.2Vdix/Nucb2tm1.2Vdix
(involves: C57BL/6) 		adipose tissue phenotype J:270674
Nucks1tm1.2Vter/Nucks1tm1.2Vter
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NSlc * FVB/N * SJL) 		increased renal fat pad weight J:211777
increased total body fat amount J:211777
Nudt6em1(IMPC)Bay/Nudt6em1(IMPC)Bay
(C57BL/6N-Nudt6em1(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
Nup62tm1b(KOMP)Wtsi/Nup62+
(C57BL/6N-Nup62tm1b(KOMP)Wtsi/Bay) 		decreased total body fat amount J:211773
Nup205em1(IMPC)J/Nup205+
(C57BL/6NJ-Nup205em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Nutm1tm1b(KOMP)Wtsi/Nutm1tm1b(KOMP)Wtsi
(C57BL/6N-Nutm1tm1b(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Obq1129T2/SvEmsJ/Obq1EL/SuzSeyFrkJ
(involves: 129T2/SvEmsJ * EL/Suz) 		increased white adipose tissue amount J:33858
Obq1EL/SuzSeyFrkJ/Obq1EL/SuzSeyFrkJ
(involves: 129T2/SvEmsJ * EL/Suz) 		increased white adipose tissue amount J:33858
Obq2129T2/SvEmsJ/Obq2129T2/SvEmsJ
(involves: 129T2/SvEmsJ * EL/Suz) 		increased white adipose tissue amount J:33858
Obq2EL/SuzSeyFrkJ/Obq2129T2/SvEmsJ
(involves: 129T2/SvEmsJ * EL/Suz) 		increased white adipose tissue amount J:33858
Obq4C57L/J/Obq4C57L/J
(involves: AKR/J * C57L/J) 		increased inguinal fat pad weight J:39947
Obq5KK/HlLt/Obq5C57BL/6J
(involves: C57BL/6J * KK/HlLt) 		increased white adipose tissue amount J:57787
Obq5KK/HlLt/Obq5KK/HlLt
(involves: C57BL/6J * KK/HlLt) 		increased white adipose tissue amount J:57787
Obq6KK/HlLt/?
(involves: C57BL/6J * KK/HlLt) 		increased total body fat amount J:57787
Obq7NZO/HlLt/Obq7NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq8NZO/HlLt/?
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq9NZO/HlLt/Obq9NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq9NZO/HlLt/Obq9SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq10NZO/HlLt/Obq10NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq10NZO/HlLt/Obq10SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq11NZO/HlLt/Obq11NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq11NZO/HlLt/Obq11SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq12NZO/HlLt/Obq12NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq12NZO/HlLt/Obq12SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq13NZO/HlLt/Obq13NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq13NZO/HlLt/Obq13SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq14NZO/HlLt/Obq14NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq14NZO/HlLt/Obq14SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq15NZO/HlLt/Obq15NZO/HlLt
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq15NZO/HlLt/Obq15SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq16129S1/SvImJ/Obq16129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		increased percent body fat/body weight J:93243
Obq16129S1/SvImJ/Obq16129S1/SvImJ
Obq18C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased percent body fat/body weight J:93243
Obq17129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased percent body fat/body weight J:93243
Obq20NZB/BlNJ/Obq20NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Obq21NZB/BlNJ/Obq21NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased retroperitoneal fat pad weight J:103841
Obq21NZB/BlNJ/Obq21SM/J
(involves: NZB/BlNJ * SM/J) 		increased retroperitoneal fat pad weight J:103841
Obq22NZB/BlNJ/Obq22NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Obq22NZB/BlNJ/Obq22SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Obq36NZO/HlLt/Obq36SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obq36SM/J/Obq36SM/J
(involves: NZO/HlLt * SM/J) 		increased white adipose tissue amount J:67838
Obsty1LG/J/?
(involves: LG/J * SM/J) 		increased mesenteric fat pad weight J:94605
increased renal fat pad weight J:94605
increased retroperitoneal fat pad weight J:94605
increased total fat pad weight J:94605
Obsty2SM/J/?
(involves: LG/J * SM/J) 		increased renal fat pad weight J:94605
Obsty3LG/J/?
(involves: LG/J * SM/J) 		increased inguinal fat pad weight J:94605
increased mesenteric fat pad weight J:94605
increased renal fat pad weight J:94605
increased total fat pad weight J:94605
Obsty4LG/J/?
(involves: LG/J * SM/J) 		increased total fat pad weight J:94605
Obsty5SM/J/?
(involves: LG/J * SM/J) 		increased mesenteric fat pad weight J:94605
increased total fat pad weight J:94605
Obwq1NZB/BlNJ/Obwq1NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased mesenteric fat pad weight J:103841
Obwq1NZB/BlNJ/Obwq1SM/J
(involves: NZB/BlNJ * SM/J) 		increased mesenteric fat pad weight J:103841
Obwq2NZB/BlNJ/Obwq2NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Obwq2NZB/BlNJ/Obwq2SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Obwq3SM/J/Obwq3SM/J
(involves: NZB/BlNJ * SM/J) 		increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Obwq4NZB/BlNJ/Obwq4NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased mesenteric fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Obwq4NZB/BlNJ/Obwq4SM/J
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased mesenteric fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Obwq5NZB/BlNJ/Obwq5NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased mesenteric fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Oca2p-23DFiOD/Oca2p-x
(Not Specified) 		increased total fat pad weight J:66645
Oca2p-30PUb/Oca2p-x
(Not Specified) 		increased total fat pad weight J:89922
Ogdhtm1e(KOMP)Wtsi/Ogdh+
(C57BL/6N-Ogdhtm1e(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		abnormal brown adipose tissue thermogenesis J:184716
abnormal mesenteric fat pad morphology J:184716
increased gonadal fat pad weight J:184716
increased white fat cell size J:184716
Opa1M1Bewi/Opa1+
(involves: C3HeB/FeJ) 		decreased total body fat amount J:154865
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl) 		abnormal abdominal fat pad morphology J:181670
abnormal brown adipose tissue morphology J:188346
abnormal white adipose tissue morphology J:188346
decreased fat cell size J:188346
decreased total body fat amount J:181670
decreased white adipose tissue amount J:188346
increased brown adipose tissue amount J:188346
Opn3tm2b(EUCOMM)Wtsi/Opn3tm2b(EUCOMM)Wtsi
(involves: C57BL/6N * FVB/N) 		abnormal adipose tissue physiology J:287419
abnormal beige fat cell morphology J:287419
abnormal white fat cell size J:287419
Opn3tm2c(EUCOMM)Wtsi/Opn3tm2c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		abnormal adipose tissue physiology J:287419
abnormal beige fat cell morphology J:287419
abnormal white fat cell size J:287419
Opn3tm2c(EUCOMM)Wtsi/Opn3tm2c(EUCOMM)Wtsi
Tg(Rax-cre)1Zkoz/0
(involves: C57BL/6N) 		adipose tissue phenotype J:287419
Opn3tm2c(EUCOMM)Wtsi/Opn3tm2c(EUCOMM)Wtsi
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		adipose tissue phenotype J:287419
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep) 		increased percent body fat/body weight J:147786
increased total body fat amount J:147786
Or4m1em1Tshu/Or4m1em1Tshu
(involves: C57BL/6J) 		decreased epididymal fat pad weight J:279017
decreased total body fat amount J:279017
Orc1tm1a(KOMP)Wtsi/Orc1+
(C57BL/6N-Orc1tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J) 		adipose tissue phenotype J:333118
Osbpl3tm1a(EUCOMM)Wtsi/Osbpl3tm1a(EUCOMM)Wtsi
(C57BL/6N-Osbpl3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Osbpl11tm1b(EUCOMM)Hmgu/Osbpl11+
(C57BL/6N-Osbpl11tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		increased epididymal fat pad weight J:214124
increased subcutaneous adipose tissue amount J:214124
white adipose tissue inflammation J:214124
Ostm1om/Ostm1om
(C3HeB/FeJ-Ostm1om) 		decreased total body fat amount J:195249
OtpM1H/Otp+
(C3H.Cg-OtpM1H) 		abnormal fat pad morphology J:251771
increased body fat mass J:251771
increased white adipose tissue amount J:251771
Otptm1Asim/Otp+
(C3H.129P2(B6)-Otptm1Asim) 		increased body fat mass J:251771
P2ry14em1(IMPC)H/P2ry14em1(IMPC)H
(C57BL/6NTac-P2ry14em1(IMPC)H/H) 		increased total body fat amount J:211773
P3h1tm1b(EUCOMM)Wtsi/P3h1tm1b(EUCOMM)Wtsi
(C57BL/6N-P3h1tm1b(EUCOMM)Wtsi/Ucd) 		increased total body fat amount J:211773
P3h1tm1Dgen/P3h1tm1Dgen
(involves: C57BL/6) 		decreased total body fat amount J:163884
Padi3tm1b(KOMP)Wtsi/Padi3tm1b(KOMP)Wtsi
(C57BL/6N-Padi3tm1b(KOMP)Wtsi/Orl) 		increased total body fat amount J:211773
Pak1tm1b(EUCOMM)Hmgu/Pak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Pak1tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Pals2em1(IMPC)Rbrc/Pals2em1(IMPC)Rbrc
(C57BL/6NJcl-Pals2em1(IMPC)Rbrc/Rbrc) 		increased total body fat amount J:211773
Pamtm1Jep/Pam+
(involves: 129S7/SvEvBrd) 		increased total body fat amount J:103533
Pbft3CASA/Rk/Pbft3CASA/Rk
(involves: C57BL/6J * CASA/Rk) 		increased percent body fat/body weight J:117547
Pbwg1.5C57BL/6J/Pbwg1.5C57BL/6J
(involves: C57BL/6J * M. m. castaneus) 		increased gonadal fat pad weight J:121981
Pbwg1.5C57BL/6J/Pbwg1.5M. m. castaneus
(involves: C57BL/6J * M. m. castaneus) 		increased gonadal fat pad weight J:121981
Pbwg1.6C57BL/6J/Pbwg1.6C57BL/6J
(involves: C57BL/6J * M. m. castaneus) 		abnormal inguinal fat pad morphology J:121981
Pbwg1.7C57BL/6J/Pbwg1.7C57BL/6J
(involves: C57BL/6J * M. m. castaneus) 		increased retroperitoneal fat pad weight J:121981
Pbwg1.7C57BL/6J/Pbwg1.7M. m. castaneus
(involves: C57BL/6J * M. m. castaneus) 		increased retroperitoneal fat pad weight J:121981
Pbwg1.8C57BL/6J/Pbwg1.8C57BL/6J
(involves: C57BL/6J * M. m. castaneus) 		increased total fat pad weight J:121981
Pbx3tm1b(EUCOMM)Wtsi/Pbx3+
(C57BL/6N-Pbx3tm1b(EUCOMM)Wtsi/H) 		decreased total body fat amount J:211773
Pcdh18tm1.1(KOMP)Vlcg/Pcdh18tm1.1(KOMP)Vlcg
(C57BL/6N-Pcdh18tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Pcif1em1(IMPC)Bay/Pcif1em1(IMPC)Bay
(C57BL/6N-Pcif1em1(IMPC)Bay/BayMmucd) 		decreased total body fat amount J:211773
Pck1tm1.1Lre/Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		abnormal brown fat cell morphology J:73977
abnormal white adipose tissue physiology J:73977
abnormal white fat cell morphology J:73977
decreased abdominal adipose tissue amount J:73977
decreased brown fat cell number J:73977
decreased brown fat cell size J:73977
decreased epididymal fat pad weight J:73977
decreased white adipose tissue amount J:73977
decreased white fat cell lipid droplet size J:73977
decreased white fat cell size J:73977
lipodystrophy J:73977
Pck1tm1Rwh/Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased percent body fat/body weight J:145210
Pcnatm1.1Scwh/Pcnatm1.1Scwh
(involves: FVB) 		abnormal adipose tissue development J:193874
decreased percent body fat/body weight J:193874
decreased white fat cell number J:193874
Pcsk1N222D/Pcsk1N222D
(C57BL/6-Pcsk1N222D) 		abnormal inguinal fat pad morphology J:109531
increased white adipose tissue amount J:109531
Pcxtm1b(EUCOMM)Wtsi/Pcx+
(C57BL/6N-Pcxtm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Pcyox1lem1(IMPC)J/Pcyox1lem1(IMPC)J
(C57BL/6NJ-Pcyox1lem1(IMPC)J/J) 		increased total body fat amount J:211773
Pde1aem1(IMPC)H/Pde1aem1(IMPC)H
(C57BL/6N-Pde1aem1(IMPC)H/H) 		decreased total body fat amount J:211773
Pde3btm1Yhc/Pde3btm1Yhc
(129X1/SvJ-Pde3btm1Yhc) 		abnormal fat cell morphology J:117353
decreased gonadal fat pad weight J:117353
decreased percent body fat/body weight J:117353
Pde8atm1b(EUCOMM)Hmgu/Pde8atm1b(EUCOMM)Hmgu
(C57BL/6N-Pde8atm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Pde10atm1Smsh/Pde10atm1Smsh
(B6NTac.Cg-Pde10atm1Smsh) 		decreased total fat pad weight J:209032
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S4/SvJaeSor * C57BL/6 * CBA) 		abnormal hypodermis fat layer morphology J:173602
abnormal inguinal fat pad morphology J:173602
abnormal mesenteric fat pad morphology J:173602
abnormal white adipose tissue morphology J:173602
abnormal white fat cell differentation J:173602
adipose tissue phenotype J:173602
increased white fat cell number J:173602
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+
Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		abnormal adipose tissue morphology J:173602
Pdia6tm1b(EUCOMM)Hmgu/Pdia6+
(C57BL/6N-Pdia6tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129X1/SvJ * C57BL/6) 		abnormal hypodermis fat layer morphology J:226194
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		decreased gonadal fat pad weight J:134336
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat,-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		increased total body fat amount J:162892
Pds5atm1.1Alos/Pds5atm1.1Alos
(involves: 129S2/SvPas) 		decreased brown adipose tissue amount J:205601
Pds5btm1.2Alos/Pds5btm1.2Alos
(involves: 129S2/SvPas) 		decreased brown adipose tissue amount J:205601
Pdss2tm1b(EUCOMM)Hmgu/Pdss2+
(C57BL/6N-Pdss2tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(involves: 129X1/SvJ * C57BL/6) 		decreased abdominal adipose tissue amount J:122399
decreased subcutaneous adipose tissue amount J:122399
decreased white adipose tissue amount J:122399
Peli3tm1a(KOMP)Mbp/Peli3tm1a(KOMP)Mbp
(C57BL/6NTac-Peli3tm1a(KOMP)Mbp/Kmpc) 		decreased total body fat amount J:211773
Penktm1(KOMP)Mbp/Penktm1(KOMP)Mbp
(C57BL/6N-Penktm1(KOMP)Mbp/Rbrc) 		increased total body fat amount J:211773
Pex3tm1a(EUCOMM)Wtsi/Pex3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pex3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Pex16tm1c(EUCOMM)Hmgu/Pex16tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ * SJL) 		decreased fat cell mitochondrial DNA content J:270463
increased brown fat cell lipid droplet size J:270463
increased gonadal fat pad weight J:270463
increased total body fat amount J:270463
increased white fat cell size J:270463
whitened brown adipose tissue morphology J:270463
PfasSofa-2J/Pfas+
(B6(Cg)-PfasSofa-2J/GrsrJ) 		decreased total body fat amount J:223062
PfasSofa-3J/Pfas+
(B6(129S7)-PfasSofa-3J/GrsrJ) 		decreased percent body fat/body weight J:223062
decreased total body fat amount J:223062
PfasSofa-4J/Pfas+
(C57BL/6J-PfasSofa-4J/GrsrJ) 		decreased percent body fat/body weight J:223062
decreased total body fat amount J:223062
PfasSofa/Pfas+
(B6(AKR)-PfasSofa/GrsrJ) 		decreased total body fat amount J:223062
Pfdn5tm1b(EUCOMM)Wtsi/Pfdn5+
(C57BL/6N-Pfdn5tm1b(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Pfkmem1(IMPC)Mbp/Pfkm+
(C57BL/6N-Pfkmem1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Pfn1tm1a(EUCOMM)Wtsi/Pfn1+
(B6Brd;B6Dnk;B6N-Tyrc-Brd Pfn1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Pgap4em1Osbir/Pgap4em1Osbir
(involves: C57BL/6NSlc) 		increased body fat mass J:333707
increased percent body fat/body weight J:333707
Pgftm1Pec/Pgftm1Pec
(involves: 129/Sv * Swiss) 		abnormal adipose tissue morphology J:116580
decreased fat cell size J:116580
decreased gonadal fat pad weight J:116580
decreased subcutaneous adipose tissue amount J:116580
decreased total body fat amount J:116580
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N) 		increased white fat cell lipid droplet size J:268130
PhexHyp-Duk/Y
(involves: BALB/cAnBomUrd) 		decreased total body fat amount J:88352
Phf2tm1.1Yima/Phf2tm1.1Yima
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		abnormal adipose tissue development J:198329
decreased epididymal fat pad weight J:198329
decreased gonadal fat pad weight J:198329
decreased mesenteric fat pad weight J:198329
decreased subcutaneous adipose tissue amount J:198329
decreased total body fat amount J:198329
decreased white fat cell number J:198329
decreased white fat cell size J:198329
Phf2tm1.2Yima/Phf2tm1.2Yima
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * SJL) 		abnormal adipose tissue development J:198329
Phf6tm1.2Avo/Y
(involves: BALB/c * BALB/cJ * C57BL/6 * FVB/N) 		increased white adipose tissue amount J:299742
Phf20Gt(XN131)Byg/Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd) 		decreased total body fat amount J:228714
Phf20l1em1(IMPC)Tcp/Phf20l1em1(IMPC)Tcp
(C57BL/6N-Phf20l1em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
PhipGt(RRJ571)Byg/PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased total body fat amount J:164354
Phkbem1(IMPC)J/Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N) 		decreased white adipose tissue amount J:142512
Pias2tm1a(KOMP)Wtsi/Pias2tm1a(KOMP)Wtsi
(C57BL/6N-Pias2tm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Pigftm1a(KOMP)Wtsi/Pigf+
(C57BL/6N-Pigftm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Pigzem1(IMPC)J/Pigzem1(IMPC)J
(C57BL/6NJ-Pigzem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased total body fat amount J:169710
Pik3c2gtm1Ehi/Pik3c2gtm1Ehi
(involves: 129 * C57BL/6) 		increased epididymal fat pad weight J:223018
increased fat cell size J:223018
Pik3catm1.1Rzl/Pik3catm1.1Rzl
Tg(Fabp4-cre)1Blw/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal white adipose tissue physiology J:315599
increased total body fat amount J:315599
Pik3catm1Bvan/Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6) 		increased fat cell size J:109024
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J) 		abnormal epididymal fat pad morphology J:234657
decreased adipocyte glucose uptake J:234657
decreased subcutaneous adipose tissue amount J:234657
decreased white fat cell size J:234657
lipodystrophy J:234657
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal brown adipose tissue morphology J:65523
Pik3r1tm1Khn/Pik3r1tm1Khn
(involves: 129S4/SvJae * C57BL/6J) 		abnormal fat cell morphology J:87598
abnormal fat pad morphology J:87598
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA) 		increased adipocyte glucose uptake J:52576
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi
Tg(Ckm-cre)28Arte/0
(involves: C57BL/6) 		increased adipocyte glucose uptake J:199213
increased fat cell size J:199213
increased gonadal fat pad weight J:199213
increased renal fat pad weight J:199213
increased total body fat amount J:199213
Pip4k2bGt(Betageo)1Lca/Pip4k2bGt(Betageo)1Lca
(involves: 129S/SvEv * C57BL/6) 		decreased total body fat amount J:91023
Pip4k2bGt(OST341064)Lex/Pip4k2bGt(OST341064)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		abnormal abdominal fat pad morphology J:85204
abnormal inguinal fat pad morphology J:85204
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		abnormal abdominal fat pad morphology J:85204
abnormal inguinal fat pad morphology J:85204
Pitx1tm1Rsd/Pitx1+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adipose tissue amount J:175799
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6) 		decreased total body fat amount J:156878
Pkd1tm2Ggg/Pkd1tm2Ggg
Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1) 		abnormal adipose tissue development J:191967
Pkn1tm1b(KOMP)Wtsi/Pkn1tm1b(KOMP)Wtsi
(C57BL/6N-Pkn1tm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:103485
Pkp1tm2d(KOMP)Wtsi/Pkp1tm2d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N * SJL/J) 		decreased subcutaneous adipose tissue amount J:233599
Pla2g1btm1Dyh/Pla2g1btm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6) 		decreased epididymal fat pad weight J:80216
decreased uterine fat pad weight J:80216
decreased white adipose tissue amount J:80216
Plaat3tm1.1Hsul/Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul) 		adipose tissue phenotype J:239202
decreased epididymal fat pad weight J:239202
decreased inguinal fat pad weight J:239202
decreased renal fat pad weight J:239202
decreased white fat cell size J:239202
Plac8tm1Bhk/Plac8+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased brown fat lipid droplet number J:179647
increased body fat mass J:179647
increased brown fat cell lipid droplet size J:179647
whitened brown adipose tissue morphology J:179647
Plac8tm1Bhk/Plac8tm1Bhk
(involves: 129S6/SvEvTac * C57BL/6) 		decreased brown fat lipid droplet number J:179647
increased body fat mass J:179647
increased brown fat cell lipid droplet size J:179647
whitened brown adipose tissue morphology J:179647
Plac9tm1b(EUCOMM)Hmgu/Plac9tm1b(EUCOMM)Hmgu
(C57BL/6N-Plac9tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Plautm1Mlg/Plautm1Mlg
(B6.129S2-Plautm1Mlg) 		decreased total body fat amount J:164542
Plb1em1(IMPC)J/Plb1em1(IMPC)J
(C57BL/6NJ-Plb1em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Plbcq2M16i/?
(involves: FVB/NJ * M16i) 		abnormal fat pad morphology J:132804
decreased percent body fat/body weight J:132804
increased percent body fat/body weight J:132804
Plbcq5M16i/?
(involves: FVB/NJ * M16i) 		abnormal fat pad morphology J:132804
decreased percent body fat/body weight J:132804
increased percent body fat/body weight J:132804
Plbcq8M16i/?
(involves: FVB/NJ * M16i) 		increased percent body fat/body weight J:132804
Plcb4tm1b(EUCOMM)Wtsi/Plcb4tm1b(EUCOMM)Wtsi
(C57BL/6N-Plcb4tm1b(EUCOMM)Wtsi/Tcp) 		decreased total body fat amount J:211773
Plekhm1tm1b(EUCOMM)Hmgu/Plekhm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Plekhm1tm1b(EUCOMM)Hmgu/Tcp) 		decreased total body fat amount J:211773
Plekhn1tm1.1Hkon/Plekhn1tm1.1Hkon
(B6.Cg-Plekhn1tm1.1Hkon) 		abnormal brown adipose tissue physiology J:251603
increased epididymal fat pad weight J:251603
Plin1tm1Asg/Plin1tm1Asg
(B6.129S6-Plin1tm1Asg) 		abnormal brown adipose tissue morphology J:121641
abnormal brown adipose tissue physiology J:121641
adipose tissue phenotype J:121641
decreased brown adipose tissue amount J:121641
decreased white adipose tissue mass J:121641
Plin1tm1Asg/Plin1tm1Asg
Tg(Fabp4-Plin*)1Asg/0
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal adipose tissue physiology J:113735
abnormal brown adipose tissue physiology J:121641
abnormal white adipose tissue mass J:121641
decreased brown adipose tissue amount J:121641
Plin1tm1Cdl/Plin1tm1Cdl
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal fat pad morphology J:69629
decreased brown fat lipid droplet number J:69629
decreased epididymal fat pad weight J:69629
decreased inguinal fat pad weight J:69629
decreased parametrial fat pad weight J:69629
decreased retroperitoneal fat pad weight J:69629
decreased subcutaneous adipose tissue amount J:69629
decreased total body fat amount J:69629
decreased total fat pad weight J:69629
Plin1tm1Chan/Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased brown fat cell lipid droplet size J:66267
decreased epididymal fat pad weight J:66267
decreased interscapular fat pad weight J:66267
decreased subcutaneous adipose tissue amount J:66267
decreased total body fat amount J:66267
decreased total fat pad weight J:66267
decreased white fat cell size J:66267
Plin1tm2Lex/Plin1tm2Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg) 		abnormal adipose tissue physiology J:196302
abnormal white fat cell morphology J:196302
decreased epididymal fat pad weight J:196302
decreased fat cell size J:196302
decreased subcutaneous adipose tissue amount J:196302
decreased total body fat amount J:196302
Plin2tm1Chan/Plin2tm1Chan
(B6.129-Plin2tm1Chan) 		adipose tissue phenotype J:105572
Plin3tm1.1Jbki/Plin3tm1.1Jbki
(B6J.129S(Cg)-Plin3tm1.1Jbki) 		abnormal beige fat cell physiology J:261132
abnormal brown fat cell morphology J:261132
abnormal inguinal fat pad morphology J:261132
abnormal white adipose tissue physiology J:261132
abnormal white fat cell morphology J:261132
decreased brown fat cell lipid droplet size J:261132
Plin4tm1Vlcg/Plin4tm1Vlcg
(B6.Cg-Plin4tm1Vlcg) 		adipose tissue phenotype J:195987
Plin5tm1e(KOMP)Wtsi/Plin5tm1e(KOMP)Wtsi
(involves: C57BL/6N) 		decreased adipocyte glucose uptake J:221539
Plscr1tm1Lex/Plscr1tm1Lex
(129S/SvEvBrd-Plscr1tm1Lex) 		abnormal fat pad morphology J:92404
increased fat cell size J:92404
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S/SvEvBrd * C57BL/6J) 		abnormal abdominal fat pad morphology J:92404
increased white fat cell size J:92404
Plvaptm1.1Rvst/Plvaptm1.1Rvst
Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J) 		decreased white adipose tissue amount J:191046
Plvaptm1.1Rvst/Plvaptm1.1Rvst
Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJae * C3H * C57BL/6) 		decreased white adipose tissue amount J:191046
Plvaptm1.2Rvst/Plvaptm1.2Rvst
(involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL) 		decreased abdominal adipose tissue amount J:191046
decreased gonadal fat pad weight J:191046
decreased retroperitoneal fat pad weight J:191046
Pmeltm1b(EUCOMM)Wtsi/Pmeltm1b(EUCOMM)Wtsi
(C57BL/6N-Pmeltm1b(EUCOMM)Wtsi/Ieg) 		decreased total body fat amount J:211773
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased percent body fat/body weight J:124658
Pnliprp1tm1Smoc/Pnliprp1tm1Smoc
(involves: 129S/SvEv * C57BL/6) 		increased abdominal adipose tissue amount J:278344
increased body fat mass J:278344
increased subcutaneous adipose tissue amount J:278344
increased white fat cell size J:278344
Pnntm1Sps/Pnntm1Sps
(involves: 129S4/SvJae * C57BL/6) 		decreased brown adipose tissue amount J:123288
Pnpla2tm1.1Hsul/Pnpla2tm1.1Hsul
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL) 		abnormal adipose tissue physiology J:176083
abnormal brown adipose tissue morphology J:176083
decreased adipocyte glucose uptake J:176083
increased brown adipose tissue amount J:176083
increased brown fat cell size J:176083
increased gonadal fat pad weight J:176083
increased inguinal fat pad weight J:176083
increased renal fat pad weight J:176083
increased total fat pad weight J:176083
increased white fat cell size J:176083
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal brown adipose tissue morphology J:108546
abnormal white adipose tissue morphology J:108546
increased brown adipose tissue amount J:108546
increased gonadal fat pad weight J:108546
increased inguinal fat pad weight J:108546
increased interscapular fat pad weight J:108546
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd) 		increased brown adipose tissue amount J:176252
increased white adipose tissue amount J:176252
Pnpla2tm1Rze/Pnpla2tm1Rze
Tg(Myh6-Pnpla2)94Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased brown adipose tissue amount J:176252
increased white adipose tissue amount J:176252
Pnpla3tm1.1Hobb/Pnpla3tm1.1Hobb
(involves: 129 * C57BL/6J) 		abnormal fat cell morphology J:264475
Pnpla3tm2.1Hobb/Pnpla3tm2.1Hobb
(involves: 129 * C57BL/6J) 		abnormal fat cell morphology J:264475
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm) 		abnormal adipose tissue amount J:333442
browned white adipose tissue morphology J:333442
decreased subcutaneous adipose tissue amount J:333442
Pnrc2tm1Shch/Pnrc2tm1Shch
(involves: 129S1/Sv * C57BL/6) 		abnormal fat cell morphology J:130294
abnormal fat pad morphology J:130294
decreased gonadal fat pad weight J:130294
decreased inguinal fat pad weight J:130294
decreased percent body fat/body weight J:130294
Polbtm1a(KOMP)Wtsi/Polb+
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Polgtm1.1Lrsn/Polgtm1.1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased subcutaneous adipose tissue amount J:91077
decreased total body fat amount J:91077
Pomctm1.1Kgm/Pomctm1.1Kgm
(involves: C57BL/6J) 		increased body fat mass J:263640
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low) 		adipose tissue phenotype J:115712
increased fat cell size J:115712
increased gonadal fat pad weight J:115712
increased inguinal fat pad weight J:115712
increased renal fat pad weight J:115712
increased retroperitoneal fat pad weight J:115712
increased total body fat amount J:115712
Pomctm2Low/Pomctm2Low
(B6.129S4-Pomctm2Low) 		increased gonadal fat pad weight J:194013
increased inguinal fat pad weight J:194013
increased retroperitoneal fat pad weight J:194013
increased total body fat amount J:194013
Pomctm2Low/Pomctm2Low
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased gonadal fat pad weight J:194013
increased inguinal fat pad weight J:194013
increased retroperitoneal fat pad weight J:194013
increased total body fat amount J:194013
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh) 		increased gonadal fat pad weight J:234615
increased retroperitoneal fat pad weight J:234615
increased subcutaneous adipose tissue amount J:234615
increased white fat cell lipid droplet size J:234615
increased white fat cell size J:234615
Porcntm1.1Vdv/Y
Tg(KRT14-cre)1Efu/0
(involves: 129S4/SvJaeSor * 129S5/SvEvBrd * C57BL/6J) 		abnormal hypodermis fat layer morphology J:186934
Pou3f2tm1Rsd/Pou3f2tm1Rsd
(involves: 129S4/SvJae * C57BL/6) 		decreased brown adipose tissue amount J:30430
Pou3f2tm1Tno/Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		abnormal brown adipose tissue morphology J:30429
absent subcutaneous adipose tissue J:30429
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz) 		increased gonadal fat pad weight J:72185
Pparatm1Gonz/Pparatm1Gonz
(B6.129S4-Pparatm1Gonz) 		increased gonadal fat pad weight J:72185
Ppardtm1.1Rev/Ppardtm1.1Rev
(Not Specified) 		abnormal adipose tissue morphology J:73557
abnormal fat cell morphology J:73557
decreased abdominal fat pad weight J:73557
decreased interscapular fat pad weight J:73557
decreased mesenteric fat pad weight J:73557
decreased subcutaneous adipose tissue amount J:73557
Ppardtm1Dsvg/Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6) 		increased bone marrow adipose tissue amount J:219677
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		abnormal gonadal fat pad morphology J:63040
increased total body fat amount J:89827
Ppardtm1Rev/Ppardtm1Rev
Tg(Fabp4-cre)1Rev/0
(Not Specified) 		adipose tissue phenotype J:73557
Ppargtm1.1Auw/Ppargtm1.1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J)) 		adipose tissue phenotype J:86705
Ppargtm1.1Auw/Ppargtm1.1Auw
(B6.Cg-Ppargtm1.1Auw) 		decreased total fat pad weight J:144344
increased adipocyte glucose uptake J:144344
Ppargtm1.2Mtz/Ppargtm1.2Mtz
Tg(Fabp4-cre/ERT2)1Ipc/0
(involves: C57BL/6) 		abnormal adipose tissue physiology J:89238
abnormal brown fat cell morphology J:89238
abnormal white fat cell morphology J:89238
decreased brown adipose tissue amount J:89238
decreased epididymal fat pad weight J:89238
decreased percent body fat/body weight J:89238
increased brown fat cell lipid droplet size J:89238
Ppargtm1Auw/Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J)) 		abnormal brown adipose tissue morphology J:86705
decreased brown adipose tissue mass J:86705
decreased white adipose tissue mass J:86705
lipodystrophy J:86705
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		abnormal adipose tissue distribution J:116568
abnormal fat cell differentiation J:116568
Ppargtm1b(KOMP)Wtsi/Pparg+
(C57BL/6N-Ppargtm1b(KOMP)Wtsi/H) 		increased total body fat amount J:211773
Ppargtm1Laz/Ppargtm1Laz
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fat cell size J:135904
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal brown fat cell morphology J:98786
abnormal epididymal fat pad morphology J:98786
decreased body fat mass J:98786
decreased white fat cell size J:98786
lipodystrophy J:98786
Ppargtm1Mae/Pparg+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal adipose tissue distribution J:91362
abnormal fat cell morphology J:91362
abnormal gonadal fat pad morphology J:91362
abnormal inguinal fat pad morphology J:91362
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA) 		abnormal fat cell morphology J:58222, J:89250
decreased brown adipose tissue amount J:58222
decreased total body fat amount J:58222
Ppargtm1Uls/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		decreased total body fat amount J:92826
Ppargtm1Yec/Ppargtm1Yec
(involves: 129S4/SvJae * C57BL/6) 		abnormal brown adipose tissue morphology J:91479
abnormal white adipose tissue morphology J:91479
abnormal white adipose tissue physiology J:91479
decreased brown fat cell lipid droplet size J:91479
decreased brown fat lipid droplet number J:91479
decreased gonadal fat pad weight J:91479
decreased inguinal fat pad weight J:91479
decreased retroperitoneal fat pad weight J:91479
decreased white adipose tissue amount J:91479
decreased white fat cell number J:91479
decreased white fat cell size J:91479
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		abnormal brown adipose tissue morphology J:125992
abnormal white adipose tissue morphology J:125992
abnormal white fat cell morphology J:125992
abnormal white fat cell size J:125992
absent subcutaneous adipose tissue J:125992
adipose tissue phenotype J:125992
decreased gonadal fat pad weight J:125992
increased brown fat cell size J:125992
increased interscapular fat pad weight J:125992
Ppargtm2Avp/Ppargtm2Avp
(Not Specified) 		abnormal adipose tissue distribution J:121693
abnormal white adipose tissue physiology J:121693
decreased total body fat amount J:121693
increased fat cell size J:121693
Ppargtm2Rev/Ppargtm2Rev
Tg(Fabp4-cre)1Rev/0
(involves: 129S4/SvJae * C57BL/6) 		abnormal brown adipose tissue morphology J:88210
abnormal brown fat cell size J:88210
abnormal white adipose tissue amount J:88210
decreased brown adipose tissue amount J:88210
decreased brown fat cell number J:88210
decreased interscapular fat pad weight J:88210
increased brown fat cell size J:88210
increased white fat cell size J:88210
Ppargtm2Rev/Ppargtm2Rev
Tg(Ucp1-cre)1Evdr/0
(involves: 129S4/SvJae * FVB) 		abnormal interscapular fat pad morphology J:278806
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		abnormal brown adipose tissue morphology J:125992
abnormal brown fat cell morphology J:125992
decreased gonadal fat pad weight J:125992
decreased subcutaneous adipose tissue amount J:125992
increased brown fat cell size J:125992
Ppargc1atm1.1Javi/Ppargc1atm1.1Javi
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Ppargc1atm1.1Javi Tg(Fabp4-cre)1Rev) 		abnormal brown fat cell morphology J:180984
adipose tissue phenotype J:180984
decreased brown fat cell size J:180984
decreased total body fat amount J:180984
decreased white fat cell size J:180984
Ppargc1atm1Aztc/Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc) 		decreased retroperitoneal fat pad weight J:82809
Ppargc1atm1Aztc/Ppargc1atm1Aztc
(C57BL/6-Ppargc1atm1Aztc) 		decreased body fat mass J:82809
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		abnormal brown adipose tissue morphology J:93896
Ppargc1atm1Brsp/Ppargc1atm2Brsp
Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6 * FVB/N) 		decreased percent body fat/body weight J:127403
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6) 		increased percent body fat/body weight J:96306
increased total body fat amount J:96306
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ) 		abnormal brown adipose tissue morphology J:137598
abnormal fat cell morphology J:137598
Ppargc1atm1Dpk/Ppargc1atm1Dpk
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N) 		abnormal brown adipose tissue morphology J:137598
abnormal fat cell morphology J:137598
Ppargc1atm2.1Brsp/Ppargc1atm2.1Brsp
Tg(Myog-cre)1Eno/0
(involves: 129 * BALB/c * C57BL/6J * C57BL/6N) 		increased percent body fat/body weight J:208380
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		abnormal white adipose tissue morphology J:116167
decreased gonadal fat pad weight J:116167
decreased white adipose tissue amount J:116167
increased white fat cell size J:116167
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N) 		abnormal brown adipose tissue morphology J:137598
abnormal fat cell morphology J:137598
adipose tissue phenotype J:137598
Ppargc1btm1.1Javi/Ppargc1btm1.1Javi
Tg(Fabp4-cre)1Rev/?
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal brown fat cell morphology J:221221
adipose tissue phenotype J:221221
decreased brown fat lipid droplet number J:221221
increased brown adipose tissue amount J:221221
increased brown fat cell lipid droplet size J:221221
Ppm1ltm1Dgen/Ppm1ltm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased total body fat amount J:134171
Ppp1r3atm1Ptwc/Ppp1r3atm1Ptwc
(involves: 129P2/OlaHsd * C57BL/6J) 		increased abdominal adipose tissue amount J:82422
increased total body fat amount J:82422
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars) 		decreased adipose tissue glycogen level J:83297
Ppp1r3gtm1Nju/Ppp1r3gtm1Nju
(B6.129-Ppp1r3gtm1Nju) 		decreased adipose tissue glycogen level J:249135
decreased body fat mass J:249135
decreased epididymal fat pad weight J:249135
Ppp2r5cem1(IMPC)Mbp/Ppp2r5cem1(IMPC)Mbp
(C57BL/6N-Ppp2r5cem1(IMPC)Mbp/Ucd) 		increased total body fat amount J:211773
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5cGt(XP0444)Wtsi
(B6.129P2-Ppp2r5cGt(XP0444)Wtsi) 		increased total body fat amount J:210365
Ppp6ctm1Shma/Ppp6ctm1Shma
Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6 * CBA * CD-1) 		decreased subcutaneous adipose tissue amount J:231809
Prc1tm1b(EUCOMM)Hmgu/Prc1+
(C57BL/6N-Prc1tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
PrcpGt(KST302)Byg/PrcpGt(KST302)Byg
(B6.129P2-PrcpGt(KST302)Byg) 		decreased femoral fat pad weight J:152535
decreased gonadal fat pad weight J:152535
decreased mesenteric fat pad weight J:152535
decreased retroperitoneal fat pad weight J:152535
decreased total fat pad weight J:152535
Prdm4tm1b(EUCOMM)Hmgu/Prdm4tm1b(EUCOMM)Hmgu
(C57BL/6N-Prdm4tm1b(EUCOMM)Hmgu/H) 		decreased total body fat amount J:211773
Prdm10tm1b(EUCOMM)Hmgu/Prdm10+
(C57BL/6N-Prdm10tm1b(EUCOMM)Hmgu/Ics) 		decreased total body fat amount J:211773
Prdm14em1(IMPC)Bay/Prdm14em1(IMPC)Bay
(C57BL/6N-Prdm14em1(IMPC)Bay/Bay) 		increased total body fat amount J:211773
Prdm14tm1a(EUCOMM)Wtsi/Prdm14tm1a(EUCOMM)Wtsi
(C57BL/6N-Prdm14tm1a(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Prdm14tm1b(EUCOMM)Wtsi/Prdm14tm1b(EUCOMM)Wtsi
(C57BL/6N-Prdm14tm1b(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal brown adipose tissue morphology J:213153
abnormal brown adipose tissue thermogenesis J:213153
abnormal interscapular fat pad morphology J:213153
decreased body fat mass J:213153
decreased brown fat lipid droplet number J:213153
decreased fat cell mitochondrial DNA content J:213153
increased brown fat cell lipid droplet size J:213153
increased interscapular fat pad weight J:213153
whitened brown adipose tissue morphology J:213153
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N) 		abnormal adipose tissue distribution J:208683
abnormal adipose tissue morphology J:208683
abnormal adipose tissue physiology J:208683
abnormal brown adipose tissue thermogenesis J:208683
decreased adipocyte glucose uptake J:208683
increased fat cell size J:208683
increased subcutaneous adipose tissue amount J:208683
increased total body fat amount J:208683
Prdx3tm1Hjha/Prdx3tm1Hjha
(involves: 129S4/SvJae * C57BL/6) 		abnormal epididymal fat pad morphology J:228860
abnormal renal fat pad morphology J:228860
abnormal white adipose tissue physiology J:228860
abnormal white fat cell differentation J:228860
increased body fat mass J:228860
increased white adipose tissue amount J:228860
increased white fat cell size J:228860
Prdx5tm1Dsle/Prdx5tm1Dsle
(involves: C57BL/6) 		abnormal epididymal fat pad morphology J:294801
abnormal inguinal fat pad morphology J:294801
Prebem1(IMPC)J/Preb+
(C57BL/6NJ-Prebem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
PrepGt(RRM213)Byg/Prep+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:151643
PrepGt(RRM213)Byg/Prep+
(B6.129P2-PrepGt(RRM213)Byg) 		increased percent body fat/body weight J:151643
Prkaa2tm1Vio/Prkaa2tm1Vio
Tg(Pomc1-cre)1Gsb/0
(involves: 129S2/SvPas * FVB/N) 		increased percent body fat/body weight J:123951
Prkab1tm1Eihl/Prkab1tm1Eihl
(involves: C57BL/6) 		decreased epididymal fat pad weight J:158295
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi) 		increased total body fat amount J:186658
Prkacatm3Gsm/Prkacatm3Gsm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		adipose tissue phenotype J:103418
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno) 		increased body fat mass J:235379
increased white fat cell size J:235379
white adipose tissue inflammation J:235379
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr) 		decreased abdominal adipose tissue amount J:225245
decreased subcutaneous adipose tissue amount J:225245
Prkar1atm1Lsk/Prkar1atm1Lsk
Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal adipose tissue distribution J:161521
Prkar1atm2Gsm/Prkar1atm2Gsm
Tg(Plp1-cre)1Bzal/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6N * DBA/2) 		decreased white adipose tissue amount J:148464
Prkar2btm1Gsm/Prkar2btm1Gsm
(Not Specified) 		decreased white adipose tissue amount J:34751
Prkar2btm2Gsm/Prkar2b+
(involves: C57BL/6) 		decreased percent body fat/body weight J:131039
Prkar2btm2Gsm/Prkar2btm2Gsm
(involves: C57BL/6) 		decreased percent body fat/body weight J:131039
Prkar2btm3Gsm/Prkar2btm2Gsm
Drd1tm1(cre)Rpa/Drd1+
(involves: C57BL/6) 		adipose tissue phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac * C57BL/6) 		adipose tissue phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Drd2-cre)ER44Gsat/0
(involves: C57BL/6 * FVB/N) 		decreased total body fat amount J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		decreased gonadal fat pad weight J:196157
decreased total body fat amount J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		adipose tissue phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		adipose tissue phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6 * CBA) 		adipose tissue phenotype J:196157
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm) 		decreased percent body fat/body weight J:196157
decreased white adipose tissue amount J:196157
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm) 		increased total body fat amount J:196157
Prkcatm1Far/Prkcatm1Far
(involves: 129/Sv * 129P2/OlaHsd) 		increased adipocyte glucose uptake J:85923
Prkcetm1Bsca/Prkcetm1Bsca
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:103337
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased adipocyte glucose uptake J:123964
Prkcitm1Rfar/Prkcitm1Rfar
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased adipocyte glucose uptake J:123964
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adipocyte glucose uptake J:92834
Prkdcscid/Prkdcscid
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129 * C3H * CF-1) 		decreased retroperitoneal fat pad weight J:129629
Prkg1tm1.1Pfe/Prkg1tm1.1Pfe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		abnormal adipose tissue development J:199222
Prkg1tm1Hfm/Prkg1tm1Hfm
(involves: C57BL/6N) 		abnormal adipose tissue development J:199222
abnormal brown adipose tissue thermogenesis J:199222
decreased brown adipose tissue amount J:199222
decreased brown fat cell lipid droplet size J:199222
decreased fat cell mitochondrial DNA content J:199222
Prkg2tm1Pfe/Prkg2tm1Pfe
(involves: 129S1/Sv * 129X1/SvJ) 		adipose tissue phenotype J:37306
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon) 		increased brown adipose tissue amount J:144729
increased fat cell size J:144729
increased white adipose tissue amount J:144729
Prlhtm2Smln/Prlhtm2Smln
(involves: C57BL/6J) 		increased epididymal fat pad weight J:215557
increased subcutaneous adipose tissue amount J:215557
increased total body fat amount J:215557
Prlhrtm1Dgen/Prlhrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased percent body fat/body weight J:127335
increased total body fat amount J:127335
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased abdominal fat pad weight J:67354
Prmt3tm1a(EUCOMM)Wtsi/Prmt3tm1a(EUCOMM)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Prmt3tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal hypodermis fat layer morphology J:232539
Prmt7tm1.2Rchd/Prmt7tm1.2Rchd
(involves: 129S4/SvJaeSor * FVB/N) 		increased epididymal fat pad weight J:271361
Prob1em1(IMPC)J/Prob1em1(IMPC)J
(C57BL/6NJ-Prob1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased fat cell size J:102652
increased total body fat amount J:102652
increased total fat pad weight J:102652
Prpf31tm1a(EUCOMM)Wtsi/Prpf31+
(C57BL/6N-Prpf31tm1a(EUCOMM)Wtsi/Nju) 		increased total body fat amount J:211773
Prr5em1(IMPC)J/Prr5em1(IMPC)J
(C57BL/6NJ-Prr5em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Prxl2atm1(KOMP)Vlcg/Prxl2atm1(KOMP)Vlcg
(C57BL/6N-Prxl2atm1(KOMP)Vlcg) 		abnormal epididymal fat pad morphology J:234040
white adipose tissue inflammation J:234040
Psip1Gt(betageo)1Hgs/Psip1Gt(betageo)1Hgs
(B6.129P2-Psip1Gt(betageo)1Hgs) 		abnormal abdominal fat pad morphology J:112975
absent epididymal fat pad J:112975
decreased total body fat amount J:112975
Psip1Gt(betageo)1Hgs/Psip1Gt(betageo)1Hgs
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1)) 		abnormal abdominal fat pad morphology J:112975
absent epididymal fat pad J:112975
decreased total body fat amount J:112975
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6) 		absent subcutaneous adipose tissue J:261081
Pstpip2em1(IMPC)Tcp/Pstpip2em1(IMPC)Tcp
(C57BL/6NCrl-Pstpip2em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		decreased total body fat amount J:88441
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp4-cre)1Abel/0
(involves: 129S4/SvJae) 		adipose tissue phenotype J:97588
Ptgr1tm1b(EUCOMM)Wtsi/Ptgr1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ptgr1tm1b(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Ptgs2tm1Unc/Ptgs2+
(D1.129P2-Ptgs2tm1Unc) 		abnormal adipose tissue physiology J:102779
decreased total fat pad weight J:102779
Pth1rtm1a(EUCOMM)Hmgu/Pth1r+
(C57BL/6N-Pth1rtm1a(EUCOMM)Hmgu/Wtsi) 		increased total body fat amount J:211773
Pthlhtm2Ack/Pthlhtm2Ack
(involves: 129S2/SvPas * C57BL/6) 		decreased total body fat amount J:142669
Ptp4a2em1(IMPC)Tcp/Ptp4a2em1(IMPC)Tcp
(C57BL/6N-Ptp4a2em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Ptpn1Gt(OST378842)Lex/Ptpn1Gt(OST378842)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S4/SvJae * C57BL/6J) 		abnormal fat cell morphology J:63236
abnormal fat pad morphology J:63236
decreased epididymal fat pad weight J:63236
decreased inguinal fat pad weight J:63236
decreased interscapular fat pad weight J:63236
decreased percent body fat/body weight J:63236
decreased white adipose tissue amount J:63236
Ptpn1tm2Bbk/Ptpn1tm2Bbk
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		abnormal fat pad morphology J:111969
Ptpn2tm1.1Ttig/Ptpn2tm1.1Ttig
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased total body fat amount J:179621
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr) 		decreased total body fat amount J:186843
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr) 		decreased total body fat amount J:186843
Ptpn2tm2.1Ttig/Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig) 		decreased total body fat amount J:186843
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal epididymal fat pad morphology J:216593
abnormal fat cell differentiation J:216593
decreased brown adipose tissue amount J:216593
decreased subcutaneous adipose tissue amount J:216593
decreased total body fat amount J:216593
decreased white fat cell number J:216593
increased adipocyte glucose uptake J:216593
increased fat cell size J:216593
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased brown adipose tissue amount J:94738
increased white adipose tissue amount J:94738
Ptprdtm1Yiw/Ptprdtm1Yiw
Ptprstm1Mtr/Ptprstm1Mtr
(B6.Cg-Ptprdtm1Yiw Ptprstm1Mtr) 		abnormal brown adipose tissue morphology J:109122
increased subcutaneous adipose tissue amount J:109122
Ptprdtm2a(KOMP)Wtsi/Ptprdtm2a(KOMP)Wtsi
(C57BL/6N-Ptprdtm2a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ptprvtm1Kry/Ptprvtm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		decreased gonadal fat pad weight J:126780
increased adipocyte glucose uptake J:126780
increased fat cell size J:126780
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6) 		abnormal epididymal fat pad morphology J:82724
Pttg1ipem1(IMPC)H/Pttg1ipem1(IMPC)H
(C57BL/6NTac-Pttg1ipem1(IMPC)H/H) 		increased total body fat amount J:211773
Pum2tm1b(KOMP)Wtsi/Pum2tm1b(KOMP)Wtsi
(C57BL/6N-Pum2tm1b(KOMP)Wtsi/Tcp) 		decreased total body fat amount J:211773
Pwwp2btm1.1Bcgen/Pwwp2btm1.1Bcgen
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		decreased body fat mass J:319940
decreased brown fat cell lipid droplet size J:319940
decreased inguinal fat pad weight J:319940
decreased white fat cell lipid droplet size J:319940
whitened brown adipose tissue morphology J:319940
Pxkem1(IMPC)Tcp/Pxkem1(IMPC)Tcp
(C57BL/6N-Pxkem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J) 		decreased subcutaneous adipose tissue amount J:308336
decreased total body fat amount J:308336
Pyytm1(cre)Hhzg/Pyytm1(cre)Hhzg
(involves: 129) 		decreased total body fat amount J:111480
increased gonadal fat pad weight J:111480
increased total body fat amount J:111480
increased white adipose tissue amount J:111480
Pyytm1.1Batt/Pyytm1.1Batt
(involves: C57BL/6 * FVB/N * SJL) 		abnormal adipose tissue distribution J:129742
increased total body fat amount J:129742
Pyytm1Mws/Pyytm1Mws
(involves: C57BL/6J) 		increased percent body fat/body weight J:130105
Qbis1C57BLKS/J/Qbis1C57BLKS/J
(involves: C57BLKS/Jcl * DBA/2Jcl) 		increased total fat pad weight J:104466
Qbis2DBA/2Jcl/Qbis2DBA/2Jcl
(involves: C57BLKS/Jcl * DBA/2Jcl) 		increased total fat pad weight J:104466
Qrfptm1Stak/Qrfptm1Stak
(B6J.129-Qrfptm1Stak) 		decreased body fat mass J:250913
Qrsl1em1(IMPC)J/Qrsl1+
(C57BL/6NJ-Qrsl1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Rab6bGt(OST68543)Lex/Rab6bGt(OST68543)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased total body fat amount J:103485
Rab10tm1c(KOMP)Wtsi/Rab10tm1c(KOMP)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		adipose tissue phenotype J:249843
decreased adipocyte glucose uptake J:249843
Rab18Gt(EUCE0233a03)Hmgu/Rab18Gt(EUCE0233a03)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J) 		increased white fat cell lipid droplet size J:211808
Rab28em1(IMPC)J/Rab28em1(IMPC)J
(C57BL/6NJ-Rab28em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Rabl2tm1.1(KOMP)Wtsi/Rabl2tm1.1(KOMP)Wtsi
(C57BL/6N-Rabl2tm1.1(KOMP)Wtsi/Ucd) 		increased total body fat amount J:211773
Rad18tm1a(EUCOMM)Wtsi/Rad18tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Rad18tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:165965
Rad23btm1Gvh/Rad23btm1Gvh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:74288
Rai1tm1Jrl/Rai1+
(B6.129S7-Rai1tm1Jrl/J) 		increased abdominal adipose tissue amount J:164451
increased white adipose tissue amount J:164451
Rai1tm2.1Luo/Rai1tm2.1Luo
Tg(Sim1-cre)1Lowl/?
(either: (involves: 129S1/Sv * C57BL/6 * FVB) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)) 		increased body fat mass J:237687
increased total fat pad weight J:237687
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J) 		increased fat cell size J:287672
increased total body fat amount J:287672
Rapgef3tm1.1Chen/Rapgef3tm1.1Chen
(B6.129(Cg)-Rapgef3tm1.1Chen) 		abnormal adipose tissue development J:207599
decreased epididymal fat pad weight J:207599
decreased total body fat amount J:207599
decreased white fat cell size J:207599
Rasgrf1tm1Esn/Rasgrf1tm1Esn
(involves: 129/Sv * C57BL/6N) 		decreased total body fat amount J:83950
Rassf9Tg(PDLIM7*)2Cml/Rassf9Tg(PDLIM7*)2Cml
(involves: ICR) 		decreased subcutaneous adipose tissue amount J:171677
Rb1tm2Brn/Rb1tm2Brn
(involves: 129 * BALB/c) 		abnormal white adipose tissue morphology J:129672
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/c) 		abnormal white adipose tissue morphology J:129672
decreased gonadal fat pad weight J:129672
decreased inguinal fat pad weight J:129672
decreased interscapular fat pad weight J:129672
decreased percent body fat/body weight J:129672
decreased total fat pad weight J:129672
decreased white adipose tissue amount J:129672
decreased white fat cell size J:129672
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N) 		decreased gonadal fat pad weight J:216929
decreased total body fat amount J:216929
Rbm45em1(IMPC)J/Rbm45+
(C57BL/6NJ-Rbm45em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Rbpms2em1(IMPC)J/Rbpms2em1(IMPC)J
(C57BL/6NJ-Rbpms2em1(IMPC)J/J) 		increased total body fat amount J:211773
Rcan1tm1b(KOMP)Wtsi/Rcan1tm1b(KOMP)Wtsi
(C57BL/6N-Rcan1tm1b(KOMP)Wtsi/Ics) 		decreased total body fat amount J:211773
Rcan2tm1Ypt/Rcan2tm1Ypt
(B6.129-Rcan2tm1Ypt) 		decreased epididymal fat pad weight J:169558
decreased retroperitoneal fat pad weight J:169558
Rdh1tm1.1Jln/Rdh1tm1.1Jln
(B6.129P2-Rdh1tm1.1Jln) 		increased percent body fat/body weight J:134843
increased total fat pad weight J:134843
Rec8tm1b(KOMP)Wtsi/Rec8tm1b(KOMP)Wtsi
(C57BL/6N-Rec8tm1b(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6J.Cg-Reep1Gt(OST398247)Tigm) 		abnormal fat cell differentiation J:239250
abnormal fat cell morphology J:239250
decreased abdominal adipose tissue amount J:239250
decreased total body fat amount J:239250
decreased white fat cell lipid droplet size J:239250
lipodystrophy J:239250
Rep15em1(IMPC)Tcp/Rep15em1(IMPC)Tcp
(C57BL/6NCrl-Rep15em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Retntm1Laz/Retntm1Laz
(involves: 129S/SvEv * C57BL/6) 		adipose tissue phenotype J:90033
Retntm1Laz/Retntm1Laz
Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6) 		white adipose tissue inflammation J:171262
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex) 		increased mesenteric fat pad weight J:235058
white adipose tissue inflammation J:235058
Retsattm1Kpal/Retsattm1Kpal
(involves: 129 * C57BL/6) 		abnormal abdominal fat pad morphology J:222367
abnormal adipose tissue development J:222367
abnormal inguinal fat pad morphology J:222367
increased percent body fat/body weight J:222367
Rgntm1Aish/Y
(involves: 129P2/OlaHsd) 		decreased percent body fat/body weight J:108295
Rgs4tm1Dgen/Rgs4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased total body fat amount J:101679
Rgs5tm1Jhk/Rgs5tm1Jhk
(involves: 129S/SvEv * C57BL/6) 		decreased total body fat amount J:133897
Rhbdf1tm1.1Mfm/Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J) 		decreased white adipose tissue amount J:203951
Rhbdf2cub/Rhbdf2cub
(B6.Cg-Rhbdf2cub) 		white adipose tissue inflammation J:82006
Rhobtb3tm1a(KOMP)Wtsi/Rhobtb3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Rhobtb3tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Ric8atm1b(KOMP)Wtsi/Ric8a+
(C57BL/6N-Ric8atm1b(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Rictortm1.1Mnh/Rictortm1.1Mnh
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev) 		increased epididymal fat pad weight J:150064
Rictortm1Rueg/Rictortm1Rueg
Rptortm1Rueg/Rptortm1Rueg
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal adipose tissue morphology J:143748
Rimklbtm1.1(KOMP)Vlcg/Rimklbtm1.1(KOMP)Vlcg
(C57BL/6N-Rimklbtm1.1(KOMP)Vlcg/J) 		decreased total body fat amount J:211773
Ripk1tm1.1Vmd/Ripk1tm1.1Vmd
(involves: C57BL/6N) 		abnormal brown adipose tissue physiology J:209137
Ripk1tm1Led/Ripk1tm1Led
(involves: 129S6/SvEvTac) 		abnormal brown adipose tissue morphology J:46522
Rln3tm1(KOMP)Mbp/Rln3tm1(KOMP)Mbp
(C57BL/6N-Rln3tm1(KOMP)Mbp/Ucd) 		increased total body fat amount J:211773
Rln3tm1Lex/Rln3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased mesenteric fat pad weight J:181242
decreased subcutaneous adipose tissue amount J:181242
decreased total body fat amount J:181242
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6) 		decreased gonadal fat pad weight J:168271
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Rnf43em1(IMPC)Tcp/Rnf43em1(IMPC)Tcp
(C57BL/6NCrl-Rnf43em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1) 		increased bone marrow adipose tissue amount J:244583
increased total body fat amount J:244583
Rock1tm1.1Itl/Rock1tm1.1Itl
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased total body fat amount J:204885
Rock1tm1.1Itl/Rock1tm1.1Itl
Agrptm1(cre)Lowl/Agrp+
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased epididymal fat pad weight J:204885
increased mesenteric fat pad weight J:204885
increased renal fat pad weight J:204885
increased total body fat amount J:204885
Rock1tm1.1Itl/Rock1tm1.1Itl
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased epididymal fat pad weight J:204885
increased mesenteric fat pad weight J:204885
increased renal fat pad weight J:204885
increased total body fat amount J:204885
Ror2tm1Anec/Ror2tm1Anec
(B6.129S1-Ror2tm1Anec) 		decreased total body fat amount J:134490
Rplp1tm1.1Melt/Rplp1tm1.2Melt
(Not Specified) 		abnormal adipose tissue development J:218949
Rps2tm1.1Geno/Rps2+
(B6.129(Cg)-Rps2tm1.1Geno) 		decreased total body fat amount J:321029
Rps6ka3tm1Ljg/Y
(involves: 129 * C57BL/6) 		decreased white adipose tissue amount J:83536
Rps6kb1tm1Nte/Rps6kb1tm1Nte
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased epididymal fat pad weight J:244749
decreased inguinal fat pad weight J:244749
decreased interscapular fat pad weight J:244749
decreased mesenteric fat pad weight J:244749
decreased retroperitoneal fat pad weight J:244749
Rps9tm1.1Geno/Rps9tm1.1Geno
(involves: C57BL/6) 		decreased body fat mass J:329922
decreased interscapular fat pad weight J:329922
decreased subcutaneous adipose tissue amount J:329922
Rptortm1Rueg/Rptortm1Rueg
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased total body fat amount J:143748
Rptortm1Rueg/Rptortm1Rueg
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J) 		decreased brown adipose tissue amount J:143749
decreased total fat pad weight J:143749
decreased white fat cell number J:143749
decreased white fat cell size J:143749
Rras2Gt(OST47398)Lex/Rras2Gt(OST47398)Lex
(B6;129S5-Rras2Gt(OST47398)Lex/Ieg) 		increased total body fat amount J:82809
Rrbp1em1(IMPC)J/Rrbp1em1(IMPC)J
(C57BL/6NJ-Rrbp1em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Rreb1tm1b(EUCOMM)Wtsi/Rreb1+
(C57BL/6N-Rreb1tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased total body fat amount J:186071
Rsbn1tm1b(EUCOMM)Wtsi/Rsbn1+
(C57BL/6N-Rsbn1tm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Rsc1a1tm1Koep/Rsc1a1tm1Koep
(B6.129-Rsc1a1tm1Koep) 		increased fat cell size J:95148
increased percent body fat/body weight J:95148
Rspo1tm1.1(KOMP)Vlcg/Rspo1tm1.1(KOMP)Vlcg
(C57BL/6N-Rspo1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Rsu1em1(IMPC)J/Rsu1+
(C57BL/6NJ-Rsu1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1)) 		decreased total body fat amount J:93240
Rusc1em1(IMPC)J/Rusc1em1(IMPC)J
(C57BL/6NJ-Rusc1em1(IMPC)J/J) 		decreased total body fat amount J:211773
Rwdd1tm1b(KOMP)Wtsi/Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Rxfp4tm1Sora/Rxfp4tm1Sora
(129S/SvEv-Rxfp4tm1Sora) 		decreased gonadal fat pad weight J:212239
decreased inguinal fat pad weight J:212239
decreased total body fat amount J:212239
Ryr1tm1.1Dhm/Ryr1+
(involves: 129S2/SvPasCrl * 129S6/SvEvTac) 		decreased total body fat amount J:155825
Ryr1tm1.1Dhm/Ryr1tm1.1Dhm
(involves: 129S6/SvEvTac * 129X1/SvJ) 		increased brown adipose tissue amount J:127629
Saa3tm1(KOMP)Vlcg/Saa3tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		increased white fat cell size J:220630
Safb2em1(IMPC)J/Safb2em1(IMPC)J
(C57BL/6NJ-Safb2em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Sagtm1a(EUCOMM)Wtsi/Sagtm1a(EUCOMM)Wtsi
(C57BL/6N-Sagtm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Samd1tm1Pfi/Samd1+
(involves: C57BL/6J * C57BL/6N) 		abnormal adipose tissue amount J:333561
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr) 		abnormal white fat cell morphology J:208616
adipose tissue phenotype J:208616
decreased gonadal fat pad weight J:208616
decreased inguinal fat pad weight J:208616
decreased total body fat amount J:208616
decreased white fat cell size J:208616
increased subcutaneous adipose tissue amount J:208616
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi
Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N) 		increased abdominal adipose tissue amount J:337869
increased percent body fat/body weight J:337869
increased white fat cell size J:337869
whitened brown adipose tissue morphology J:337869
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi
Tg(Sim1-cre)1Lowl/0
(involves: 129 * C57BL/6 * FVB) 		adipose tissue phenotype J:337869
decreased brown adipose tissue amount J:337869
decreased percent body fat/body weight J:337869
Sat1tm1Alh/Sat1tm1Alh
(B6.129X1-Sat1tm1Alh) 		abnormal white adipose tissue physiology J:120870
increased percent body fat/body weight J:120870
increased total fat pad weight J:120870
sbse/sbse
(C57BL/6J-sbse/GrsrJ) 		decreased percent body fat/body weight J:128399
Sc5dtm1Fdp/Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal brown adipose tissue morphology J:84450
Scara5tm1Ktry/Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry) 		adipose tissue inflammation J:195536
Scarb2em2(IMPC)Tcp/Scarb2em2(IMPC)Tcp
(C57BL/6NCrl-Scarb2em2(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Scd1Gt(OST102902)Lex/Scd1Gt(OST102902)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:185494
Scd1tm1Ntam/Scd1tm1Ntam
(involves: 129S6/SvEvTac) 		decreased white adipose tissue amount J:78607
Scd1tm1Ntam/Scd1tm1Ntam
(involves: C57BL/6) 		decreased white adipose tissue amount J:130441
Scd1tm2Ntam/Scd1tm2Ntam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam) 		abnormal fat pad morphology J:130441
decreased gonadal fat pad weight J:130441
decreased inguinal fat pad weight J:130441
decreased retroperitoneal fat pad weight J:130441
decreased white adipose tissue amount J:130441
Scfpq1L6/Scfpq1L6
(involves: L6 * M16i) 		abnormal adipose tissue distribution J:87793
Scfpq1L6/Scfpq1M16i
(involves: L6 * M16i) 		abnormal adipose tissue distribution J:87793
Scfq1L6/Scfq1L6
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Scfq1L6/Scfq1M16i
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Scfq2L6/Scfq2L6
(involves: L6 * M16i) 		abnormal fat pad morphology J:87793
Scfq3L6/Scfq3L6
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Scfq4L6/Scfq4L6
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Scfq4L6/Scfq4M16i
(involves: L6 * M16i) 		decreased subcutaneous adipose tissue amount J:87793
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		abnormal adipose tissue distribution J:53349, J:77510
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr) 		decreased total body fat amount J:124895
Scube3m1Mhda/Scube3m1Mhda
(C3HeB/FeJ-Scube3m1Mhda) 		decreased body fat mass J:237904
Sdc3tm1Rau/Sdc3+
(B6.129S-Sdc3tm1Rau) 		decreased percent body fat/body weight J:94417
Sdc3tm1Rau/Sdc3tm1Rau
(B6.129S-Sdc3tm1Rau) 		decreased percent body fat/body weight J:94417
Sdhctm1c(EUCOMM)Wtsi/Sdhctm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1.1(rtTA,tetO-cre)Bkmn/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		increased body fat mass J:284745
seb/seb
(Him:OF1) 		decreased total body fat amount J:20987
Sec23atm1a(KOMP)Wtsi/Sec23a+
(C57BL/6N-Sec23atm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(B6JTyr;B6N-Sec24atm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		decreased total body fat amount J:164159
Sec61a1m1Gek/Sec61a1m1Gek
Tg(Ins2-Sec61a1)#Gek/0
(C57BL/6-Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek) 		decreased total body fat amount J:164159
Secisbp2lem1(IMPC)J/Secisbp2lem1(IMPC)J
(C57BL/6NJ-Secisbp2lem1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Selenoktm1a(EUCOMM)Wtsi/Selenoktm1a(EUCOMM)Wtsi
(C57BL/6N-Selenoktm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Selenomtm1(KOMP)Vlcg/Selenomtm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased gonadal fat pad weight J:203545
increased inguinal fat pad weight J:203545
Sema4dtm1b(EUCOMM)Wtsi/Sema4dtm1b(EUCOMM)Wtsi
(C57BL/6N-Sema4dtm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Senp1tm1Wami/Senp1tm1Wami
Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		abnormal fat cell morphology J:228009
decreased fat cell size J:228009
decreased total fat pad weight J:228009
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc) 		abnormal white adipose tissue physiology J:343846
decreased adipocyte glucose uptake J:343846
increased epididymal fat pad weight J:343846
increased inguinal fat pad weight J:343846
increased white adipose tissue apoptosis J:343846
increased white fat cell size J:343846
white adipose tissue inflammation J:343846
Serpina12tm1Jwada/Serpina12+
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased epididymal fat pad weight J:208508
increased fat cell size J:208508
Serpina12tm1Jwada/Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada) 		abnormal fat cell morphology J:208508
increased epididymal fat pad weight J:208508
increased fat cell size J:208508
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal epididymal fat pad morphology J:87982
decreased subcutaneous adipose tissue amount J:87982
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex) 		decreased brown adipose tissue mass J:194928
decreased brown fat cell size J:194928
decreased epididymal fat pad weight J:194928
decreased percent body fat/body weight J:194928
decreased subcutaneous adipose tissue amount J:194928
decreased white fat cell size J:194928
increased brown fat cell number J:194928
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd) 		decreased adipocyte glucose uptake J:189021
Setd1atm1a(EUCOMM)Wtsi/Setd1a+
(C57BL/6N-Setd1atm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Sfrp1tm1Bsk/Sfrp1tm1Bsk
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased total body fat amount J:89547
Sgms1tm1a(EUCOMM)Wtsi/Sgms1tm1a(EUCOMM)Wtsi
(C57BL/6N-Sgms1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Sgms1tm1Kenw/Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6) 		decreased white adipose tissue amount J:168726
Sgms2tm1Kenw/Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw) 		decreased epididymal fat pad weight J:175924
Sgshem3(IMPC)Tcp/Sgshem3(IMPC)Tcp
(C57BL/6NCrl-Sgshem3(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Sh3kbp1tm1Ivdi/Sh3kbp1tm1Ivdi
(B6.129S-Sh3kbp1tm1Ivdi) 		decreased subcutaneous adipose tissue amount J:162088
Sh3pxd2bGt(GST_1527_E5)Lex/Sh3pxd2bGt(GST_1527_E5)Lex
(involves: 129X1/SvJ * C57BL/6) 		decreased abdominal adipose tissue amount J:158635
decreased subcutaneous adipose tissue amount J:158635
Sh3pxd2bnee/Sh3pxd2bnee
(B10.Cg-H2h4 Sh3pxd2bnee/GrsrJ) 		decreased white adipose tissue amount J:153369
Sh3pxd2btm1.1Arte/Sh3pxd2btm1.1Arte
(involves: C57BL/6NTac) 		abnormal adipose tissue development J:235640
decreased body fat mass J:235640
decreased gonadal fat pad weight J:235640
decreased renal fat pad weight J:235640
decreased subcutaneous adipose tissue amount J:235640
lipodystrophy J:235640
Shhtm1b(EUCOMM)Wtsi/Shh+
(C57BL/6N-Shhtm1b(EUCOMM)Wtsi/H) 		increased total body fat amount J:211773
Shisa7em1(IMPC)J/Shisa7em1(IMPC)J
(C57BL/6NJ-Shisa7em1(IMPC)J/J) 		decreased total body fat amount J:211773
shsn/shsn
(B6(129P2)-shsn/GrsrJ) 		decreased percent body fat/body weight J:183310
Sik1tm1.1(KOMP)Vlcg/Sik1tm1.1(KOMP)Vlcg
(C57BL/6N-Sik1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd) 		abnormal fat cell differentiation J:229999
decreased adipocyte glucose uptake J:229999
increased white fat cell size J:229999
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi) 		decreased total body fat amount J:211773
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N) 		abnormal fat cell differentiation J:183827
decreased brown adipose tissue amount J:183827
decreased fat cell size J:183827
decreased gonadal fat pad weight J:183827
decreased mesenteric fat pad weight J:183827
decreased renal fat pad weight J:183827
decreased subcutaneous adipose tissue amount J:183827
Sim1tm1.1Az/Sim1+
(involves: 129X1/SvJ * C57BL/6 * FVB) 		increased total body fat amount J:95410
Sim1tm1Fan/Sim1+
(involves: 129/Sv * C57BL/6) 		abnormal brown adipose tissue morphology J:70586
abnormal white adipose tissue morphology J:70586
increased brown adipose tissue amount J:70586
increased white adipose tissue amount J:70586
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal inguinal fat pad morphology J:133127
Sirt1tm2.1Mcby/Sirt1tm2.1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased white adipose tissue amount J:180628
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac) 		increased total body fat amount J:178653
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased subcutaneous adipose tissue amount J:112817
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * BALB/cJ) 		decreased subcutaneous adipose tissue amount J:247143
Sirt6tm2.1Cxd/Sirt6tm2.1Cxd
(involves: 129S6/SvEvTac * NIH Black Swiss) 		decreased subcutaneous adipose tissue amount J:167023
decreased total body fat amount J:167023
Sirt6tm2.2Cxd/Sirt6tm2.2Cxd
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		decreased subcutaneous adipose tissue amount J:167023
decreased total body fat amount J:167023
Sirt7tm1Evbo/Sirt7tm1Evbo
(involves: 129/Sv * C57BL/6) 		decreased subcutaneous adipose tissue amount J:147652
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv) 		decreased epididymal fat pad weight J:205529
Sisem1(IMPC)J/Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J) 		decreased percent body fat/body weight J:344683
sky/sky
(DBA/2J-sky/J) 		abnormal adipose tissue morphology J:136875
abnormal brown adipose tissue morphology J:136875
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB) 		decreased adipocyte glucose uptake J:110773
increased adipocyte glucose uptake J:110773
Slc2a4tm1Jdz/Slc2a4tm1Jdz
(involves: 129S1/Sv * C57BL/6) 		decreased adipocyte glucose uptake J:123335
Slc2a4tm1Jdz/Slc2a4tm1Jdz
Tg(ACTA1-cre)1Jdz/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased adipocyte glucose uptake J:123335
increased adipocyte glucose uptake J:123335
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL) 		increased fat cell size J:43650
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL) 		decreased gonadal fat pad weight J:49328
decreased total body fat amount J:49328
Slc2a6em1Rbr/Slc2a6em1Rbr
(C57BL/6J-Slc2a6em1Rbr) 		decreased total body fat amount J:266077
Slc2a9tm1Khm/Slc2a9tm1Khm
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		increased body fat mass J:221544
increased percent body fat/body weight J:221544
Slc3a1pbl/Slc3a1pbl
(C3HeB/FeJ-Slc3a1pbl) 		decreased total body fat amount J:85461
Slc3a1pbl/Slc3a1pbl
(involves: C3HeB/FeJ * MRL/MpJ) 		decreased total body fat amount J:85461
Slc3a1tm1.1(KOMP)Vlcg/Slc3a1tm1.1(KOMP)Vlcg
(C57BL/6N-Slc3a1tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Slc5a1Gt(OST315271)Lex/Slc5a1Gt(OST315271)Lex
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased total body fat amount J:195941
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		adipose tissue phenotype J:195941
decreased total body fat amount J:195941
Slc5a7tm1a(KOMP)Wtsi/Slc5a7+
(C57BL/6N-Slc5a7tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Slc5a10tm1Csk/Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk) 		decreased epididymal fat pad weight J:199406
Slc6a8tm1.1Clar/Y
Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6 * C57BL/6J * FVB/N) 		decreased percent body fat/body weight J:190081
Slc6a19tm1Dgen/Slc6a19tm1Dgen
(involves: 129 * C57BL/6J) 		decreased total body fat amount J:175382
Slc7a5tm1.1Daca/Slc7a5tm1.1Daca
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased gonadal fat pad weight J:213820
Slc12a2tm1Ges/Slc12a2tm1Ges
(Not Specified) 		decreased total body fat amount J:57651
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf) 		decreased total body fat amount J:176732
Slc16a1tm2.1Lupel/Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel) 		decreased percent body fat/body weight J:205481
decreased white adipose tissue amount J:205481
Slc16a13em1Tac/Slc16a13em1Tac
(C57BL/6N-Slc16a13em1Tac) 		adipose tissue phenotype J:309785
decreased body fat mass J:309785
Slc17a6tm1Lowl/Slc17a6tm1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Nr5a1-cre)2Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB) 		increased body fat mass J:129860
Slc20a2tm1b(EUCOMM)Wtsi/Slc20a2+
(C57BL/6N-Slc20a2tm1b(EUCOMM)Wtsi/Ieg) 		increased total body fat amount J:211773
Slc25a15tm1b(EUCOMM)Hmgu/Slc25a15+
(C57BL/6N-Slc25a15tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Slc25a18em1(IMPC)Mbp/Slc25a18em1(IMPC)Mbp
(C57BL/6NCrl-Slc25a18em1(IMPC)Mbp/Mmucd) 		increased total body fat amount J:211773
Slc25a21tm1a(KOMP)Wtsi/Slc25a21tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc25a21tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Slc25a21tm1d(KOMP)Wtsi/Slc25a21tm1d(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Slc25a21tm1a(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Slc25a24tm1Sinos/Slc25a24tm1Sinos
(B6(Cg)-Slc25a24tm1Sinos) 		decreased white adipose tissue amount J:312208
Slc25a25tm1.1Kz/Slc25a25tm1.1Kz
(involves: C57BL/6J * FVB/N) 		abnormal adipose tissue amount J:170924
decreased total body fat amount J:170924
Slc25a30tm1a(EUCOMM)Wtsi/Slc25a30tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a30tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Slc25a44em1Kajim/Slc25a44em1Kajim
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6 * FVB) 		abnormal brown adipose tissue physiology J:345254
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129) 		decreased epididymal fat pad weight J:124916
decreased retroperitoneal fat pad weight J:124916
Slc29a1tm2b(NCOM)Mfgc/Slc29a1tm2b(NCOM)Mfgc
(C57BL/6N-Slc29a1tm2b(NCOM)Mfgc/Tcp) 		decreased total body fat amount J:211773
Slc29a3em1(IMPC)Wtsi/Slc29a3em1(IMPC)Wtsi
(C57BL/6N-Slc29a3em1(IMPC)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Slc30a5tm1Ynak/Slc30a5tm1Ynak
(involves: C57BL/6) 		abnormal fat pad morphology J:86455
increased gonadal fat pad weight J:86455
increased inguinal fat pad weight J:86455
increased mesenteric fat pad weight J:86455
increased retroperitoneal fat pad weight J:86455
Slc30a7Gt(XC827)Byg/Slc30a7Gt(XC827)Byg
(B6.129P2-Slc30a7Gt(XC827)Byg) 		decreased percent body fat/body weight J:128927
Slc32a1tm1.1Bgc/Slc32a1tm1.1Bgc
(involves: 129X1/SvJ) 		abnormal adipose tissue distribution J:158888
Slc37a1tm1b(EUCOMM)Hmgu/Slc37a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc37a1tm1b(EUCOMM)Hmgu/Orl) 		increased total body fat amount J:211773
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Slc38a10tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased total body fat amount J:213427
Slc40a1tm1b(EUCOMM)Hmgu/Slc40a1+
(C57BL/6N-Slc40a1tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Slc51bem1(IMPC)Mbp/Slc51bem1(IMPC)Mbp
(C57BL/6NCrl-Slc51bem1(IMPC)Mbp/Mmucd) 		decreased total body fat amount J:211773
Slc52a2tm1.1(KOMP)Vlcg/Slc52a2+
(C57BL/6N-Slc52a2tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Slntm1Peri/Slntm1Peri
(involves: C57BL/6J) 		increased body fat mass J:193427
increased brown fat cell lipid droplet size J:193427
increased total fat pad weight J:193427
increased white fat cell lipid droplet size J:193427
Slurp1tm1Lex/Slurp1tm1Lex
(Not Specified) 		decreased percent body fat/body weight J:210836
decreased total body fat amount J:210836
Slurp2tm1.1Sgy/Slurp2tm1.1Sgy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased percent body fat/body weight J:231067
decreased total fat pad weight J:231067
Slurp2tm1Lex/Slurp2tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		decreased percent body fat/body weight J:231067
decreased total fat pad weight J:231067
Smc3tm1a(EUCOMM)Wtsi/Smc3+
(B6Dnk;B6Brd;B6N-Tyrc-Brd Smc3tm1a(EUCOMM)Wtsi/WtsiH) 		decreased total body fat amount J:175295
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased total body fat amount J:220422
Smc6tm1b(EUCOMM)Hmgu/Smc6+
(C57BL/6N-Smc6tm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Smdt1em2Fink/Smdt1em2Fink
(involves: C57BL/6J * C57BL/6N * CBA/J * CD-1) 		decreased total body fat amount J:287405
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6) 		abnormal adipose tissue distribution J:104648
absent subcutaneous adipose tissue J:104648
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified) 		increased white adipose tissue amount J:226064
increased white fat cell size J:226064
Snap47tm1a(EUCOMM)Wtsi/Snap47tm1a(EUCOMM)Wtsi
(C57BL/6N-Snap47tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Snord115em1Jcav/Snord115+
(B6.Cg-Snord115em1Jcav) 		increased brown adipose tissue amount J:305741
Snord116tm1.1Uta/Snord116+
(involves: C57BL/6J) 		decreased percent body fat/body weight J:131662
decreased total body fat amount J:131662
Snord116tm1Uta/Snord116+
Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J) 		decreased percent body fat/body weight J:131427
decreased total body fat amount J:131427
Snrktm1.1Hxu/Snrktm1.1Hxu
Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr) 		abnormal adipose tissue distribution J:257980
brown adipose tissue inflammation J:257980
decreased fat cell size J:257980
white adipose tissue inflammation J:257980
Snrktm1Hxu/Snrk+
(C57BL/6-Snrktm1Hxu) 		abnormal brown fat cell morphology J:257980
abnormal white fat cell morphology J:257980
decreased brown fat cell size J:257980
decreased subcutaneous adipose tissue amount J:257980
decreased white adipose tissue amount J:257980
Snrpntm1Rsnk/Snrpn+
(either: 129S1-Snrpntm1Rsnk or (involves: 129S1/Sv * C57BL/6J)) 		increased total body fat amount J:105412
Socs2tm1Wehi/Socs2tm1Wehi
(C57BL/6-Socs2tm1Wehi) 		adipose tissue phenotype J:63006
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J) 		increased renal fat pad weight J:186227
Socs3tm1Ayos/Socs3tm1Ayos
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6) 		decreased body fat mass J:91796
Socs3tm1Ayos/Socs3tm1Ayos
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6) 		decreased body fat mass J:91796
Socs3tm1Jni/Socs3+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:91797
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J) 		abnormal body fat mass J:219360
Sod2tm1Leb/Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J) 		decreased total body fat amount J:36148
Sod2tm1Shs/Sod2tm1Shs
Tg(TNNI2-icre)1Vrmn/0
(involves: C57BL/6) 		adipose tissue phenotype J:155917
Sorbs1tm1Krc/Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc) 		abnormal white adipose tissue physiology J:121762
increased fat cell size J:121762
Sox8tm1Weg/Sox8tm1Weg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased total body fat amount J:71578
Sox9Bbfc/Sox9+
(C57BL/6J-Sox9Bbfc/GrsrJ) 		decreased percent body fat/body weight J:223062
decreased total body fat amount J:223062
Sox18Ra/Sox18+
(involves: AG/Cam) 		decreased total body fat amount J:13089
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Sparttm1.1Xen/Sparttm1.1Xen
(involves: C57BL/6J) 		abnormal adipose tissue morphology J:185987
abnormal fat cell morphology J:185987
decreased fat cell size J:185987
increased total body fat amount J:185987
Speer4f1em1(IMPC)Mbp/Speer4f1+
(C57BL/6NCrl-Speer4f1em1(IMPC)Mbp/Mmucd) 		increased total body fat amount J:211773
Spg11em1(IMPC)J/Spg11em1(IMPC)J
(C57BL/6NJ-Spg11em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Spidrtm1b(EUCOMM)Hmgu/Spidrtm1b(EUCOMM)Hmgu
(C57BL/6N-Spidrtm1b(EUCOMM)Hmgu/Bay) 		increased total body fat amount J:211773
Spnem1(IMPC)Ics/Spnem1(IMPC)Ics
(C57BL/6N-Spnem1(IMPC)Ics/Ics) 		increased total body fat amount J:211773
Sprtntm1Yjm/Sprtntm1Yjm
(involves: 129S/SvEv * C57BL/6) 		decreased gonadal fat pad weight J:225198
decreased inguinal fat pad weight J:225198
decreased interscapular fat pad weight J:225198
decreased renal fat pad weight J:225198
decreased total fat pad weight J:225198
decreased white fat cell size J:225198
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1) 		decreased total body fat amount J:44313
Sqstm1tm1.1Ewa/Sqstm1tm1.1Ewa
Tg(Nes-cre)1Kag/0
(involves: C57BL/6J) 		increased abdominal adipose tissue amount J:201732
Sqstm1tm1Hwl/Sqstm1tm1Hwl
(B6.129P2-Sqstm1tm1Hwl) 		decreased subcutaneous adipose tissue amount J:181228
Sqstm1tm2.1Jmos/Sqstm1tm2.1Jmos
Tg(Fabp4-cre)1Rev/0
(Not Specified) 		abnormal brown adipose tissue thermogenesis J:194291
increased brown fat cell lipid droplet size J:194291
increased total body fat amount J:194291
increased white fat cell size J:194291
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N) 		abnormal epididymal fat pad morphology J:214131
decreased brown adipose tissue amount J:214131
decreased brown fat cell size J:214131
decreased subcutaneous adipose tissue amount J:214131
decreased total body fat amount J:214131
decreased white fat cell size J:214131
Srsf3tm1Pjln/Srsf3tm1Pjln
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA) 		decreased brown adipose tissue amount J:205756
Ssbp2tm1b(KOMP)Wtsi/Ssbp2tm1b(KOMP)Wtsi
(C57BL/6N-Ssbp2tm1b(KOMP)Wtsi/Tcp) 		decreased total body fat amount J:211773
Ssh2em1(IMPC)J/Ssh2em1(IMPC)J
(C57BL/6NJ-Ssh2em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Ssttm1b(KOMP)Wtsi/Ssttm1b(KOMP)Wtsi
(C57BL/6N-Ssttm1b(KOMP)Wtsi/Rbrc) 		increased total body fat amount J:211773
St18tm1a(KOMP)Wtsi/St18tm1a(KOMP)Wtsi
(C57BL/6N-St18tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Stag1Gt(P099A04)Wrst/Stag1Gt(P099A04)Wrst
(involves: 129S2/SvPas) 		decreased brown adipose tissue amount J:184719
decreased total body fat amount J:184719
Stag3tm1e.1(KOMP)Wtsi/Stag3tm1e.1(KOMP)Wtsi
(C57BL/6N-Stag3tm1e.1(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Stard13tm1Ioln/Stard13tm1Ioln
(B6.129S7-Stard13tm1Ioln) 		decreased total body fat amount J:152475
Stat3tm1Flv/Stat3tm1Flv
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal brown adipose tissue morphology J:89242
abnormal white adipose tissue morphology J:89242
increased total body fat amount J:89242
Stat3tm1Jbha/Stat3tm1Jbha
Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv * C57BL/6) 		increased brown adipose tissue amount J:136030
increased fat cell size J:136030
increased gonadal fat pad weight J:136030
increased inguinal fat pad weight J:136030
increased percent body fat/body weight J:136030
increased retroperitoneal fat pad weight J:136030
increased total body fat amount J:136030
Stat5atm1Jni/Stat5atm1Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ)) 		abnormal fat pad morphology J:77412
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ)) 		abnormal fat pad morphology J:77412
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		increased total body fat amount J:119237
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased total body fat amount J:127051
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal fat pad morphology J:132806
increased percent body fat/body weight J:132806
increased total body fat amount J:132806
increased total fat pad weight J:132806
Stat5btm1Hwd/Stat5btm1Hwd
(involves: 129 * BALB/c) 		decreased total body fat amount J:41784
Stat5btm1Jni/Stat5btm1Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ)) 		abnormal fat pad morphology J:77412
Stat5btm1Mam/Stat5btm1Mam
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased total body fat amount J:127051
Stat5btm1Mam/Stat5btm1Mam
Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal fat pad morphology J:132806
increased percent body fat/body weight J:132806
increased total body fat amount J:132806
increased total fat pad weight J:132806
Stau2tm1a(EUCOMM)Wtsi/Stau2tm1a(EUCOMM)Wtsi
(C57BL/6N-Stau2tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal white adipose tissue morphology J:187736
decreased adipocyte glucose uptake J:187736
increased subcutaneous adipose tissue amount J:187736
Stk32ctm2b(KOMP)Wtsi/Stk32ctm2b(KOMP)Wtsi
(C57BL/6N-Stk32ctm2b(KOMP)Wtsi/J) 		decreased total body fat amount J:211773
Stmn2em1(IMPC)Kmpc/Stmn2+
(C57BL/6NTac-Stmn2em1(IMPC)Kmpc/Kmpc) 		decreased total body fat amount J:211773
Stra6tm1Nbg/Stra6tm1Nbg
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal adipocyte glucose uptake J:203449
Sufutm1b(KOMP)Wtsi/Sufu+
(C57BL/6N-Sufutm1b(KOMP)Wtsi/Ucd) 		decreased total body fat amount J:211773
Sufutm1Hui/Sufutm1Hui
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		abnormal white adipose tissue morphology J:166285
abnormal white adipose tissue physiology J:166285
abnormal white fat cell morphology J:166285
adipose tissue phenotype J:166285
decreased subcutaneous adipose tissue amount J:166285
decreased white adipose tissue amount J:166285
decreased white fat cell number J:166285
decreased white fat cell size J:166285
Sugcttm1.2Kald/Sugcttm1.2Kald
(B6.Cg-Sugcttm1.2Kald) 		abnormal fat cell morphology J:293423
white adipose tissue inflammation J:293423
Sun1tm1b(EUCOMM)Wtsi/Sun1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sun1tm1b(EUCOMM)Wtsi/Orl) 		increased total body fat amount J:211773
Supt7ltm1a(EUCOMM)Wtsi/Supt7l+
(C57BL/6N-Supt7ltm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		decreased subcutaneous adipose tissue amount J:144991
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * CD-1 * FVB/N) 		adipose tissue phenotype J:144991
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased subcutaneous adipose tissue amount J:144991
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased total body fat amount J:144991
Susd6tm1b(KOMP)Wtsi/Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay) 		decreased total body fat amount J:211773
Swt1em1(IMPC)J/Swt1em1(IMPC)J
(C57BL/6NJ-Swt1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Syce2em1(IMPC)Tcp/Syce2em1(IMPC)Tcp
(C57BL/6N-Syce2em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Syktm1b(EUCOMM)Hmgu/Syk+
(C57BL/6N-Syktm1b(EUCOMM)Hmgu/Ieg) 		increased total body fat amount J:211773
Syne2em1(IMPC)J/Syne2em1(IMPC)J
(C57BL/6N-Syne2em1(IMPC)J/J) 		decreased total body fat amount J:211773
T2dm2saA/JNshm/T2dm2saA/JNshm
(involves: SM.A-(D2Mit295-D2Mit281)) 		increased total body fat amount J:107889
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng) 		increased total fat pad weight J:100831
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
Tanidd1TALLYHO/Jng/Tanidd1TALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng) 		increased total fat pad weight J:100831
Tacr3em1(IMPC)J/Tacr3em1(IMPC)J
(C57BL/6NJ-Tacr3em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Taf5em1(IMPC)J/Taf5+
(C57BL/6NJ-Taf5em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Taf7ltm1.1Jw/Y
(B6J.Cg-Taf7ltm1.1Jw) 		abnormal brown adipose tissue morphology J:228546
abnormal brown adipose tissue thermogenesis J:228546
abnormal brown fat cell differentiation J:228546
decreased brown adipose tissue amount J:228546
decreased brown fat lipid droplet number J:228546
decreased interscapular fat pad weight J:228546
TafatTALLYHO/Jng/TafatTALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng) 		decreased white adipose tissue amount J:70227
TafatTALLYHO/Jng/TafatTALLYHO/Jng
(involves: CAST/Ei * TALLYHO/Jng) 		decreased white adipose tissue amount J:70227
Tardbptm1.1Pcw/Tardbp+
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL) 		abnormal brown fat cell morphology J:164406
abnormal white fat cell morphology J:164406
Tardbptm1.1Pcw/Tardbptm1.1Pcw
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL) 		abnormal brown fat cell morphology J:164406
abnormal white adipose tissue morphology J:164406
abnormal white fat cell morphology J:164406
decreased mesenteric fat pad weight J:164406
decreased total body fat amount J:164406
Tars3em1(IMPC)J/Tars3em1(IMPC)J
(C57BL/6NJ-Tars3em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Tatem1(IMPC)J/Tatem1(IMPC)J
(C57BL/6NJ-Tatem1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Tatdn3tm1b(EUCOMM)Wtsi/Tatdn3tm1b(EUCOMM)Wtsi
(C57BL/6N-Tatdn3tm1b(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Tbc1d1Gt(E140H06)Wrst/Tbc1d1Gt(E140H06)Wrst
(B6.129P2-Tbc1d1Gt(E140H06)Wrst) 		decreased total body fat amount J:203285
Tbc1d1Nobq1-NZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom) 		increased white adipose tissue amount J:66744
Tbc1d1Nobq1-SJL/NBom/Tbc1d1Nobq1-SJL/NBom
(B6.SJL-(D5Mit302-D5Mit307)) 		decreased total body fat amount J:143559
Tbc1d4tm1.1Arte/Tbc1d4tm1.1Arte
(involves: C57BL/6) 		increased adipocyte glucose uptake J:169477
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA) 		decreased adipocyte glucose uptake J:194026
increased adipocyte glucose uptake J:194026
Tbc1d4tm1Lex/Tbc1d4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N) 		decreased adipocyte glucose uptake J:191749
increased adipocyte glucose uptake J:191749
increased epididymal fat pad weight J:191749
increased parametrial fat pad weight J:191749
increased white fat cell size J:191749
Tbl1xr1em2H/Tbl1xr1em2H
(C57BL/6J-Tbl1xr1em2H) 		decreased body fat mass J:335355
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		abnormal adipose tissue physiology J:198124
abnormal white adipose tissue morphology J:198124
increased abdominal fat pad weight J:198124
increased inguinal fat pad weight J:198124
increased total body fat amount J:198124
increased white fat cell number J:198124
increased white fat cell size J:198124
Tceal1em1(IMPC)Tcp/Tceal1em1(IMPC)Tcp
(C57BL/6NCrl-Tceal1em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Tcf7l2em1Nobr/Tcf7l2+
(involves: CD-1) 		decreased total body fat amount J:175874
Tcf7l2em2Nobr/Tcf7l2+
(involves: CD-1) 		decreased total body fat amount J:175874
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Tcf20em1(IMPC)Wtsi/Tcf20em1(IMPC)Wtsi
(C57BL/6N-Tcf20em1(IMPC)Wtsi/Wtsi) 		increased total body fat amount J:211773
Tchptm1Inag/Tchptm1Inag
(B6.129P2-Tchptm1Inag) 		abnormal adipose tissue amount J:304307
abnormal adipose tissue development J:304307
abnormal fat cell differentiation J:304307
abnormal white adipose tissue physiology J:304307
decreased body fat mass J:304307
decreased fat cell size J:304307
Tcp11l2em1(IMPC)Bay/Tcp11l2em1(IMPC)Bay
(C57BL/6N-Tcp11l2em1(IMPC)Bay/BayMmucd) 		increased total body fat amount J:211773
Tdmq1C57BLKS/J/Tdmq1C57BLKS/J
(involves: BKS.Cg M +/+ Leprdb * DBA/2) 		increased parametrial fat pad weight J:97535
Tead1tm1b(KOMP)Wtsi/Tead1+
(C57BL/6N-Tead1tm1b(KOMP)Wtsi/Bay) 		increased total body fat amount J:211773
Telo2em1(IMPC)J/Telo2+
(C57BL/6NJ-Telo2em1(IMPC)J/J) 		increased total body fat amount J:211773
Tenm4em1(IMPC)Tcp/Tenm4em1(IMPC)Tcp
(C57BL/6NCrl-Tenm4em1(IMPC)Tcp/Tcp) 		decreased total body fat amount J:211773
Terctm1Rdp/Terctm1Rdp
(B6J.Cg-Terctm1Rdp) 		abnormal adipose tissue distribution J:213181
Terctm1Rdp/Terctm1Rdp
Wrntm1Lgu/Wrntm1Lgu
(involves: 129/Sv * BALB/c * C57BL/6 * SLJ) 		abnormal adipose tissue distribution J:213181
decreased subcutaneous adipose tissue amount J:91715
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N) 		abnormal abdominal fat pad morphology J:199372
increased abdominal adipose tissue amount J:199372
increased abdominal fat pad weight J:199372
increased percent body fat/body weight J:199372
increased subcutaneous adipose tissue amount J:199372
Tex261tm1b(EUCOMM)Wtsi/Tex261tm1b(EUCOMM)Wtsi
(C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Tfamtm1.1Ncdl/Tfamtm1.1Ncdl
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * CBA) 		decreased subcutaneous adipose tissue amount J:213840
Tfap4tm1.1(KOMP)Vlcg/Tfap4tm1.1(KOMP)Vlcg
(C57BL/6N-Tfap4tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Tfebtm1b(EUCOMM)Wtsi/Tfeb+
(C57BL/6N-Tfebtm1b(EUCOMM)Wtsi/Bay) 		increased total body fat amount J:211773
Tg(ACTA1-Il15)10941Lsq/0
(involves: C3H * C57BL/6) 		adipose tissue phenotype J:145611
Tg(ACTA1-Il15*)11650Lsq/0
(involves: C3H * C57BL/6) 		decreased abdominal adipose tissue amount J:145611
decreased fat cell size J:145611
decreased percent body fat/body weight J:145611
Tg(ACTA1-UCP3)1Clap/0
(involves: C57BL/6 * CBA) 		abnormal epididymal fat pad morphology J:142293
Tg(ACTB-tetR*)19Ywz/0
Tg(tetO-Vegfa)1Ywz/0
(involves: 129S1/Sv * 129X1/SvJ) 		browned white adipose tissue morphology J:189035
Tg(Adipoq-Apol6)#Hsul/0
(C57BL/6J-Tg(Adipoq-Apol6)#Hsul) 		increased epididymal fat pad weight J:344362
increased renal fat pad weight J:344362
increased white adipose tissue mass J:344362
increased white fat cell size J:344362
white adipose tissue inflammation J:344362
Tg(Adipoq-cre)1Evdr/0
Tg(CAG-Jmjd8)#Kaso/0
(involves: C57BL/6 * FVB/NJ) 		white adipose tissue inflammation J:319518
Tg(Adipoq-Zc3h10)#Hsul/0
(Not Specified) 		abnormal brown adipose tissue physiology J:287066
abnormal brown adipose tissue thermogenesis J:287066
abnormal brown fat cell morphology J:287066
abnormal white adipose tissue physiology J:287066
Tg(Adipoq-Zc3h10*)#Hsul/0
(Not Specified) 		abnormal brown adipose tissue thermogenesis J:287066
abnormal brown fat cell morphology J:287066
Tg(ADRB1)1Srr/0
(Swiss Webster) 		abnormal fat cell morphology J:37585
decreased white adipose tissue amount J:37585
increased brown adipose tissue amount J:37585
Tg(Alb-MYLIP*)1Pton/?
(involves: C57BL/6J) 		abnormal body fat mass J:228420
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6) 		abnormal epididymal fat pad morphology J:185313
abnormal fat pad morphology J:185313
abnormal inguinal fat pad morphology J:185313
increased body fat mass J:185313
increased subcutaneous adipose tissue amount J:249664
increased white adipose tissue amount J:249664
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL) 		abnormal brown adipose tissue morphology J:50770
abnormal brown fat cell morphology J:50770
abnormal epididymal fat pad morphology J:50770
abnormal interscapular fat pad morphology J:50770
abnormal white adipose tissue morphology J:50770
adipose tissue phenotype J:125992
decreased epididymal fat pad weight J:50770
decreased subcutaneous adipose tissue amount J:249664
decreased white adipose tissue amount J:50770, J:249664
increased brown adipose tissue amount J:50770
increased brown fat cell lipid droplet size J:50770
increased brown fat cell size J:50770
increased interscapular fat pad weight J:50770
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2) 		decreased brown adipose tissue amount J:57075
decreased white adipose tissue amount J:57075
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N) 		decreased brown adipose tissue amount J:69591
decreased white adipose tissue amount J:69591
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh) 		abnormal abdominal fat pad morphology J:65036
absent subcutaneous adipose tissue J:65036
Tg(APOC3)3707Bres/0
(involves: C57BL/6J * CBA/J) 		adipose tissue phenotype J:119638
Tg(APOE-ANGPTL4)1Akos/0
(involves: C57BL/6 * SJL) 		adipose tissue phenotype J:103363
Tg(APOE-GHRL)1Jagu/0
Tg(APOE-MBOAT4)1Jagu/0
(Not Specified) 		increased total body fat amount J:151420
Tg(Apoe-Lep)1Kry/0
(involves: FVB) 		decreased total body fat amount J:88655
Tg(AZIP/F)1Vsn/0
(involves: FVB/N) 		decreased brown adipose tissue amount J:50807
decreased white adipose tissue amount J:50807
Tg(BAC144D14)5A2Masu/0
(B6J.Cg-Tg(BAC144D14)5A2Masu) 		abnormal interscapular fat pad morphology J:232408
abnormal retroperitoneal fat pad morphology J:232408
abnormal white adipose tissue morphology J:232408
decreased inguinal fat pad weight J:232408
decreased mesenteric fat pad weight J:232408
decreased retroperitoneal fat pad weight J:232408
increased brown adipose tissue amount J:232408
increased brown fat cell number J:232408
increased interscapular fat pad weight J:232408
Tg(BAC144D14)5D3Masu/0
(B6J.Cg-Tg(BAC144D14)5D3Masu) 		abnormal beige fat cell morphology J:232408
abnormal interscapular fat pad morphology J:232408
abnormal retroperitoneal fat pad morphology J:232408
abnormal white adipose tissue morphology J:232408
decreased inguinal fat pad weight J:232408
decreased mesenteric fat pad weight J:232408
decreased retroperitoneal fat pad weight J:232408
increased brown adipose tissue amount J:232408
increased brown fat cell number J:232408
increased interscapular fat pad weight J:232408
Tg(CAG-Angptl6)8.1Yo/0
(involves: C57BL/6 * CBA) 		abnormal white adipose tissue morphology J:97552
decreased total body fat amount J:97552
decreased white adipose tissue amount J:97552
Tg(CAG-COX7A2L)#Sinos/0
(involves: C57BL/6) 		adipose tissue phenotype J:215964
Tg(CAG-Ndufab1)#Xiwa/0
(involves: C57BL/6J) 		decreased brown fat cell lipid droplet size J:293657
decreased brown fat cell size J:293657
Tg(CAG-PPARG*,-tdTomato)#Sig/0
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N * SJL) 		adipose tissue phenotype J:242422
increased body fat mass J:242422
increased brown adipose tissue mass J:242422
increased subcutaneous adipose tissue amount J:242422
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Rai1,-EGFP)463Walz/0
(involves: C57BL/6J * CBA/J) 		decreased abdominal fat pad weight J:207141
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Rai1,-EGFP)479Walz/0
(involves: C57BL/6J * CBA/J) 		decreased abdominal fat pad weight J:207141
Tg(Ckm-Cd36)1Naa/0
(involves: FVB) 		decreased total body fat amount J:57650
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J) 		abnormal adipose tissue distribution J:101818
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J) 		abnormal adipose tissue distribution J:101818
Tg(Ckm-Mstn)1Nfg/?
(involves: BALB/c * C57BL/6) 		increased epididymal fat pad weight J:123052
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA) 		decreased abdominal adipose tissue amount J:129848
decreased subcutaneous adipose tissue amount J:129848
Tg(Ckmm-Ucp1)1Boud/0
(involves: C57BL/6J * DBA/2J) 		decreased percent body fat/body weight J:80053
Tg(Ckmm-Ucp1)1Boud/Tg(Ckmm-Ucp1)1Boud
(involves: C57BL/6J * DBA/2J) 		decreased percent body fat/body weight J:80053
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		abnormal adipose tissue morphology J:95465
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove) 		decreased body fat mass J:94602
Tg(Cyp17a1-NGF)2456Oje/Tg(Cyp17a1-NGF)2456Oje
(involves: C57BL/6J * DBA/2J) 		increased total body fat amount J:218686
Tg(Fabp4-Adissp)#Yxw/0
(involves: C57BL/6J * SJL) 		abnormal fat cell morphology J:332979
abnormal inguinal fat pad morphology J:332979
abnormal white adipose tissue morphology J:332979
abnormal white adipose tissue physiology J:332979
browned white adipose tissue morphology J:332979
decreased white adipose tissue mass J:332979
decreased white fat cell size J:332979
Tg(Fabp4-Aebp1)1Hsro/?
(involves: FVB) 		abnormal fat cell morphology J:125334
increased white adipose tissue amount J:125334
Tg(Fabp4-Agt)2Mte/0
(involves: C57BL/6 * CD-1 * DBA/2 * ICR) 		abnormal fat cell morphology J:73163
increased epididymal fat pad weight J:73163
increased fat cell size J:73163
increased total body fat amount J:73163
Tg(Fabp4-Angptl2)5Yo/0
(involves: C57BL/6) 		white adipose tissue inflammation J:152387
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul) 		increased body fat mass J:344362
increased epididymal fat pad weight J:344362
increased renal fat pad weight J:344362
increased white adipose tissue mass J:344362
increased white fat cell size J:344362
white adipose tissue inflammation J:344362
Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N) 		abnormal epididymal fat pad morphology J:110277
Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J) 		decreased fat cell size J:182179
Tg(Fabp4-Fam13a)1Iked/0
(C57BL/6J-Tg(Fabp4-Fam13a)1Iked) 		abnormal white adipose tissue physiology J:258290
adipose tissue phenotype J:258290
increased white fat cell size J:258290
Tg(Fabp4-Fcor)1Jnak/0
(involves: C57BL/6 * DBA/2) 		decreased subcutaneous adipose tissue amount J:184684
decreased total body fat amount J:184684
decreased white adipose tissue amount J:184684
decreased white fat cell size J:184684
Tg(Fabp4-FOXC2)ASven/0
(involves: C57BL/6J * CBA) 		browned white adipose tissue morphology J:94144
decreased total body fat amount J:94144
decreased white adipose tissue mass J:94144
decreased white fat cell size J:94144
increased brown adipose tissue mass J:94144
increased white fat cell lipid droplet size J:94144
Tg(Fabp4-Hsd11b1)7Jesf/0
(FVB-Tg(Fabp4-Hsd11b1)7Jesf) 		abnormal adipose tissue distribution J:107046
increased fat cell size J:107046
Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J) 		abnormal fat pad morphology J:67311
abnormal gonadal fat pad morphology J:67311
abnormal interscapular fat pad morphology J:67311
abnormal white fat cell morphology J:67311
decreased brown fat lipid droplet number J:67311
decreased gonadal fat pad weight J:67311
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc) 		abnormal fat pad morphology J:84349
abnormal white fat cell size J:84349
decreased white adipose tissue amount J:84349
decreased white fat cell size J:84349
increased subcutaneous adipose tissue amount J:84349
increased white fat cell size J:84349
Tg(Fabp4-LMNA*R482Q)11ACdl/0
(FVB-Tg(Fabp4-LMNA*R482Q)11ACdl) 		abnormal epididymal fat pad morphology J:149858
abnormal fat cell morphology J:149858
decreased adipocyte glucose uptake J:149858
decreased brown adipose tissue amount J:149858
decreased epididymal fat pad weight J:149858
decreased renal fat pad weight J:149858
decreased retroperitoneal fat pad weight J:149858
decreased total body fat amount J:149858
increased brown fat cell lipid droplet size J:149858
Tg(Fabp4-LMNA*R482Q)17CCdl/0
(FVB/N-Tg(Fabp4-LMNA*R482Q)17CCdl) 		abnormal adipose tissue morphology J:149858
abnormal adipose tissue physiology J:149858
Tg(Fabp4-LMNA*R482Q)#Hjw/0
(FVB.Cg-Tg(Fabp4-LMNA*R482Q)#Hjw) 		abnormal adipose tissue morphology J:237920
abnormal fat cell morphology J:237920
abnormal parametrial fat pad morphology J:237920
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1) 		abnormal adipose tissue amount J:242981, J:230172
abnormal brown fat cell morphology J:230172
abnormal white adipose tissue morphology J:230172
abnormal white adipose tissue physiology J:230172
abnormal white fat cell morphology J:230172
increased brown adipose tissue amount J:230172
increased subcutaneous adipose tissue amount J:230172
increased white fat cell size J:230172
Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl) 		decreased epididymal fat pad weight J:208508
Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB) 		decreased white adipose tissue amount J:189510
lipodystrophy J:189510
Tg(Fabp4-TLE3)#aPton/0
(involves: C57BL/6) 		abnormal brown fat cell morphology J:198134
increased epididymal fat pad weight J:172245
Tg(Fabp4-Wdct1*)1Jmgr/?
(involves: ICR) 		abnormal white adipose tissue morphology J:129966
increased fat cell size J:129966
increased total body fat amount J:129966
Tg(Fabp4-Wdtc1)1Jmgr/?
(involves: ICR) 		abnormal fat cell morphology J:129966
decreased total body fat amount J:129966
Tg(Fabp4-Zfp516)#Hsul/0
(Not Specified) 		browned white adipose tissue morphology J:218161
Tg(GAS7)63.2Lus/0
(involves: FVB/N) 		abnormal adipose tissue amount J:148831
decreased gonadal fat pad weight J:148831
decreased mesenteric fat pad weight J:148831
decreased total fat pad weight J:148831
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron) 		increased abdominal fat pad weight J:210298
increased epididymal fat pad weight J:210298
Tg(GHRL-TAg)3-1Hiwa/0
(C57BL/6-Tg(GHRL-TAg)3-1Hiwa) 		decreased total body fat amount J:152492
Tg(IGFBP2)1Miel/0
(FVB/N-Tg(IGFBP2)1Miel) 		abnormal abdominal fat pad morphology J:121961
abnormal fat cell morphology J:121961
decreased total body fat amount J:121961
Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat) 		decreased body fat mass J:314874
Tg(K6ODCtr)55Tgo/0
(involves: C3H * C57BL/6) 		decreased subcutaneous adipose tissue amount J:29098
Tg(K6ODCtr)55Tgo/0
(C57BL/6-Tg(K6ODCtr)55Tgo/J) 		decreased subcutaneous adipose tissue amount J:62356
Tg(KRT14-PTHLH)7Wmp/0
(Not Specified) 		decreased subcutaneous adipose tissue amount J:65043
Tg(Lactb)1Lus/0
(involves: FVB) 		increased total body fat amount J:148831
Tg(Mt1-GH1)#Jjk/0
(C57BL/6J-Tg(Mt1-GH1)#Jjk) 		decreased percent body fat/body weight J:132437
Tg(Myh6-Jup)2Ajm/0
(involves: FVB/N) 		abnormal fat cell morphology J:192719
Tg(Myh6-Jup*)1Ajm/0
(involves: FVB/N) 		abnormal fat cell differentiation J:192719
abnormal fat cell morphology J:192719
Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno) 		abnormal interscapular fat pad morphology J:186193
decreased interscapular fat pad weight J:186193
decreased total body fat amount J:186193
decreased white adipose tissue amount J:186193
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		decreased epididymal fat pad weight J:76323
decreased retroperitoneal fat pad weight J:76323
decreased total body fat amount J:76323
increased brown adipose tissue amount J:76323
Tg(Myog-Ppargc1a_i4)#Brsp/0
(Not Specified) 		decreased body fat mass J:211329
decreased epididymal fat pad weight J:211329
decreased subcutaneous adipose tissue amount J:211329
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		decreased mesenteric fat pad weight J:207713
Tg(Neurog3-cre)C1Able/0
Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub/0
(involves: 129 * C57BL/6 * CD-1) 		increased abdominal fat pad weight J:158215
increased epididymal fat pad weight J:158215
increased percent body fat/body weight J:158215
Tg(Pmch-ATXN3*)3Rck/0
(involves: FVB/NJ) 		decreased percent body fat/body weight J:104264
decreased total body fat amount J:104264
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA) 		abnormal adipose tissue morphology J:182671
abnormal brown adipose tissue morphology J:182671
abnormal brown adipose tissue physiology J:182671
decreased body fat mass J:182671
decreased brown fat cell lipid droplet size J:182671
decreased epididymal fat pad weight J:182671
decreased white fat cell size J:182671
increased adipocyte glucose uptake J:182671
Tg(RP11-578M14)5Mkru/0
(involves: FVB/N) 		increased body fat mass J:256501
increased brown adipose tissue amount J:256501
increased white adipose tissue amount J:201055, J:256501
increased white fat cell size J:256501
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N) 		abnormal adipose tissue morphology J:91800
abnormal fat pad morphology J:91800
decreased white adipose tissue amount J:91800
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL) 		abnormal adipose tissue morphology J:91800
abnormal fat pad morphology J:91800
Tg(Sp7-Mir188)1Xhl/0
(C57BL/6-Tg(Sp7-Mir188)1Xhl) 		abnormal fat cell morphology J:222099
Tg(SREBP1a)7343Reh/0
(involves: C57BL/6J * SJL/J) 		abnormal fat pad morphology J:35770
decreased epididymal fat pad weight J:35770
Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh) 		lipodystrophy J:100328
Tg(tetO-Xbp1_is)#Pesch/0
Tg(Adipoq-rtTA)2Zvw/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		abnormal white adipose tissue morphology J:260830
decreased body fat mass J:260830
decreased brown adipose tissue mass J:260830
decreased fat cell size J:260830
decreased white adipose tissue mass J:260830
Tg(TNFSF11)5519Edou/0
(involves: C57BL/6J * CBA/J) 		increased bone marrow adipose tissue amount J:233240
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1) 		decreased subcutaneous adipose tissue amount J:73757
Tg(Ttr-IGF1)1Sykr/0
(FVB/N-Tg(Ttr-IGF1)1Sykr) 		decreased gonadal fat pad weight J:157350
decreased percent body fat/body weight J:157350
decreased total body fat amount J:157350
Tg(Ucp1-cre)1Evdr/0
Zc3h10tm1c(EUCOMM)Wtsi/Zc3h10tm1c(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6N * FVB) 		abnormal brown adipose tissue thermogenesis J:287066
increased body fat mass J:287066
Tg(UCP3,UCP2)1Ful/0
(Not Specified) 		abnormal epididymal fat pad morphology J:114746
decreased white adipose tissue amount J:114746
Tg(UcpDta)1Kz/?
(involves: FVB/N) 		decreased brown adipose tissue amount J:78211
increased percent body fat/body weight J:78211
Tg(Vil1-cre)997Gum/?
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J) 		increased total fat pad weight J:229155
Tg(Wap-tAg)1Gmn/?
(involves: NMRI) 		abnormal mammary fat pad morphology J:69711
Tg(ZFP90)1Eesc/0
(involves: FVB) 		abnormal adipose tissue amount J:148831
abnormal fat pad morphology J:148831
increased mesenteric fat pad weight J:148831
increased retroperitoneal fat pad weight J:148831
increased total body fat amount J:148831
increased total fat pad weight J:148831
Tgm3Btlr/Tgm3Btlr
(C57BL/6J-Tgm3Btlr) 		decreased body fat mass J:265197
Tgfatm1Unc/Tgfatm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adipose tissue distribution J:4605
Tgfb1tm1(Tgfb3)Kul/Tgfb1tm1(Tgfb3)Kul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased subcutaneous adipose tissue amount J:204892
decreased total body fat amount J:204892
decreased white fat cell size J:204892
Tgfbr2tm1Dgen/Tgfbr2+
(involves: 129P2/OlaHsd) 		abnormal fat pad morphology J:148831
increased total body fat amount J:148831
Thoc1em1(IMPC)Ccpcz/Thoc1+
(C57BL/6NCrl-Thoc1em1(IMPC)Ccpcz/Ccpcz) 		increased total body fat amount J:211773
Thratm1b(EUCOMM)Wtsi/Thra+
(C57BL/6N-Thratm1b(EUCOMM)Wtsi/Ics) 		decreased total body fat amount J:211773
Thratm1Brnt/Thra+
(involves: 129S4/SvJae * C57BL/6) 		increased epididymal fat pad weight J:85803
increased total body fat amount J:85803
Thratm2Ven/Thra+
(involves: 129P2/OlaHsd * BALB/c) 		increased total body fat amount J:72959
Thratm2Ven/Thratm2Ven
(involves: 129P2/OlaHsd * BALB/c) 		increased total body fat amount J:72959
Tial1tm1b(EUCOMM)Wtsi/Tial1+
(C57BL/6N-Tial1tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Timm50tm1b(EUCOMM)Wtsi/Timm50+
(C57BL/6N-Timm50tm1b(EUCOMM)Wtsi/Ics) 		decreased total body fat amount J:211773
Timo/Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		abnormal fat pad morphology J:127183
increased mesenteric fat pad weight J:127183
increased percent body fat/body weight J:127183
increased renal fat pad weight J:127183
increased total body fat amount J:127183
increased uterine fat pad weight J:127183
Timo/Timo+
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		increased mesenteric fat pad weight J:127183
increased percent body fat/body weight J:127183
increased total body fat amount J:127183
Tk2tm1Anka/Tk2tm1Anka
(involves: 129X1/SvJ * C57BL/6) 		abnormal brown adipose tissue morphology J:137664
absent subcutaneous adipose tissue J:137664
Tkttm1Jpi/Tkt+
(involves: 129X1/SvJ * C57BL/6J) 		decreased white adipose tissue amount J:78430
Tle3Gt(XP0165)Wtsi/Tle3Gt(XP0165)Wtsi
(involves: 129P2/OlaHsd) 		abnormal adipose tissue development J:172245
Tle3tm1.1Pton/Tle3tm1.1Pton
Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/NJ) 		abnormal brown adipose tissue morphology J:198134
abnormal brown fat cell morphology J:198134
abnormal inguinal fat pad morphology J:198134
Tle4em1(IMPC)Mbp/Tle4em1(IMPC)Mbp
(C57BL/6NCrl-Tle4em1(IMPC)Mbp/Mmucd) 		increased total body fat amount J:211773
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		abnormal body fat mass J:158035
abnormal white fat cell size J:158035
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		decreased fat cell size J:162168
decreased gonadal fat pad weight J:162168
increased adipocyte glucose uptake J:162168
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d) 		decreased epididymal fat pad weight J:126488
decreased fat cell size J:126488
decreased percent body fat/body weight J:118467
Tlr4lps-del/Tlr4lps-del
(C57BL/10ScN) 		decreased percent body fat/body weight J:118467
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
Tg(Itgax-cre,-EGFP)4097Ach/?
(involves: C57BL/6J * C57BL/6NTac) 		decreased total fat pad weight J:229155
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		abnormal adipose tissue physiology J:158055
increased epididymal fat pad weight J:158055
increased total body fat amount J:158055
Tmeff2tm1Fawa/Tmeff2tm1Fawa
(involves: 129P2/OlaHsd) 		decreased white adipose tissue amount J:187163
Tmem9bem1(IMPC)J/Tmem9bem1(IMPC)J
(C57BL/6NJ-Tmem9bem1(IMPC)J/J) 		increased total body fat amount J:211773
Tmem18tm1a(EUCOMM)Wtsi/Tmem18tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem18tm1a(EUCOMM)Wtsi) 		increased body fat mass J:244315
increased brown adipose tissue mass J:244315
increased gonadal fat pad weight J:244315
Tmem63cem1(IMPC)Rbrc/Tmem63cem1(IMPC)Rbrc
(C57BL/6NJcl-Tmem63cem1(IMPC)Rbrc/Rbrc) 		increased total body fat amount J:211773
Tmem68tm1a(EUCOMM)Wtsi/Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi) 		decreased body fat mass J:339870
Tmem72tm1b(KOMP)Wtsi/Tmem72tm1b(KOMP)Wtsi
(C57BL/6N-Tmem72tm1b(KOMP)Wtsi/Kmpc) 		decreased total body fat amount J:211773
Tmem108tm1b(EUCOMM)Wtsi/Tmem108tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmem108tm1b(EUCOMM)Wtsi/Ics) 		increased total body fat amount J:211773
Tmem129tm1.1(KOMP)Vlcg/Tmem129tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem129tm1.1(KOMP)Vlcg/J) 		increased total body fat amount J:211773
Tmem132atm1b(KOMP)Wtsi/Tmem132a+
(C57BL/6N-Tmem132atm1b(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Tmem161btm2b(EUCOMM)Hmgu/Tmem161b+
(C57BL/6N-Tmem161btm2b(EUCOMM)Hmgu/Bay) 		increased total body fat amount J:211773
Tmem163em1(IMPC)Kmpc/Tmem163em1(IMPC)Kmpc
(C57BL/6NTac-Tmem163em1(IMPC)Kmpc/Kmpc) 		increased total body fat amount J:211773
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Tmem260tm1a(KOMP)Wtsi/Tmem260tm1a(KOMP)Wtsi
(C57BL/6N-Tmem260tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Tmprss15tm1a(KOMP)Wtsi/Tmprss15tm1a(KOMP)Wtsi
(C57BL/6N-Tmprss15tm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Tmub1tm1Lex/Tmub1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased abdominal adipose tissue amount J:171883
decreased total body fat amount J:171883
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		abnormal fat pad morphology J:42579
decreased percent body fat/body weight J:42579
Tniktm3a(EUCOMM)Wtsi/Tniktm3a(EUCOMM)Wtsi
(C57BL/6N-Tniktm3a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Tnk1tm1b(EUCOMM)Hmgu/Tnk1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnk1tm1b(EUCOMM)Hmgu/J) 		decreased total body fat amount J:211773
Tnks2tm1.1Yjc/Tnks2tm1.1Yjc
(involves: 129S1/Sv) 		decreased adipocyte glucose uptake J:137985
Tnksem1(IMPC)Hmgu/Tnksem1(IMPC)Hmgu
(C57BL/6N-Tnksem1(IMPC)Hmgu/Ieg) 		decreased total body fat amount J:211773
TnksGt(RRC239)Byg/TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased epididymal fat pad weight J:154388
decreased renal fat pad weight J:154388
Tnntm1b(KOMP)Wtsi/Tnntm1b(KOMP)Wtsi
(B6N(Cg)-Tnntm1b(KOMP)Wtsi) 		abnormal gonadal fat pad morphology J:302206
Tnni2tm1.1(KOMP)Vlcg/Tnni2+
(C57BL/6N-Tnni2tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Tns2nph/Tns2nph
(involves: ICR) 		decreased abdominal adipose tissue amount J:24698
Tom1l2Gt(XG909)Byg/Tom1l2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased total body fat amount J:133892
Tox2em1(IMPC)H/Tox2em1(IMPC)H
(C57BL/6NTac-Tox2em1(IMPC)H/H) 		increased total body fat amount J:211773
Tpgs1Gt(ROSA22)Sor/Tpgs1Gt(ROSA22)Sor
(involves: 129S/SvEv * C57BL/6) 		decreased total body fat amount J:79292
Tph1tm2Lex/Tph1tm2Lex
Tph2tm1Lex/Tph2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased percent body fat/body weight J:144582
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)) 		decreased body fat mass J:44360
Trafd1tm1a(EUCOMM)Wtsi/Trafd1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Trafd1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:165965
Traj18em1Hwata/Traj18em1Hwata
(C57BL/6-Traj18em1Hwata) 		abnormal fat pad morphology J:256533
decreased fat cell size J:256533
Tram1em1(IMPC)J/Tram1em1(IMPC)J
(C57BL/6NJ-Tram1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		increased body fat mass J:294716
Trappc10tm1b(KOMP)Wtsi/Trappc10tm1b(KOMP)Wtsi
(C57BL/6N-Trappc10tm1b(KOMP)Wtsi/Wtsi) 		increased total body fat amount J:211773
Trarg1tm1a(KOMP)Wtsi/Trarg1tm1a(KOMP)Wtsi
(C57BL/6N-Trarg1tm1a(KOMP)Wtsi) 		decreased adipocyte glucose uptake J:234039
Trfem1(IMPC)J/Trf+
(C57BL/6NJ-Trfem1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Trib1tm1Aki/Trib1tm1Aki
(involves: 129P2/OlaHsd) 		abnormal epididymal fat pad morphology J:196449
decreased white fat cell size J:196449
lipodystrophy J:196449
Trim29tm1b(EUCOMM)Wtsi/Trim29tm1b(EUCOMM)Wtsi
(C57BL/6N-Trim29tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Trim35em1(IMPC)J/Trim35em1(IMPC)J
(C57BL/6NJ-Trim35em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Trim55tm1Slbt/Trim55tm1Slbt
Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6) 		decreased total body fat amount J:130921
Trim66tm1a(EUCOMM)Wtsi/Trim66tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim66tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Trip10tm1Sejc/Trip10tm1Sejc
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		increased adipocyte glucose uptake J:159952
Trip13tm1.1(KOMP)Vlcg/Trip13tm1.1(KOMP)Vlcg
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd) 		increased total body fat amount J:211773
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6) 		adipose tissue inflammation J:173271
Trp53tm1Ldo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased subcutaneous adipose tissue amount J:73757
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6) 		abnormal epididymal fat pad morphology J:233434
abnormal renal fat pad morphology J:233434
increased body fat mass J:233434
Trpa1em1(IMPC)J/Trpa1em1(IMPC)J
(C57BL/6NJ-Trpa1em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ) 		decreased abdominal fat pad weight J:137026
decreased fat cell size J:137026
decreased subcutaneous adipose tissue amount J:137026
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ) 		abnormal adipose tissue physiology J:223992
decreased percent body fat/body weight J:223992
TsnGt(OST63223)Lex/TsnGt(OST63223)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased abdominal fat pad weight J:85466
increased percent body fat/body weight J:85466, J:185494
Tspan9em1(IMPC)J/Tspan9em1(IMPC)J
(C57BL/6NJ-Tspan9em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Tspan13em1(IMPC)Kmpc/Tspan13em1(IMPC)Kmpc
(C57BL/6NTac-Tspan13em1(IMPC)Kmpc/Kmpc) 		increased total body fat amount J:211773
Tspoap1em1(IMPC)H/Tspoap1em1(IMPC)H
(C57BL/6N-Tspoap1em1(IMPC)H/H) 		decreased total body fat amount J:211773
Ttc7em1(IMPC)J/Ttc7+
(C57BL/6NJ-Ttc7em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Tubtub/Tubtub
(C57BL/6J-Tubtub) 		increased total body fat amount J:13772
Tulp3tm1b(EUCOMM)Hmgu/Tulp3+
(C57BL/6N-Tulp3tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Tusc1em1(IMPC)J/Tusc1em1(IMPC)J
(C57BL/6NJ-Tusc1em1(IMPC)J/J) 		increased total body fat amount J:211773
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		adipose tissue necrosis J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		adipose tissue necrosis J:119985
Twist1em1(IMPC)Rbrc/Twist1+
(C57BL/6NJcl-Twist1em1(IMPC)Rbrc/Rbrc) 		decreased total body fat amount J:211773
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ) 		abnormal brown fat cell morphology J:81485
abnormal interscapular fat pad morphology J:81485
absent subcutaneous adipose tissue J:81485
decreased total body fat amount J:81485
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129X1/SvJ * C57BL/6) 		decreased subcutaneous adipose tissue amount J:169191
Txniptm1b(EUCOMM)Hmgu/Txniptm1b(EUCOMM)Hmgu
(C57BL/6N-Txniptm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Tyk2tm1Shmd/Tyk2tm1Shmd
(either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		abnormal brown adipose tissue morphology J:195099
abnormal fat cell differentiation J:195099
Ubbtm1Rrk/Ubbtm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased total body fat amount J:132767
Ube2j1tm1.1(NCOM)Mfgc/Ube2j1tm1.1(NCOM)Mfgc
(C57BL/6N-Ube2j1tm1.1(NCOM)Mfgc/Rbrc) 		increased total body fat amount J:211773
Ube2j2em1(IMPC)Rbrc/Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc) 		increased total body fat amount J:211773
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6N-Ube3ctm1b(EUCOMM)Hmgu/Rbrc) 		increased total body fat amount J:211773
Ube4aem1(IMPC)Tcp/Ube4aem1(IMPC)Tcp
(C57BL/6N-Ube4aem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Ubr1tm1Avar/Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J)) 		decreased total body fat amount J:72859
Ucp1tm1Kz/Ucp1tm1Kz
(involves: 129S2/SvPas) 		increased brown adipose tissue amount J:40053
Ucp1tm1Kz/Ucp1tm1Kz
(129S1.Cg-Ucptm1Kz) 		increased brown adipose tissue amount J:69573
Ucp1tm1Kz/Ucp1tm1Kz
(B6.Cg-Ucptm1Kz) 		decreased white adipose tissue amount J:81820
increased brown adipose tissue amount J:81820
Ucp3tm1Rei/Ucp3tm1Rei
(involves: 129S6/SvEvTac) 		abnormal epididymal fat pad morphology J:142293
Ufl1tm1a(EUCOMM)Wtsi/Ufl1+
(C57BL/6N-Ufl1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Uhrf2tm1b(EUCOMM)Wtsi/Uhrf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Uhrf2tm1b(EUCOMM)Wtsi/Tcp) 		increased total body fat amount J:211773
UmodUrehd1/Umod+
(C3HeB/FeJ-UmodUrehd1) 		decreased total body fat amount J:121470
UmodUrehd1/Umod+
(involves: C3HeB/FeJ) 		decreased total body fat amount J:201084
Umodurehr4/Umod+
(C3HeB/FeJ-Umodurehr4) 		decreased percent body fat/body weight J:153895
decreased total body fat amount J:153895
Umodurehr4/Umodurehr4
(C3HeB/FeJ-Umodurehr4) 		decreased percent body fat/body weight J:153895
decreased total body fat amount J:153895
Unc5crcmTg(Tert)5Hwl/Unc5crcmTg(Tert)5Hwl
(involves: FVB/N) 		abnormal epididymal fat pad morphology J:85446
abnormal fat pad morphology J:85446
Unc79Lwt/Unc79+
(B6.D2-Unc79Lwt) 		decreased total body fat amount J:163308
Upb1tm1a(EUCOMM)Wtsi/Upb1tm1a(EUCOMM)Wtsi
(C57BL/6N-Upb1tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Ush1ctm1a(KOMP)Wtsi/Ush1ctm1a(KOMP)Wtsi
(C57BL/6N-Ush1ctm1a(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Usp13tm1b(EUCOMM)Hmgu/Usp13tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp13tm1b(EUCOMM)Hmgu/Wtsi) 		increased total body fat amount J:211773
Usp15tm1b(EUCOMM)Wtsi/Usp15tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp15tm1b(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Usp20em1Cya/Usp20em1Cya
(Not Specified) 		decreased body fat mass J:299971
Usp20em1Gpt/Usp20em1Gpt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA) 		decreased body fat mass J:299971
decreased fat cell size J:299971
decreased white adipose tissue mass J:299971
Usp31em1(IMPC)H/Usp31em1(IMPC)H
(C57BL/6NTac-Usp31em1(IMPC)H/H) 		decreased total body fat amount J:211773
Usp33tm1a(EUCOMM)Wtsi/Usp33tm1a(EUCOMM)Wtsi
(C57BL/6N-Usp33tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Usp38tm1b(EUCOMM)Hmgu/Usp38tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp38tm1b(EUCOMM)Hmgu/H) 		increased total body fat amount J:211773
Vcpip1em1Zlou/Vcpip1em1Zlou
(C57BL/6NHsd-Vcpip1em1Zlou) 		abnormal inguinal fat pad morphology J:297179
Vegfbem1Ywz/Vegfbem1Ywz
(involves: C57BL/6 * DBA) 		increased white adipose tissue amount J:255656
whitened brown adipose tissue morphology J:255656
Vegfdtm1Hrl/Y
(involves: 129S/SvEv * Swiss) 		adipose tissue phenotype J:143070
Vgftm1Srjs/Vgftm1Srjs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal epididymal fat pad morphology J:56499
decreased total body fat amount J:56499
decreased white adipose tissue amount J:56499
Vgftm1Srjs/Vgftm1Srjs
(B6.129-Vgftm1Srjs) 		decreased total body fat amount J:143370
Vgftm1Vlcg/Vgftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac) 		decreased total body fat amount J:143370
Vil1em1(IMPC)Wtsi/Vil1em1(IMPC)Wtsi
(C57BL/6N-Vil1em1(IMPC)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Vipr2tm1Hmh/Vipr2tm1Hmh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased total body fat amount J:106803
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased epididymal fat pad weight J:28591
Vps13bem1(IMPC)Tcp/Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Vps25tm1.1(KOMP)Vlcg/Vps25+
(C57BL/6N-Vps25tm1.1(KOMP)Vlcg/Tcp) 		increased total body fat amount J:211773
Vsig4tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J) 		decreased total body fat amount J:211773
Vsig4tm1b(EUCOMM)Hmgu/Vsig4tm1b(EUCOMM)Hmgu
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J) 		decreased total body fat amount J:211773
Wars2mpc151H/Wars2mpc151H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased body fat mass J:234901
Wdr11Gt(Ayu21-KBW205)Imeg/Wdr11+
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg) 		increased percent body fat/body weight J:257035
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased epididymal fat pad weight J:225111
increased white fat cell size J:225111
Wdr13tm1Kuma/Wdr13tm1Kuma
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased gonadal fat pad weight J:225111
increased white fat cell size J:225111
Wdtc1Gt(RRF015)Byg/Wdtc1+
(involves: 129P2/OlaHsd * ICR) 		increased fat cell size J:129966
Wg2bCAST/EiJ/Wg2bCAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased total fat pad weight J:125711
Wg2cCAST/EiJ/Wg2cCAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		increased gonadal fat pad weight J:125711
increased retroperitoneal fat pad weight J:125711
increased total fat pad weight J:125711
Wg2dC57BL/6J/Wg2dCAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased total fat pad weight J:125711
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs) 		decreased total body fat amount J:5538
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adipose tissue physiology J:202499
Wnt10atm1.1(KOMP)Vlcg/Wnt10atm1.1(KOMP)Vlcg
(C57BL/6N-Wnt10atm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Wrntm1Led/Wrntm1Led
(B6.129S6(BKSW)-Wrntm1Led) 		increased abdominal adipose tissue amount J:106446
increased inguinal fat pad weight J:106446
increased retroperitoneal fat pad weight J:106446
Wwtr1tm1Benj/Wwtr1tm1Benj
(129S6/SvEvTac-Wwtr1tm1Benj) 		decreased fat cell size J:125326
Wwtr1tm1Benj/Wwtr1tm1Benj
(129S-Wwtr1tm1Benj/J) 		decreased fat cell size J:156586
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Adipoq-rtTA)2Zvw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * C57BL/6N) 		increased body fat mass J:260830
Xdhtm1Fink/Xdhtm1Fink
(involves: 129X1/SvJ * C57BL/6J) 		decreased abdominal adipose tissue amount J:166326
Xdhtm1Mrc/Xdh+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased total body fat amount J:80993
Xxylt1tm1a(EUCOMM)Hmgu/Xxylt1tm1a(EUCOMM)Hmgu
(C57BL/6N-Xxylt1tm1a(EUCOMM)Hmgu/Wtsi) 		increased total body fat amount J:211773
Ydjctm1(KOMP)Wtsi/Ydjctm1(KOMP)Wtsi
(C57BL/6N-Ydjctm1(KOMP)Wtsi/Wtsi) 		decreased total body fat amount J:211773
Ylpm1tm1b(KOMP)Wtsi/Ylpm1+
(C57BL/6N-Ylpm1tm1b(KOMP)Wtsi/J) 		increased total body fat amount J:211773
Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Ypel4tm1a(EUCOMM)Wtsi/Wtsi) 		increased total body fat amount J:211773
Ythdc2em1(IMPC)Bay/Ythdc2em1(IMPC)Bay
(C57BL/6N-Ythdc2em1(IMPC)Bay/Bay) 		increased total body fat amount J:211773
Zbtb16em1(IMPC)Mbp/Zbtb16em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb16em1(IMPC)Mbp/MbpMmucd) 		decreased total body fat amount J:211773
Zbtb22em1Yga/Zbtb22em1Yga
(Not Specified) 		abnormal brown adipose tissue morphology J:344976
decreased body fat mass J:344976
decreased white fat cell lipid droplet size J:344976
decreased white fat cell size J:344976
Zbtb48em1(IMPC)Mbp/Zbtb48em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb48em1(IMPC)Mbp/Mmucd) 		increased total body fat amount J:211773
Zdhhc4em1Smoc/Zdhhc4em1Smoc
(C57BL/6-Zdhhc4em1Smoc) 		adipose tissue phenotype J:270120
Zdhhc5tm1.1Smoc/Zdhhc5tm1.1Smoc
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/NJ) 		adipose tissue phenotype J:270120
Zdhhc13skc4/Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6) 		decreased brown adipose tissue amount J:161519
decreased white adipose tissue amount J:161519
Zdhhc19em1(IMPC)J/Zdhhc19em1(IMPC)J
(C57BL/6NJ-Zdhhc19em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Zeb1tm1.1Ajg/Zeb1tm2.1Ajg
(C57BL/6-Zeb1tm1.1Ajg/Zeb1tm2.1Ajg) 		increased percent body fat/body weight J:177274
increased total body fat amount J:177274
Zeb1Tw/Zeb1+
(STOCK PCS) 		abnormal abdominal fat pad morphology J:274
abnormal inguinal fat pad morphology J:274
increased total body fat amount J:274
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw) 		increased percent body fat/body weight J:177274
Zfand5Gt(OST223460)Lex/Zfand5Gt(OST223460)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased total body fat amount J:105931
Zfp30em1Snpk/Zfp30em1Snpk
(C57BL/6J-Zfp30em1Snpk/Mmnc) 		adipose tissue phenotype J:300801
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified) 		absent subcutaneous adipose tissue J:33986
Zfp52em1(IMPV)J/Zfp52em1(IMPV)J
(C57BL/6NJ-Zfp52em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Zfp92em1(IMPC)J/Y
(C57BL/6NJ-Zfp92em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Zfp202em1(IMPC)J/Zfp202em1(IMPC)J
(C57BL/6NJ-Zfp202em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Zfp217em1Sjia/Zfp217+
(involves: C57BL/6J) 		abnormal adipose tissue development J:307358
decreased fat cell size J:307358
decreased percent body fat/body weight J:307358
decreased total fat pad weight J:307358
Zfp251em1Hgseo/Zfp251em1Hgseo
(C57BL/6J-Zfp251em1Hgseo) 		increased fat cell size J:334395
Zfp462em1(IMPC)Tcp/Zfp462+
(C57BL/6N-Zfp462em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Zfp467tm1.1(KOMP)Vlcg/Zfp467tm1.1(KOMP)Vlcg
(B6(Cg)-Zfp467tm1.1(KOMP)Vlcg) 		abnormal adipose tissue development J:302865
decreased bone marrow adipose tissue amount J:302865
decreased fat cell size J:302865
decreased inguinal fat pad weight J:302865
decreased total body fat amount J:302865
Zfp469em1Chms/Zfp469em1Chms
(C57BL/6J-Zfp469em1Chms) 		decreased subcutaneous adipose tissue amount J:311083
Zfp516Gt(A044B05)Wrst/Zfp516Gt(A044B05)Wrst
(involves: 129S2/SvPas * C57BL/6J) 		abnormal brown fat cell differentiation J:218161
abnormal brown fat cell morphology J:218161
decreased white fat cell size J:218161
Zfp593em1(IMPC)J/Zfp593em1(IMPC)J
(C57BL/6NJ-Zfp593em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Zfp629em1(IMPC)Tcp/Zfp629em1(IMPC)Tcp
(C57BL/6N-Zfp629em1(IMPC)Tcp/Tcp) 		increased total body fat amount J:211773
Zfp746tm1b(EUCOMM)Hmgu/Zfp746tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp746tm1b(EUCOMM)Hmgu/Kmpc) 		increased total body fat amount J:211773
Zg16tm1Lex/Zg16tm1Lex
(B6.129S-Zg16tm1Lex) 		increased abdominal fat pad weight J:239095
Zhx3tm1.1(KOMP)Vlcg/Zhx3tm1.1(KOMP)Vlcg
(C57BL/6N-Zhx3tm1.1(KOMP)Vlcg/Ucd) 		decreased total body fat amount J:211773
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6) 		absent subcutaneous adipose tissue J:76209
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/OlaHsd) 		decreased subcutaneous adipose tissue amount J:164373
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6) 		decreased subcutaneous adipose tissue amount J:79501
Zmym2em1(IMPC)J/Zmym2+
(C57BL/6NJ-Zmym2em1(IMPC)J/Mmjax) 		increased total body fat amount J:211773
Zmynd8tm1a(EUCOMM)Wtsi/Zmynd8+
(B6JTyr;B6N-Zmynd8tm1a(EUCOMM)Wtsi/Wtsi) 		decreased total body fat amount J:175295
Znfx1em1(IMPC)J/Znfx1em1(IMPC)J
(C57BL/6NJ-Znfx1em1(IMPC)J/Mmjax) 		decreased total body fat amount J:211773
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory